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Background 
Chronic Obstructive Pulmonary Disease, i.e. COPD, is characterized by a progressive airflow 
limitation, not fully reversible, due to an abnormal inflammatory response of the lungs (B.R. Celli, 
MacNee, et al. 2004; GOLD 2013). Exercise intolerance, symptoms such as dyspnea and several 
extra-pulmonary effects, for example skeletal muscle wasting, may contribute to increase patients 
disabilities, affecting their quality of life and reducing the maintenance of an active lifestyle (Kim et 
al. 2008; Caress et al. 2010; Glaab et al. 2010; Huertas & Palange 2011; Vorrink et al. 2011). 
Despite lung function parameters don’t improve after pulmonary rehabilitation, exercise training is 
considered the most effective non-pharmacological intervention to improve COPD patients health 
and exercise capacity (B.R. Celli, MacNee, et al. 2004; Nici et al. 2006; D. E. O’Donnell et al. 2008; 
Fromer & C. B. Cooper 2008; GOLD 2013). Unfortunately, there are few available health-care 
structured programs of physical activity (Valero et al. 2009; Dourado et al. 2009) and a 
considerable proportion of eligible patients decline participation or drop out (Faulkner et al. 2010). 
Reasons for decline and drop-out from pulmonary rehabilitation and exercise training programs 
have seldom been investigated systematically (Fischer et al. 2007).  
Moreover, a considerable debate continues with regards to what kind of model of physical activity 
and exercise training intervention is more effective to improve COPD patients health related 
parameters (W.D-C Man et al. 2009a), to increase their quality of life (Monninkhof et al. 2003), their 
share of physical activity (Hirvensalo et al. 2003; Sørensen et al. 2008) and to maintain an active 
lifestyle over the time (Leidy 2008; Leinonen et al. 2007).  
Finally, evidences support notions that daily physical activity, health related quality of life, muscle 
strength and performance are likely intimately interlinked. Although, muscle wasting is common in 
COPD patients across all disease stages (Seymour et al. 2010), leading to a low skeletal muscle 
strength of lower limb (Kim et al. 2008; Donaldson et al. 2012), surprisingly it has been observed 
that eccentric contraction results greater compared to healthy control subjects (Mathur et al. 2007). 
The majority of research about COPD leg muscle function has used isometric or concentric 
quadriceps torque (Butcher et al. 2012), but there is lack of knowledge about the association 
between eccentric muscle strength and fast-velocity muscle contractions in COPD patients (Mathur 
et al. 2007; Butcher et al. 2012). 
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Purpose 
The aims of this research are to:  
 outline motivation and barriers which reduced COPD patients recruitment in a exercise training 
program and hindered an active lifestyle acquisition, in order to determine the recruitment 
feasibility; 
 over the time access modifications in several COPD health related parameters provided by two 
different and easily applied-field models of adapted fitness activity for COPD patients in order 
to evaluate their effects in the long-term maintenance of an active lifestyle;  
 investigate COPD patients strength performances as a function of contraction modalities and 
velocities to access lower limb muscle functionality comparing with healthy control group. 
 
Design 
The fist study is a qualitative research, designed as a single-centre, multi-practice, randomized, 
parallel-group clinical trial, in which recruitment steps were recorded in order to assess patients’ 
motivation of decline or drop out.  
The second study is a descriptive research, designed as a longitudinal randomized controlled trial, 
in which baseline (T1), 3 months (T2), 6 months (T3) and follow up (T4) evaluations were 
performed to verify changes in anthropometry, functional health-related, lifestyle and quality of life 
parameters. 
The third study is a case/control research, designed as a cross over and observational trial, in 
which architectural muscle measurements, concentric and eccentric quadriceps contractions at two 
different velocities, lifestyle and health-related parameters of both COPD patients and healthy 
control subjects were recorded to highlight differences of muscle functionality. 
Ethical approval by Department of Neurological, Neuropsychological, Morphological and Movement 
Sciences, University of Verona, Medical Hospital Management approval of ULSS20, and informed 
consent by patients and subjects evaluated were obtained. 
 
 
Subjects 
The first study concerned the several steps of recruitment patients, starting by an initial number of 
269 COPD males, established from the Respiratory Division of ULSS 20. Subsequently, it was 
recorded the motivations leading to participate at an exercise and physical activity program by 132 
eligible patients and, finally, it were analyzed magnitude and characteristics of intrinsic motivation 
to practice physical activity of 38 recruited COPD patients.  
The second study involved 38 COPD males patients for 6-months of exercise training and 3-
months of follow up. Patients were aged 65±5 years, affected by mild to severe COPD and didn’t 
show any evidences of clinical instability, instable cardiac diseases, malignances and bone 
fractures. Participants were randomized for both disease stage, intrinsic motivations and share of 
practiced physical activity, and assigned to one of the three evaluation groups: Fitness Center 
based group (FC=13), Educational PA group (EDU=12) and Control group (CG=13).  
The third study analyzed 60 males subjects, 35 COPD patients with mild to severe disease and 25 
Healthy Control. COPD patients were aged 67.21±4.7 years, affected by mild to severe COPD 
(FEV1=64.76±20.08% of predicted; FEV1/FVC= 57.35±13.56% of predicted) and didn’t show any 
evidences of clinical instability, instable cardiac diseases, malignances and bone fractures. Healthy 
control subject were aged 65.15±5.69 years and did not show pulmonary limitations (FEV1= 
115.06±17.43% of predicted; FEV1/FVC=101.87±6.62% of predicted) and evidences of clinical 
instability, cardiovascular and metabolic diseases, malignances and bone fractures.  
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Measures 
The first qualitative study was based on administration of a semi-structured interview and the EMI-
2 structured questionnaire (Markland & Hardy, 1997).  
Over the time, in the second descriptive research, several evaluations were performed. Body mass 
and bone density compositions were assessed by DXA scan. Functional health-related 
parameters, such as 6 minutes walking test, one-repetition maximum of leg press, leg extension, 
bicep curl and chest press, back scratch test, sit & reach test and one leg stance test, were 
recorded. Lifestyle was investigated with International Physical Activity questionnaire, i.e. IPAQ-
short form, and SenseWear PRO-2 acquisitions. Finally, quality of life was collected using Maugeri 
Respiratory Failure questionnaire, i.e. MRF-26. 
The third study was focused on assessing muscle architectural measurements, i.e. fascicle length, 
thickness and pennation angle of vastus lateralis (Acuson P50, Siemens, Germany), and both 
concentric and eccentric quadriceps performances at 30deg/s and 210deg/s at isokinetic 
dynamometry (Cybex Norm, USA). Also measurements of functional health-related parameters 
and lifestyle were recorded.   
 
Results 
The major cause of not-participation was related to mismatched inclusion criteria (65.53%). No-
interest in exercise training (8.94%), lack of available time (6.81%) and inability to access at the 
physical activity structures (1.7%) were the most commonly cited reasons to decline participation. 
Recruitment of this study showed higher adherence (25.7%), confirmed by the lower number of 
drop out after 6 months of program (10.52%). Low total scores of intrinsic motivation to practice 
physical activity were recorded in COPD patients (mean 81.69pt ±48.08; 44.27% of maximum total 
score) although they seems to be motivated by quality of life-related items (mean improving health 
= 39.69pt ±12.73, 59.09% of maximum item score; mean management of body weight = 13.49pt 
±6.65,  58% of maximum item score; mean decreasing stress = 17.06pt ±7.24, 58.52% of 
maximum item score). Significant improvements in total score motivation were observed after 3 
months (+43.99%, p<0.05) and after 6 months of exercise training (+47.42%, p<0.05) by the FC 
group. After three months, FC subjects showed significant increases in both Socio/Emotional 
aspects (p<0.01), Weight management (p<0.05) and Enjoyment items (p<0.01). At the end of the 6 
months, significant improvement in FC groups were observed in Socio/Emotional aspects (p<0.01) 
and in Enjoyment items (p<0.05).  
 
In the second study, 4 patients dropped out during the 6 months trial and 3 in the follow up period. 
No accident occurred. Between T1-T2, FC group shows significant improvement in %BMC (0.112 
±0.029, p<0.01), Biceps curl 1RM (1.9kg ±0.6, p<0.05), Chest press 1RM (8.1kg ±1.7, p<0.001) 
and  Balance test (48.5sec ±14.2, p<0.05). EDU group shows significant modification in FAT (-
736.4g ±240.0, p<0.05), BMI (-0.332 ±0.106, p<0.05), Leg Extension 1RM (7.2kg ±2.4, p<0.05), 
Chest Press 1RM (6.1kg±1.7, p<0.05) and Back Scratch (2.7cm ±0.7, p<0.01). The CG group 
shows significant differences in BMI (-0.588 ±0.157, p<0.01),  FAT (-1086.4g ±365, p<0.05), and 
TBM (-1849.8g ±494.1 p<0.01). Between T1-T3, the FC shows significant improvement in %BMC 
(0.071 ±0.024 p<0.05), Chest Press 1RM (9.8kg ±2.4, p<0.01), Balance (57.0sec±13.3, p<0.01), 
IPAQ moderate activity (1024 ±272, p<0.01), IPAQ sedentary hours (-3.3 ±0.7, p<0.01) and MRF-
26 (-2.3 ±0.7, p<0.05). EDU group shows significant modification in 6MWT Borg score (-1.37 ±0.41 
p<0.05), IPAQ walking activity (618 ±208, p<0.05), IPAQ sedentary hours (-3.6 ±0.7, p=0.000)  
and MRF-26 (-2.1 ±0.7, p<0.05). CG group did not shows significant differences. At follow up, FC 
shows significant changes in %BMC (-0.069 ±0.020 p<0.05), 6MWD (-48.2 ±14.8, p<0.05), Leg 
Extension 1RM (-9.3 ±2.8, p<0.05), Chest Press 1RM (-11.6 ±2.1, p=0.000), Sit & Reach (-3.8 
±0.9, p<0.01), Balance (-21.0 ±7 p<0.05). 
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EDU group shows significant modification in 6MWT Borg score (-1.36 ±0.41 p<0.05), Leg Press 
1RM (-32.6 ±9.1, p<0.05), Leg Extension 1RM (-10+5 ±1.9, p<0.001), Chest Press 1RM (-14.3 
±1.3, p=0.000), Back Scratch (-4.3 ±1.3, p<0.05), IPAQ  
sedentary hours (-3.5 ±0.9, p<0.01) and MRF-26 (-2.9 ±0.8, p<0.05). CG group shows significant 
difference in Chest Press 1RM (-10.9 ±2.6, p<0.01). No significant modification were observed in 
SenseWear PRO-2 administration. 
 
In the third study, healthy control subjects were significantly different in lung function parameters, 
i.e. FEV1 (p<0.001) and FEV1/FVC (p<0.001), and in exercise capacity, such as 6MWT 
performances (p<0.001) and 1RM Leg Press (p<0.05) than COPD patients. Of all contractions 
performed, only concentric 30deg/s peak torque was significantly higher in healthy control subjects 
compared to COPD patients (p<0.05). No differences in muscle architecture, fast concentric and/or 
eccentric peak torque were observed between groups. However, significant differences were found 
between groups in eccentric/concentric peak torque ratio (30 deg/sec p<0.001; 210 deg/sec 
p<0.01). Finally, significant correlations were found between FEV1 and 6MWT (0.719 p<0.001), 
1RM Leg Press (0.449 p<0.001), peak torque contraction at 30 deg/sec (0.427 p<0.01; 0.280 
p<0.05), at 210 deg/sec (0.285 p<0.05; 0.276 p<0.05) and eccentric/concentric peak torque ratio at 
both velocities (-0.562 p<0.001; -0.292 p<0.05). Same results were observed between FEV1/FVC 
and parameters assessed. 
 
Conclusion 
 
Recruitment of COPD patients becomes very challenging especially if exercise training and 
physical activity programs are complex or have restrictive entry criteria (Bell-Syer, 2000). Indeed, 
cause of not-participation into our program was related to mismatched inclusion criteria. 
Considered the impossibility to modify inclusion/exclusion criteria, the higher adherence (25.7%) 
and the lower number of drop out recorded by our study (10.52%) compared to literature 
(recruitment 25.7% vs. 6.5% Faulkner’s study,;  drop out 10.52% vs. 29.26% Pitta’s study, 2008; 
27.92% Steel’s study, 2008; 25% Woo’s study, 2009; 46.87%  Ringbaek’s study, 2010) suggest 
that our great effort practice of recruitment, managed by only one person and characterized by 
persistence and flexibility strategies towards patients, seems to be more effective to establish a 
relationship of confidence between patients and the exercise specialist. Although patients provided 
low total scores of intrinsic motivation to practice physical activity, significant improvements in 
health-related and pleasure motivation items were observed after participation into an exercise 
training. These findings suggest that an high, structured and constantly supervision of an exercise 
specialist could be useful to increase participation at exercise training, improve motivation to 
practice physical activity and decrease risk of poor exercise adherence, which is the most 
important reason for declining effect of pulmonary rehabilitation (Ringbaek et al. 2010). Moreover, 
considered that it’s well-known the low ratio of COPD patients with a true knowledge about 
characteristics of physical activity for pulmonary rehabilitation (Karapolat et al. 2012) and that a 
lack of perceived benefits, a low influence of specialist, a program timing and a disruption to usual 
routine may reduce COPD patients interest and motivation to take part in a pulmonary 
rehabilitation program (Keating et al. 2011; Fischer et al. 2007), it should be improve the level of 
liaison between specialist physicians and other healthcare professionals engaged in pulmonary  
management, in order to increase COPD patients perceptions of illness, to enhance the chances of 
treatment disease modalities and to provide more realistic information about benefits on heath 
related quality of life available by practice of physical activity and maintenance of an active lifestyle. 
 
 
 
9 
 
 
 
According to expert panel position stand (Glaab et al. 2010), the second study confirms the need of 
a multifaceted approach in PR programs. Our study demonstrates that also an easily applied-field 
models of COPD specific APA training could be efficient in order to improve some of these HRQL. 
The improvements in bone mass content, strength of trunk muscles and patients’ self-perceived 
disability seem to be better provide by the “well rounded” APA program. Moreover, our study 
shows that APA exercise specialist support is necessary to provide and maintain long-term 
significant health’s gains. Finally, our trial highlights that improvement in functional exercise 
capacity does not automatically turn into a more active lifestyle. According to Conn (2008), furthers 
studies are aimed to identify feasible, acceptable and effective APA intervention, which transfer 
achievements provide reachable changes in lifestyle, both at short- and long-term.    
 
The third study, i.e. the case/control research about differences of lower muscle functionality, 
highlighted that COPD patients are characterized by lower health related parameters and 
performed lower concentric contraction compared to healthy controls subjects. Interestingly, COPD 
preserved eccentric contractions and fast concentric torque. Considered that eccentric contraction 
seems to involve fast twitch motor units (Duchateau & Enoka 2008) and COPD hypoxia leads fiber 
shift towards IIx fibers (H.R. Gosker, Van Mameren, et al. 2002), COPD males seem to develop a 
favorable profile to minimize the strength loss likely due to neural-muscular modification. Moreover, 
as observed in our study, the favorable profile of COPD patients in preservation of eccentric 
contraction seems to confirm the notion about the great contribution of eccentric strength in 
functional performance of patients with COPD (Butcher et al. 2012). Finally, considered the 
effectiveness of eccentric training to produce muscle hypertrophy, strength gains and neural 
adaptation without stressing cardiopulmonary system (Roig et al. 2008) further investigations seem 
to be necessary in order to verify the usefulness of eccentric training as a modalities to provide 
greater strength improvements, to reduce muscle wasting and to enhance quality of life of COPD 
patients.  
   
 
 
Key words: COPD; adults and elderly people; exercise training; physical activity; active lifestyle, 
recruitment; adherence; motivation; type of modalities training; functional health related 
parameters; quality of life; behavior change; muscle wasting; eccentric contraction; low and fast 
contractions; isokinetic device   
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THE CHRONIC OBSTRUCTIVE PULMONARY DISEASE 
 
Definition of COPD 
 
COPD is a slowly progressive lung disease characterized by airflow obstruction with breathing-
related symptoms resulting in a gradual loss of function (Mannino 2001; Qaseem et al. 2007; B.R. 
Celli, MacNee, et al. 2004; GOLD 2013). The symptoms of COPD range from chronic cough, 
sputum production, and wheezing to more severe symptoms, such as dyspnea, poor exercise 
tolerance, and, at the end stage, signs or symptoms of right-sided heart failure (Qaseem et al. 
2007). In literature there are two different definitions of COPD provided by the ATS/ERS (1995; 
2004) and GOLD (2001; 2006; 2010; 2013) (Viegi et al. 2007) (Table 1.1). 
 
Table 1.1 – COPD definition 
ATS/ERS definition GOLD definition 
Chronic obstructive pulmonary disease (COPD) 
is a preventable and treatable disease state 
characterized by airflow limitation that is not fully 
reversibly. The airflow limitation is usually 
progressive and associated with an abnormal 
inflammatory response of the lungs to noxious 
particles or gases, primarily caused by cigarette 
smoking. Although COPD affects the lungs, it 
also produces significant systematic 
consequences (B.R. Celli, MacNee, et al. 2004). 
Chronic Obstructive Pulmonary Disease 
(COPD), a common preventable and treatable 
disease, is characterized by persistent airflow 
limitation that is usually progressive and 
associated with an enhanced chronic 
inflammatory response in the airways and the 
lung to noxious particles or gases. 
Exacerbations and comorbidities contribute to 
the overall severity in individual patients (GOLD 
2013). 
 
 
ATS/ERS position stand (2004) updates the position papers on COPD published by the two 
Society in 1995 (N. M. Siafakas et al. 1995). Both societies felt the need to update the previous 
documents due to the increasing in prevalence and overall importance of COPD as an health 
problem, the need to highlight advances in the research field ad to support the dissemination of 
the GOLD to the battle against COPD (B.R. Celli, MacNee, et al. 2004). The GOLD program was 
initiated in 1998 and its aim was to produce recommendations to manage the COPD, based on 
the best scientific information available. Its committee was established in 2002 and reviewed the 
published research on COPD management and prevention to establish the impact on 
recommendations. GOLD strategies aim to manage short-term impact of COPD, relieving and 
reducing impact of symptoms on patients, and long-term impact to reduce the risk of adverse 
health events that may affect the patients (GOLD 2010b; GOLD 2010a; GOLD 2013).  
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Pathology, Pathogenesis and Patophysiology of COPD 
 
Despite different definitions provided, COPD is a respiratory disorder largely caused by smoking, 
characterized by progressive airway obstruction, no-reversiblity, lung hyperinflation, systemic 
manifestations and high frequency of exacerbations (D. E. O’Donnell et al. 2008). Several risk 
factors, such as smoking and others noxious particles inhaled, cause an inflammatory response 
of the lungs, which lead into a pulmonary and systemic chronic inflammation (B.R. Celli, MacNee, 
et al. 2004; van der Vlist & Janssen 2010; GOLD 2013). 
 
Pathology  
 
The chronic airflow limitation in COPD is caused by a persistent inflammation of proximal and 
peripheral airways, lung parenchyma and pulmonary vasculature. The chronic inflammation leads 
to an increased number of specific inflammatory cell types in different parts of the lung and 
structural changes results from repeated injury and repair. In fact, when injured, normal lungs 
undergo tissue-repair processes that return the tissue to normal or near normal functioning. 
However, in the presence of the tissue destruction associated with emphysema, these repair 
processes are altered, and the balance between destruction and repair is affected. Therefore, this 
imbalance between the lung’s repair and defense mechanisms results in a small airway fibrosis 
(B.R. Celli, MacNee, et al. 2004; Nici et al. 2006; D. E. O’Donnell et al. 2008; GOLD 2010b; 
GOLD 2013). Remodeling of the small airways is a key factor in development of the COPD 
irreversible airflow limitation and describes persistent changes that occur within the structural 
components of the airways in response to inflammation (B.R. Celli, MacNee, et al. 2004; D. E. 
O’Donnell et al. 2008; GOLD 2013). Caused by these structural changes in the airway walls, the 
resistance in the peripheral airways increases, resulting in the major sites of obstruction (D. E. 
O’Donnell et al. 2008; Fromer & C. B. Cooper 2008; GOLD 2013; Rabe et al. 2007). Moreover, 
the relative contributions of which components, i.e. more injury processes or less repair 
mechanisms, vary from to person. The destruction of the parenchymal tissue in the lungs could 
result into emphysema disease, which is characterized by enlarged alveolar sacs and structural 
damage to the expiratory bronchioles (Nici et al. 2006; D. E. O’Donnell et al. 2008; GOLD 2013).  
In general, inflammatory and structural changes (Table 1.2) in airways increase with disease 
severity and persist on smoking cessation (GOLD 2013; Rabe et al. 2007). 
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Table 1.2 - Mechanisms Underlying Airflow Limitation in COPD 
Small airways disease 
Airway inflammation 
Airway fibrosis; luminal plugs 
Increased airway resistance 
Parenchymal destruction 
Loss of alveolar attachments 
Decrease of elastic recoil 
  
AIRFLOW  LIMITATION 
 
(from GOLD 2013) 
 
Pathogenesis 
 
COPD is an insidious and progressive disease: there are no characteristic symptoms in the early 
stages of the disease, and, in later stages, the symptoms are partially, but not fully, reversible. 
COPD usually occurs in mid-life following long-term exposure to noxious particles or gases when 
the normal protective and repair functions in the lungs are overwhelmed or functioning sub-
optimally (Fromer & C. B. Cooper 2008). This exposure of chronic irritants causes an 
inflammation in the respiratory tract of COPD patients, which is an exaggeration of inflammatory 
responses normally seen in the respiratory tracts of individuals who smoke, but do not have 
COPD (Fromer & C. B. Cooper 2008; Rabe et al. 2007; GOLD 2013). The mechanisms for this 
amplified inflammation are not yet understood, but, probably, genetically determined. Indeed, it 
has been reported that some patients could develop COPD without any history of cigarette 
smoking (Figure 1.a) (GOLD 2010b; GOLD 2013; Rabe et al. 2007; Nici et al. 2006).  However, 
chronic inflammation is usually characterized by presence of chronic or recurrent increase in 
bronchial secretion sufficient to cause expectoration, i.e. most days of a minimum of 3 months per 
year for the least two successive years and cannot be attributed to other pulmonary or cardiac 
causes (B.R. Celli, MacNee, et al. 2004; Rabe et al. 2007; Fromer & C. B. Cooper 2008; GOLD 
2010b; GOLD 2013). 
 
Inflammatory cells and mediators 
COPD is characterized by a specific pattern of inflammation involving neutrophils, macrophages 
and lymphocytes, and high levels of inflammatory markers, such as i C-reactive protein, TNF-α, 
interleukin IL-8, IL-6 and monocyte chemo-attractant protein-1, were observed in the lungs and 
serum circulation. These cells release inflammatory mediators and interact with structural cells in 
the airways and lung parenchyma. The wide variety of inflammatory mediators attract 
inflammatory process, i.e. pro-inflammatory cytokines, and induce structural changes, i.e. growth  
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Figure 1.a: Pathogenesis of the COPD 
 
(from GOLD 2010b) 
 
factors, and correlate with measurements of COPD including FEV1, dyspnea levels and 
exacerbation rates. (Table 1.3) (GOLD 2010b) Fromer & C. B. Cooper 2008). 
 
Oxidative stress and Protease-Antiprotease Imbalance  
Moreover, lung inflammation is further amplified by oxidative stress and by an imbalance of 
proteinases, such as elastase which degrades connective tissue in the lungs, and 
antiproteinases, such as AAT, in the lungs (B.R. Celli, MacNee, et al. 2004; GOLD 2013). The 
oxidant/antioxidant balance is generated by cigarette smoke, inflammation, respiratory infections, 
genetic factors and dietary factors, and released from activated inflammatory cells, such as 
macrophages and neutrophils. However, the several adverse consequences of oxidative stress 
can occur in the lungs, including an increased inflammation, an activation of inflammatory genes, 
an inactivation of protective antiproteases, a stimulation of mucus secretion and a stimulation of 
increase plasma exudation (Van der Vlist & Janssen 2010; GOLD 2013). The protease-
antiprotease imbalance is thought to contribute to the irreversible lung damage seen in COPD, 
particularly in patients with emphysema and it may be caused by worsening lung inflammation or 
by environmental or genetic factors (B.R. Celli, MacNee, et al. 2004; GOLD 2010b; GOLD 2013). 
Indeed, AAT deficiency is an important genetic factor for the development of COPD: AAT is an 
antiprotease which exerts a protective effect on lung tissue by inhibiting the elastase that breaks 
down lung connective tissue. Approximately 3% of COPD patients have this deficiency (B.R. 
Celli, MacNee, et al. 2004; Rabe et al. 2007; Fromer & C. B. Cooper 2008; GOLD 2010b; GOLD 
2013) 
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Table 1.3 – Inflammatory cells and mediator in COPD 
In
fl
am
m
at
o
ry
 c
el
ls
 
Neutrophils Increase in sputum of normal smokers 
 Further increase in COPD and related to disease severity 
 
Few neutrophils are seen in tissue and they may be important in mucus hypersecretion 
and release of proteases 
Machrophages Greatly increase in airway lumen, lung parenchyma and bronchoalveolar lavage fluid 
 
Produce increased inflammatory mediators and proteases in COPD patients in response 
to cigarette smoke 
 They may shaw defective phagocytosis 
T Lymphocytes Increase CD4+ and CD8+ in airway wall and lung parenchyma 
 Increase CD8+/CD4+ ratio 
 Increase CD8+ Tcells (Tc1) and Th1 cells 
 CD8+ cells may be cytotoxic to alveolar cells, contributing to their destruction 
B Lymphocytes Increase in peripheral airways and within lymphoid follicles 
 May be a response to chronic colonization and infection of the airways 
Eosinophils Increase proteins in sputum during exacerbations 
 Increase eosinophils in airway during exacerbation 
Epithelial cells May be activated by cigarette smoke to produce inflammatory mediators 
In
fl
am
m
at
o
ry
 
m
ed
ia
to
rs
 
Chemotactic 
factors 
Lipid mediators, i.e. s LTB4; attracts neutrophils and T lymphocytes 
 Chemokines, i.e. IL8; attracts neutrophils and monocytes 
Proinflammator
y cytokines 
TNF-α, IL-1β and IL6; amplify the inflammatory process and may contribute to some of 
the systemic effects of COPD 
Growth factors Transforming TGF-β; may induce fibrosis in small airways 
 
(from GOLD 2010b) 
 
Pathophysiology 
 
The physiologic changes that occur as COPD worsens include mucus hyper-secretion, ciliary 
dysfunction, airflow limitation, pulmonary hyperinflation, abnormal gas exchange, pulmonary 
hypertension and cor pulmonale (Figure 1.b) (Fromer & C. B. Cooper 2008).  
 
Mucus hyper-secretion 
Mucus hyper-secretions, resulting in a chronic productive cough, is a feature of Chronic 
Bronchitis and is not necessary associated to airflow limitation. Conversely, not all patients with 
24 
 
COPD have mucus hyper-secretion. When present, it is due to an increased number of goblet 
cells and enlarged mucosal glands in response to chronic airway irritation. Several mediators and 
proteases stimulate mucus hyper-secretion, activating the EGFR (GOLD 2010b; GOLD 2013). 
 
 
 
Figure 1.b – Influence of pathophysiologic characteristics of COPD on patient outcomes 
 
(from Fromer & Cooper 2008) 
 
Airflow limitation and Pulmonary Hyperinflation 
The extent of inflammation, fibrosis and luminal exudates in small airways is correlated with the 
reduction in lung function parameters and probably with the accelerated decline in FEV1 
characteristic of COPD patients (GOLD 2013). In fact, expiratory flow limitation is the 
pathophysiological hallmark of COPD (D. E. O’Donnell et al. 2008). Therefore, chronic 
inflammation causes an expiratory flow limitation (Fromer & C. B. Cooper 2008). Proximal and 
peripheral airways disease, coupling with destruction of the lung parenchyma and vasculature, 
lead to the loss of alveolar attachment. This loss of alveolar attachment compromises the ability 
of patients to expel air during expiration, which is due to a diminished lung recoil. Air trapping and 
lung hyperinflation result from this wasting air expiration. Indeed it’s well known that hyperinflation 
occurs when air is trapped within the lungs after each breath and it’s caused by an imbalance 
between volumes of inhaled and exhaled air. Evidences suggest that, in patients with COPD, the 
time to exhale is more prolonged, inspiratory capacity is reduced and functional residual capacity 
is increased than healthy people, particularly during exercise, i.e. dynamic hyperinflation. As 
COPD progresses, the insidious physiologic changes, especially hyperinflation, cause 
progressively worsening dyspnea, first as patients exercise, and over time, even at rest. Acute-
on-chronic hyperinflation has been shown to contribute to shortness of breath during exercise, 
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acute exacerbation in COPD and reduced QoL in patients (D. E. O’Donnell et al. 2008; GOLD 
2013; Viegi et al. 2007; Fromer & C. B. Cooper 2008; GOLD 2010b; Rabe et al. 2007). 
 
Gas Exchange Abnormalities 
Gas exchange abnormalities result especially in hypoxemia, i.e. decreased level of O2 in arterial 
blood, and hyper-capnia, i.e. increased CO2 concentration in arterial blood. In general, gas 
transfer for oxygen and carbon dioxide worsen as the disease progress. Reduced ventilation may 
also be due to reduced ventilator drive. This may lead to carbon dioxide retention when it is 
combined with reduced ventilation due to a high work of breathing because of severe obstruction 
and hyperinflation coupled with ventilator muscle impairment. The abnormalities in alveolar 
ventilation and a reduced pulmonary vascular bed further worsen the VA/Q abnormalities (GOLD 
2010b; GOLD 2013). 
 
Pulmonary hypertension 
Pulmonary hypertension may develop late in the course of COPD and is due mainly to hypoxic 
vasoconstriction of small pulmonary arteries, eventually resulting in structural changes that 
include intimal hyperplasia and later smooth muscle hypertrophy/hyperplasia. There is an 
inflammatory response in vessels similar to that seen in the airways and evidence of endothelial 
cells dysfunction. The loss of pulmonary capillarity bed in emphysema may also contribute to 
increase pressure in the pulmonary circulation. Progressive pulmonary hypertension may lead on 
to right ventricular hypertrophy and, eventually, to right-side cardiac failure, i.e. cor polmonale 
(GOLD 2010b; GOLD 2013).   
 
Diagnosis of COPD 
 
COPD runs an insidious course, measured over years, with an often undiagnosed initial phase 
(B.R. Celli, MacNee, et al. 2004). Most individual with COPD are not diagnosed until the disease 
is well advanced (D. E. O’Donnell et al. 2008). Usually, patients tend to underreport their 
symptoms because they may be minimal or perceived to be a normal part of ageing or clinically 
insignificant (Viegi et al. 2007; Fromer & C. B. Cooper 2008).  So, to accurately diagnosis COPD, 
patient histories, physical examinations and lung function testing need to be provided (Fromer & 
C. B. Cooper 2008). A mass screening of asymptomatic individuals for COPD is not supported 
and recommended by the current evidence (D. E. O’Donnell et al. 2008). In presence of some 
indicators (Table 1.4) in an individual over age 40, a diagnosis of COPD need to be confirmed 
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physiologically through assessment of lung function with simple spirometry (B.R. Celli, MacNee, 
et al. 2004; Fromer & C. B. Cooper 2008; GOLD 2010b; GOLD 2013). Moreover, AAT deficiency 
testing should be considered if symptoms of COPD occur in patients younger than 45 years of 
age where a link with obvious risk factors cannot be made, in patients with lower-lobe 
predominant emphysema, or in patients within a family cluster of COPD cases where there has 
been no remarkable exposure to primary or secondary tobacco smoke (Fromer & C. B. Cooper 
2008).  
 
Table 1.4 – Key indicator for considering a diagnosis of COPD 
Consider COPD, and perform spirometry, if any of these indicators are present in an individual 
over age 40. These indicators are not diagnostic themselves, but the presence of multiple key 
indicators increases the probabilities of a diagnosis of COPD.  Spirometry is needed to establish 
a diagnosis of COPD  
Dyspnea Progressive (worsens over time) 
 Usually worse with exercise 
 Persistent (present every day) 
 
Described by the patients as an “increased effort to breathe”, 
“heaviness”, “air hunger” or “gasping” 
Chronic Cough May be intermittent and may be unproductive 
Chronic sputum 
production 
Any pattern of chronic sputum production may indicate COPD 
History of expose to 
risk factors 
Tobacco smoke 
 Occupational dusts and chemicals 
 Smoke from home cooking and heating fuels 
 
(from GOLD 2010b) 
 
Medical history 
 
COPD is a generally a progressive disease but it has a variable natural history and not all 
individuals follow the same clinical course over time. Chronic cough and phlegm may 
predominate in some patients, whereas others may report only effort dyspnea. Some individuals 
show a rapidly accelerated lung function decline, while others a slowly progressive, roughly 
“stable” decline is observed (Viegi et al. 2007). Therefore, healthcare providers should provide a 
detailed medical history to consider a diagnosis of COPD for any patient, especially those over 40 
years of age, which present some indicator risk, such as dyspnea, chronic cough, chronic sputum 
production and history of expose to risk factors (GOLD 2010b; GOLD 2010a; GOLD 2010c; 
27 
 
GOLD 2013). The medical assessment should to consider topics about patients’ exposure to risk 
factors, past medical history, family history of COPD or other respiratory diseases, pattern of 
symptoms development, history of exacerbation or previous hospitalizations for respiratory 
disease, presence of co-morbidities, impact of disease in on patient’s life, social and family 
support and possibilities for reducing risk factors (B.R. Celli, MacNee, et al. 2004; Fromer & C. B. 
Cooper 2008; GOLD 2010a; GOLD 2010b; GOLD 2013). 
 
Physical examination 
 
Although it is an important part of patients care, the physical examination is rarely diagnostic in 
COPD. Indeed, physical signs of airflow limitation are usually not present in the early stage of 
COPD and they could be observed until significant impairment of lung function has occurred. 
Moreover their detection has a relatively low sensitivity and specificity. The aim of the physical 
examination should be to elicit the presence of respiratory and systemic effects of COPD through 
inspection of central cyanosis, chest wall abnormalities, resting respiratory, pursed-lip breathing, 
resting muscle activation, ankle ore leg edema, palpation and percussion to assess the presence 
of hyperinflation and auscultation (B.R. Celli, MacNee, et al. 2004; GOLD 2010b; GOLD 2013). 
 
Measurement of airflow limitation  
 
Considered that patients may not have significant symptoms at the time of initial diagnosis, lung 
function measurements are an essential and objective tools to check the presence of a 
pulmonary disease, to provide the right diagnosis and evaluate the stage of airflow obstruction 
(Gooneratne et al. 2010; M.R. Miller, Hankinson, et al. 2005). To assess COPD, the most 
important spirometric parameters are the FVC, which is the volume delivered during an expiration 
made as forcefully and completely as possible starting from full inspiration, and the FEV1, i.e. the 
volume delivered in the first second of an FVC maneuver. Also the FEV1/FVC ratio expressed as 
a percentage should be calculated (M.R. Miller, Hankinson, et al. 2005; GOLD 2010c). When 
compared with predicted normal values determined on the basis of age, height, sex, and 
ethnicity, a measure of the severity of airway obstruction can be determined. Spirometry is 
however only one way of interpreting COPD disease severity. Other measures, such as the MRC 
dyspnea scale for measuring breathlessness, exacerbation frequency, BODE-index, QoL 
assessment, and exercise capacity, may help to build a more complete picture. Finally, 
spirometry is a reliable method of differentiating between obstructive airways disorders, i.e. 
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COPD, asthma, and restrictive diseases, where the size of the lungs is reduced, i.e. fibrotic lung 
disease (B.R. Celli, MacNee, et al. 2004; Rabe et al. 2007; GOLD 2010b; GOLD 2013; GOLD 
2010c; M.R. Miller, Hankinson, et al. 2005). 
 
Interpreting measurement 
Spirometric classification has proved useful in predicting health status and is applicable to 
populations and not to substitute clinical judgment in the evaluation of the severity of disease in 
individual patients (Gooneratne et al. 2010). Assessment of airflow abnormalities is provided by 
observation of pulmonary function values, i.e. FEV1 and FV1/FVC in volume-time curve, and also 
by the analysis of expiratory flow rate seen in through the flow-volume curve morphology (Figure 
1.c, Figure 1.d) (GOLD 2010c). Assessing bronchodilator reversibility is important to determine 
whether fixed airway narrowing is present. In patients with COPD, post-bronchodilator FEV1/FVC 
remains < 0.7, whereas FEV1 may improve significantly, i.e. change of > 12% and > 200 mL in 
FEV1 can occur in COPD.  In addition, degree of bronchodilator reversibility can vary from day to 
day. Larger changes in FEV1 do not negate a diagnosis of COPD, although the greater these 
changes are the greater the likelihood that the patient has asthma, either instead of or in addition 
to COPD (GOLD 2010b; GOLD 2010a; GOLD 2010c; GOLD 2013). 
 
 
Figure 1.c – FEV1 and FVC in volume-time curve; 
FEV1 <80% predicted normal; FVC usually reduced but to a lesser extent than FEV1; FEV1/FVC ratio <0.7 
 
(from Bellamy et al. 2005) 
  
 
Figure 1.d – Morphology of flow-volume curves in obstructive (1) and severe obstructive disorder (2); 
(1) PEF is reduced and the decline in airflow to complete exhalation follows a dipping curve; 
(2) particularly with emphysema, the characteristic “steeple pattern” is seen in the expiratory flow trace. 
 
(Bellamy et al. 2005) 
(1) (2) 
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COPD classification 
The updated GOLD guidelines disregarded the stage 0 “at risk” provided previously by ATS/ERS 
statement, and are based only to the grading of FEV1% predicted level (Viegi et al. 2007; GOLD 
2010b; GOLD 2013). Stage 0 has been removed because there is incomplete evidence that 
patients with this stage 0, i.e.  post-bronchodilator FEV1/FVC >0.7; FEV1% pred. ≥80, necessarily 
progress to stage I COPD (Fromer & C. B. Cooper 2008). Therefore the severity of COPD is 
classified according to the degree of abnormality in spirometric readings, the level of symptoms 
and the presence of comorbid conditions that can lead to complications (B.R. Celli, MacNee, et 
al. 2004; Fromer & C. B. Cooper 2008; GOLD 2010b; GOLD 2013) (Table 1.5). 
 
Table 1.5 – GOLD spirometric criteria for COPD severity 
The spirometric criterion required for a diagnosis of COPD is a 
FEV1/FVC ratio below 0.7 after bronchodilator 
 classification lung parameters symptoms 
 
Stage I 
MILD COPD 
FEV1/FVC <0.7 
FEV1≥ 80% pred. 
symptoms of chronic 
cough and sputum 
production may be 
present, but not 
always; 
 
Stage II 
MODERATE COPD 
FEV1/FVC <0.7 
50% ≤ FEV1 > 80% pred. 
shortness of breath on 
exertion;  
cough and sputum 
production; 
 
Stage III 
SEVERE COPD 
FEV1/FVC <0.7 
30% ≤ FEV1 > 50% pred. 
greater shortness of 
breath;  
reduced exercise 
capacity and presence 
of fatigue; 
repeated 
exacerbations; 
 
Stage IV 
VERY SEVERE 
COPD 
FEV1/FVC <0.7 
FEV1 < 30% pred. 
or 
FEV1 <50% pred. plus 
chronic respiratory failure 
impaired quality of life; 
 
(adapted from GOLD 2010c; GOLD 2010b; GOLD 2013) 
 
Respiratory failure is defined as a Pa,O2, less than 8.0 kPa or 60 mmHg, with or without a PaCO2 
greater than 6.7 kPa or 50 mmHg, while breathing air at sea level, and it may lead to effects on 
the heart such as cor pulmonale, i.e. right heart failure. At this stage, QoL is very impaired and 
exacerbations may be life threatening (B.R. Celli, MacNee, et al. 2004; Rabe et al. 2007). 
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Differential diagnosis 
Chest radiography helps in differential diagnosis and other tests be useful to better determine the 
phenotype and physiological characteristics of individual patients (Table 1.6) (Celli et al. 2007; 
GOLD 2013). In some patients with chronic asthma, a clear distinction from COPD is not possible 
using current imaging and physiologic testing techniques, and it is assumed that asthma and 
COPD coexist in these patients. In these cases, current management is similar to that of asthma. 
Other potential diagnoses are usually easier to distinguish from COPD (Rabe et al. 2007; GOLD 
2013). 
 
Table 1.6 – Differential diagnosis of COPD 
Diagnosis Suggestive features 
COPD Mid-life onset 
 Slowly progressing symptoms 
 Long history of smoking 
Asthma Early onset 
 Varying symptoms 
 Symptoms during the night/early morning 
 Presence of allergy, rhinitis and/or eczema 
 A family history  
 Airflow limitation that is largely reversible 
Congestive heart failure Fine basilar crackles on auscultation 
 Dilated heart on chest radiography 
 Pulmonary edema 
 Volume restriction not airflow limitation on pulmonary function test 
Bronchiecstasis Large volume of purulent sputum 
 Commonly associated with bacterial infection 
 Coarse crackles/clubbing on auscultation 
 Bronchial dilation and bronchial wall thickening on chest radiography/CT  
Tuberculosis Onset at all ages 
 Lung infiltrate on chest radiography 
 Microbiological confirmation 
 High local prevalence of tuberculosis 
Obliterative bronchiolitis Younger onset and in nonsmokers 
 History of rheumatoid arthritis/fume exposure 
 
Hypodense areas on expiration on Computed Tomography  suggestive of 
bronchiolitis 
Diffuse panbronchiolitis Effects mostly male nonsmokers 
 Almost all have chronic sinusitis 
 
Diffuse small centrilobular nodular opacities and hyperinflation on chest 
radiography and High Resolution Computed Tomography 
 
(from Celli et al. 2004) 
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Risk factor of COPD 
 
Conventionally, risk factors are subdivided into endogenous or host risk factors and exogenous or 
environmental risk factors (N. M. Siafakas et al. 1995; Viegi et al. 2007). Identification of cigarette 
smoking as the most commonly encountered risk factor has led to incorporate smoking cessation 
programs into all of prevention and management COPD interventions. However, although 
smoking is the best-studied COPD risk factor, consistent evidences from epidemiologic studies 
about COPD nonsmokers patients (Figure 1.e) (Salvi & Barnes 2009) had well established that 
cigarette smoke is not the only one cause to develop chronic airflow obstruction (Rabe et al. 
2007). The well-recognized host risk factors are genetics, age, gender and asthma, instead the 
environmental risk are smoking, socio-economic status, occupation,  environmental pollution, 
perinatal events, childhood illness, recurrent bronchopulmonary infections and diet  (Figure  1.f) 
(Viegi et al. 2007). 
 
 
 
 
Figure 1.e – Proportion of patients with COPD who are non-smokers worldwide; 
 
* Australia, Belgium, Denmark, France, Germany, Iceland, Ireland, Italy, Netherlands, New Zeland, Spain, Sweden, 
Switzerland, UK, and USA 
 
(from Salvi & Barnes 2009) 
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Figure 1.f – Increased risk of COPD by sex associated with risk factors; 
 
NS: no-significant; NA: not applicable; # derived by multiple regression models; ¶ expressed in decades; + expressed 
in dm; § borderline significance (0.1>p>0.05); * p<0.05; ** p<0.01; ***p>0.001; 
 
(from Viegi et al. 2007) 
 
Genetic factors 
 
Results from studies assessing genetic components of COPD are not always consistent, probably 
reflecting differences in disease diagnosis criteria (Viegi et al. 2007). COPD was recognized as a 
polygenic disease and a classic example of gene-environment interaction (Rabe et al. 2007; Viegi 
et al. 2007; GOLD 2013; GOLD 2010b). In fact, in the Kurzius-Spencer study (2001) it was 
reported a significant correlation between FEV1 slopes among all sibling pairs, suggesting a 
strong genetic component relating susceptibility to smoking and rate of decline in FEV1. 
Moreover, several studies involving families with members with symptomatic disease reported 
evidence of genetic influence on FEV1 (Viegi et al. 2007). Although genetic association needs to 
be further investigated, the best documented genetic risk factor is the severe hereditary 
deficiency of AAT, i.e. major circulating inhibitor of serine proteases and a rare recessive trait 
most commonly seen in Northern European origins’ individuals (Rabe et al. 2007; GOLD 2010b; 
GOLD 2013). Premature and accelerated development of panlobular emphysema and decline in 
lung functioning were observed in both smokers and nonsmokers with the severe deficiency 
(Viegi et al. 2007; GOLD 2010b). 
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Age, lung growth and gender 
 
Age is often listed as a risk factor for COPD, but it is yet unclear if healthy aging as such leads to 
COPD or if age reflect the sum of cumulative exposure through life (Figure 1.g) (GOLD 2013). 
Aging process itself results in a decline of pulmonary function, i.e. average annual decline of 
FEV1 about 26/29 ml/year for men and 22/25 ml/year for women (Burrows et al. 1983; Cheng et 
al. 2003; Pelkonen et al. 2003). Moreover, lung growth is related to process occurring during 
gestation, birth and exposures during childhood and adolescence. Therefore, any factors that 
affects lung growth has the potential for increasing an individual’s risk of developing COPD. 
Indeed, several studies confirmed a positive association between birth weight and FEV1 in 
adulthood (Lawlor et al. 2005; GOLD 2010b; GOLD 2013). The role of gender in determining 
COPD risk remains unclear (GOLD 2010b). In the past, most studies showed a COPD greater 
prevalence and mortality in males than females, but recent data show that the prevalence of the 
disease is now almost equal between genders, probably reflecting the changing patterns of 
tobacco smoking (Rabe et al. 2007; GOLD 2013). 
 
 
 
Figure 1.g – Different type of decline in FEV1 
 
(adapted from GOLD 2013) 
 
Asthma and Bronchial Hyper-reactivity 
 
Asthma seems to be a risk factor for the development of COPD although the evidence is not 
conclusive. The Tucson Epidemiological Study of Airway Obstructive Diseases highlighted that 
adults with asthma show a twelve-fold higher risk to develop COPD over time than those without 
asthma, after adjusting for smoking (Silva et al. 2004). Moreover, Vonk et collegues (2003) 
observed that the 20% of patients with asthma develop functional sign of COPD, irreversible 
airflow limitation and reduced transfer coefficient (Vonk et al. 2003; GOLD 2010b; GOLD 2013). 
In the European Respiratory Community Health Survey, bronchial hyper-responsiveness was 
second only to cigarette smoking as the leading risk factor for COPD, responsible for 15% of the 
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population attributable risk. The pathology of chronic airflow limitation in asthmatic non-smokers 
and non-asthmatic smokers is markedly different, suggesting that the two disease entities remain 
different even with similar reduction in lung function (Tashkin et al. 1996). 
 
Exposure to particles 
 
Because individuals may be exposed to a variety of different types of inhaled particles over their 
lifetime, it is helpful to think in terms of the total burden of inhaled particles (Figure 1.h) (Rabe et 
al. 2007; GOLD 2010b). 
 
 
 
Figure 1.h – COPD risk related to the total burden of inhaled particles  
 
(from Rabe et al. 2007) 
 
Cigarette smoking is the most commonly encountered risk factor for COPD (GOLD 2013), 
showing higher prevalence of respiratory symptoms and lung function abnormalities, greater 
annual decline in FEV1 and COPD mortality rate than nonsmokers (Rabe et al. 2007; GOLD 
2013). The occurrence of respiratory symptoms increases with number of cigarettes smoked and 
decreases with smoking cessation. Moreover, age of starting smoking, total pack-yrs smoked and 
current smoking status are all predictive of COPD mortality  (Figure 1.i) (Viegi et al. 2007). Other 
type of tobacco, i.e. pipe, cigar, water pipe and marijuana, are also risk factors for COPD, and 
this smokers have greater COPD morbidity and mortality rates than nonsmokers, although their 
rates are lower than those for cigarette smokers (Rabe et al. 2007; GOLD 2013). Smoking during 
pregnancy may also pose a risk for the fetus, by affecting lung growth and development in utero 
and possibly the priming of the immune system (Rabe et al. 2007). Finally, passive exposure to 
cigarette smoke may also contribute to respiratory symptoms and COPD by increasing the lungs’ 
total burden of inhaled particles and gases (Rabe et al. 2007; GOLD 2013). 
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Figure 1.i – FEV1 decline associated with tobacco smoke in longitudinal studies; 
(■) current smokers; (    ) former smokers; (□) never smokers; 
(#) males; (¶) females;   
 
(from Viegi et al 2007) 
 
Occupational exposures, including organic and inorganic dusts and chemical agents and fumes, 
are an underappreciated risk factor for COPD. In USA, it was observed that of almost 10.000 
adults aged 30-75 years, the fraction of COPD attributable to work was 19.2% overall, and 31% 
among never-smokers (GOLD 2010b; GOLD 2013). Moreover, an ATS statement establish 
occupational exposures as a cause for 10 to 20% of either symptoms or functional impairment 
consistent with COPD and risks are higher in females (ATS 2003; Rabe et al. 2007; GOLD 
2010b; GOLD 2013). Furthermore, a large cohort study observed increased rates of lung cancer 
in COPD male Swedish construction workers (Viegi et al. 2007). Evidence about indoor pollution 
from biomass cooking and heating in poorly ventilated dwellings as risk factor for COPD (Rabe et 
al. 2007). Indoor air pollution may increase risk of irritation phenomena, allergic sensitization, 
acute and chronic respiratory disorders and lung function impairment. Finally, several studies 
reported increased rates’ prevalence of COPD diagnosis or symptoms in urban and more polluted 
areas and elevated risk due to pollutants for COPD or respiratory hospitalization and for disease 
parameters in advanced COPD panels (Viegi et al. 2007). 
 
Infections 
 
Viral and bacterial infections may contribute to the pathogenesis and progression of COPD, and 
bacterial colonization is associated with airway inflammation and exacerbations (GOLD 2010b; 
GOLD 2013). History of severe childhood respiratory infection has been associated with reduced 
lung function and increased respiratory symptoms in adulthood (Rabe et al. 2007; GOLD 2010b; 
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GOLD 2013). History of tuberculosis is associated with airflow obstruction in adults older than 40 
years (GOLD 2010b; GOLD 2013). In addition, tuberculosis is both a differential diagnosis to 
COPD and a potential comorbidy (GOLD 2013).  
 
Socio-economic status 
 
Poverty is clearly a risk factor for developing COPD, but the its components effect are unclear. 
Several studies observed an inversely risk of COPD development related to socioeconomic 
status. It is not clear, however, whether this pattern reflects exposures to cigarette smoke, indoor 
and outdoor air pollutants, crowding, poor nutrition, or other factors that are related to low 
socioeconomic status (Rabe et al. 2007; GOLD 2010b; GOLD 2013). 
 
Nutrition 
 
The role of nutrition as an independent risk factor for the development of COPD is unclear. 
Malnutrition and weight loss can reduce respiratory muscle strength and endurance, apparently 
by reducing both respiratory muscle and mass and the strength of the remaining muscle fibers 
(GOLD 2010b). 
 
Epidemiology of COPD 
 
COPD is a leading cause of morbidity and mortality worldwide and results in an economic and 
social burden that is both substantial and increasing. COPD prevalence, morbidity, and mortality 
vary across countries and across different groups within countries (GOLD 2013). In recent 
decades, COPD has become a leading global disease with a prevalence of over 10% worldwide 
(Van der Vlist & Janssen 2010) and its burden is projected to increase due to continued exposure 
to COPD risk factors (Van der Vlist & Janssen 2010; GOLD 2013). Also, changing in age 
structure of the world’s population could affect the prevalence ratio (Rabe et al. 2007; GOLD 
2013). 
 
Prevalence 
 
Existing COPD prevalence data show remarkable variation due to differences in survey method, 
diagnostic criteria and analytic approaches (GOLD 2013). Prevalence and morbidity data greatly 
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underestimate the total burden of COPD because the disease is usually not diagnosed until it is 
clinically apparent and moderately advanced (R. A. Pauwels et al. 2001; B.R. Celli, MacNee, et 
al. 2004). The lowest estimates of prevalence are those based on self-reporting of a doctor 
diagnosis of COPD or equivalent condition (Rabe et al. 2007; GOLD 2013). Moreover, previous 
imprecise and variable definitions of COPD made difficult to quantify prevalence, morbidity, and 
mortality (Rabe et al. 2007).  Despite these complexities, several systematic reviews and meta-
analysis studies highlighted that COPD prevalence is appreciably higher in smokers and ex-
smokers compared to non smokers, in those older than 40 years compared with those younger 
than 40 years, and in men compared with women (Rabe et al. 2007; GOLD 2013). In Europe, 
prevalence of clinically relevant COPD varies between countries, i.e. 4-10% of the adult 
population, although there is a paucity of prevalence data from Central and Western countries 
(Figure 1.j). In the USA, more than 12 million people suffered from shortness of breath and 
disabling effects (Dressendorfer et al. 2002; GOLD 2013).The PLATINO investigation (2005) 
observed increased prevalence of COPD with ageing, from a lower value of 7.8% in Mexico city 
to an higher of 19.7% in Montevideo and differences in gender, i.e. appreciably higher in men 
than in women (Figure 1.k) (Menezes et al. 2005; GOLD 2013). 
 
Figure 1.j – Prevalence of COPD in Europe; 
 
(from www.oecd.org) 
 
 
 
Figure 1.k – Prevalence of COPD by age in five Latin-American cities; 
 
(adapted from Menezes et al. 2005) 
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Morbidity 
 
Morbidity measures traditionally include physician visits, emergency department visits and 
hospitalization, but COPD databases are less readily available. The limited data available indicate 
morbidity related to COPD increase with age and greater, i.e.  male > female (Rabe et al. 2007; 
GOLD 2013). In early stages COPD is usually not recognized, diagnosed, or treated, therefore 
may not be included as a diagnosis in a patient’s medical record (Rabe et al. 2007). Moreover, in 
patients with more advantaged disease, COPD morbidity may be misattributed to others clinical 
conditions (GOLD 2013). 
 
Mortality 
 
Data about COPD mortality must be interpreted cautiously caused by an inconsistent use of 
terminology. Indeed, the 10th revision of the ICD, deaths from COPD or chronic airways 
obstruction are included in the broad category of “COPD and other conditions”. Although COPD is 
often the primary cause of death, usually it is consider as a contributor. Between 1979 and 1993, 
mortality trend analysis in USA estimated 8% related to obstructive lung disease, among 31 
million death certificates (GOLD 2013). At present, COPD is considered the fifth leading cause of 
death in the world and the mortality rate is expected to increase more than 30% during the next 
year (W.D. Reid et al. 2012). In EU, the latest data estimate COPD as the third most common 
cause of death (Figure 1.l) (A. D. Lopez, Mathers, et al. 2006; Niederlaender 2006).  
 
 
 
Figure 1.l – Prevalence of COPD in Europe; 
 
(from www.oecd.org) 
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Economic and Social Burden of COPD 
 
Epidemiologic dates confirmed COPD as a significant public health problem which needs to be 
taken into account health personnel and decision-makers (B.R. Celli, MacNee, et al. 2004) 
because it is associated with significant economic and social burden (Rabe et al. 2007; GOLD 
2013). In 2001, total direct costs in the European Union of respiratory disease were estimated to 
be about 6% of the total health care budget, with COPD accounting for 56%, i.e. €38.6 billion: 
€4.7 billion for ambulatory care, €2.7 billion for drugs, €2.9 billion for inpatient care and €28.4 
billion for lost work days (Rabe et al. 2007; Viegi et al. 2007; GOLD 2013). In 2002, the USA 
direct costs of COPD were $18 billion and the indirect costs totaled $14.1 billion (Rabe et al. 
2007). The latest data estimated a direct cost of COPD about $29.5 billion and the indirect cost 
about $20.4 billion. COPD exacerbations account for the greatest proportion of the total COPD 
burden on the health care system (GOLD 2013). However, costs per patients will vary across 
countries caused by differences in health care system characteristics (Rabe et al. 2007). Any 
estimate of direct medical expenditure for home care under-represents the true cost of home care 
to society, because it ignores the economic value of the care provided to those with COPD by 
family members. Therefore, it was designed an estimation methods, i.e. DALY, to assess 
disability-adjusted life year, i.e. sum of years lost because of premature mortality and years of life 
lived with disability, adjusted for the severity of disabilities. If in 1990, COPD was estimated to be 
the twelfth leading cause of DALYs lost worldwide, in 2030 it will be projected to become the 
seventh (GOLD 2013).  
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ENHANCING QUALITY OF LIFE IN COPD 
 
Definition of Quality and Health-Related Quality of Life 
 
The term QoL is difficult to define either precisely or economically. Perhaps, many people, 
particularly politicians, have found it to be so useful to describe the gap between that which is 
desired and that which is achievable. So, in the context of medicine, the term health-related QoL 
is used to signify the gap between desires and achievements that is specifically due to disease. 
The major difficulty with this topic is the requirement for standardization. Therefore, the 
identification of the health status or “Health Related Quality of Life measurement”, i.e. HRQL, has 
become a central feature of studies in COPD. Health status measurement is a means of 
quantifying, in a standardized and objective manner, the impact of disease on patients’ daily life, 
health, and wellbeing (P. W. Jones 2001) (Table 2.1).  
 
Table 2.1 – Definition of QoL and HRQL 
QOL HRQL 
Quantification of the impact of disease on daily 
life and well-being in a formal and standardized 
manner (P. W. Jones 1995). 
Functional effect of an illness and its consequence 
therapy upon a patients, as perceived by the patients 
(P. W. Jones 1995; P. W. Jones 2001). 
 
Relevance of measuring Quality of Life in COPD 
 
COPD is a heterogeneous, multi-component disease associated with significant clinical burden. 
Though the presence of airflow limitation is well recognized as the pathophysiological basis, 
COPD as a complex disorder requires a multifaceted approach with regard to clinical assessment 
and response to therapy (Glaab et al. 2010). Despite the presence of the airflow limitation, in the 
early stages of COPD, patients appear to be symptomless and may not present to a physician 
until the condition is quite advanced, often only after an acute exacerbation (GOLD 2013). All that 
may be noticed is increasing breathlessness during leisure activities and recreational pursuits. 
Also, delay in recognition of the true impact of COPD may occur because the disease develops at 
a time of life when people generally begin to modify their leisure and recreational activity to less 
strenuous pursuits (P. W. Jones 1995). Instead, in advanced stages, patients show cough, 
excessive mucus production and feel dyspnea, not only during exercise but also at rest (GOLD 
2013). The extra-effort breathlessness may cause reduction, either consciously or unconsciously, 
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of DPA level. This will result in a loss of cardiopulmonary fitness and some disuse atrophy of leg 
muscles (S. C. Lareau et al. 1996; van der Vlist & Janssen 2010). It’s well known that, once FEV1 
falls below threshold of 50% predicted, essential ADL become disturbed and patients are clearly 
disabled (P. W. Jones 1995). Therefore, it has been suggested the model of “downward spiral of 
symptom-induced inactivity” in which patients with COPD may be enter with the disease 
progression. Physical inactivity and the sedentary lifestyle lead to a physical deconditioning, 
resulting in a sub-consequent reduction of QoL, an increase of disability and enhanced risk of 
death (Figure 2.a) (B.R. Celli, MacNee, et al. 2004; M.A. Spruit et al. 2004; Pitta et al. 2005; Pitta 
et al. 2006; Vorrink et al. 2011). Current methods for assessing COPD progression and risk of 
death mainly rely on lung function tests (B.R. Celli, C. G. Cote, et al. 2004; Glaab et al. 2010), but 
COPD patients show systemic manifestations no-related only by FEV1, which affected their QoL 
(P. W. Jones 1995; P. W. Jones 2001; Domingo-Salvany et al. 2002; B.R. Celli, C. G. Cote, et al. 
2004; Duiverman et al. 2008; Glaab et al. 2010; Divo et al. 2012).  
 
 
 
Figure 2.a - Downward spiral of COPD symptom; 
 
(from B.R. Celli, C.G. Cote et al. 2004) 
 
Determinants of Health-related Quality of Life in COPD 
 
COPD has three types of effects: primary in lungs, which may be structural or mechanical, 
secondary in other organs, defined as systemic manifestations, and tertiary in the interaction 
between patients and environment. From the patients perspective, health is related to better 
functioning, symptom relief and longer life. Effects on pulmonary function or secondary effects on 
organs are important because they may reduce QoL or shorten life expectancy. Therefore, 
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improving in QoL is what patients want to achieve with their medical treatment. A treatment that 
alters a physiological parameter, such as FEV1, but does nothing for quality of life, may not be 
successful (P. W. Jones & R. M. Kaplan 2003; Domingo-Salvany et al. 2002).  
 
Systemic manifestations in COPD 
 
Although COPD affects the lungs, the disease is associated with several systemic manifestations, 
which could effectively result in impaired functional capacity, worsening dyspnea, reduced HRQL 
and increased mortality (B.R. Celli, MacNee, et al. 2004; Barnes & B.R. Celli 2009). Indeed, at 
present, COPD is acknowledged as a multifactorial systemic disease in which several 
extrapulmonary manifestations and comorbidity factors complicate their evolution, alterating 
prognosis and patients QoL (Kim et al. 2008; Huertas & Palange 2011). Concomitant 
cardiovascular compromise, malnutrition, body weight loss, dysfunction of skeletal muscles, 
osteoporosis, anaemia, increased gastro-esophageal reflux and clinical depression and anxiety 
were observed (Table 2.2).  
 
Table 2.2 – Systemic effects of Chronic Obstructive Pulmonary Disease 
Systemic inflammation 
Oxidative stress 
Activated inflammatory cells (neutrophils/lymphocytes) 
Increased plasma levels of cytokines and acute phase proteins 
Nutritional abnormalities and weight loss 
Increased resting energy expenditure 
Abnormal body composition 
Abnormal amino acid metabolism 
Skeletal musle dysfunction 
Loss of muscle mass 
Abnormal structure/function 
Exercise limitation 
Other potential systemic effects 
Cardiovascular effects 
Nervous system effects 
Osteoskeletal effects 
 
(from Agusti et al. 2003) 
 
Importantly, presence ofairflow limitation greatly increase COPD patients’s risk to develop lung 
cancer over the time. Moreover, often, patients affected by COPD are older and frequently 
present important comorbidities, that also required medical attention (Barnes & B.R. Celli 2009). 
Although these systemic manifestations have been described for years in COPD patients, it is still 
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unclear whether they represent consequences of the pulmonary disorder, or whether COPD 
should be considered as a systemic disease (Barnes & B.R. Celli 2009; Huertas & Palange 
2011). However, considering that the presence of comorbidities significantly increase the patients 
risk of hospitalization, mortality and, consequently, the healthcare direct and indirect costs of 
COPD (R. A. Pauwels et al. 2001; Niederlaender 2006), there is an increasing realization that 
these systemic effects are clinically relevant and may contribute to better understand and 
manage the disease.  
 
Systemic Inflammation in COPD 
Systemic inflammation has been widely studied and considered an important key between the 
pulmonary disease and the related systemic manifestations (Huertas & Palange 2011). It is 
currently accepted that an excessive/inadequate inflammatory response of the lungs to a variety 
of noxious inhaled gases or particles, mostly cigarette smoke, is a key pathogenic mechanism in 
COPD (GOLD 2013; A. G. N. Agusti et al. 2003). Various studies have reported changes in 
various inflammatory cells and mediators and have shown that the lung inflammatory response is 
characterized by increased numbers of neutrophils, macrophages and T-lymphocytes with a 
CD8z predominance, augmented concentrations of pro-inflammatory cytokines, such as 
leukotriene B4, interleukin IL-8 and TNF-α, among others and evidence of oxidative stress 
caused by the inhalation of oxidants, such as tobacco smoke, and/or the activated inflammatory 
cells (A. G. N. Agusti et al. 2003; Huertas & Palange 2011). In Gan and colleagues’ meta-analysis 
(2004) it highlighted that systemic inflammation is present during COPD exacerbations and stable 
phases of the disease (Gan et al. 2004). Furthermore, systemic inflammation has been implicated 
in the pathogenesis of the majority of COPD systemic effects, including weight loss, skeletal 
muscle dysfunction, cardiovascular diseases, and osteoporosis, although it is still controversial 
whether this so-called low-grade systemic inflammation represents the consequence of 
pulmonary inflammation into the systemic vascular bed or whether it is a systemic inflammation 
(A. G. N. Agusti et al. 2003; Huertas & Palange 2011). Although inflammation is certainly one of 
the major features of COPD, we still need to understand whether the local inflammation is 
sufficient to induce systemic effects, or whether a second pathogenetic event is required. 
Therefore, further studies are aimed to elucidate the origin of the systemic inflammation in COPD 
(Huertas & Palange 2011). 
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Abnormalities in Body Composition in COPD 
Various studies described presence of nutritional and body composition abnormalities in patients 
with COPD, including alterations in caloric intake, basal metabolic rate, intermediate metabolism 
and body composition (Bolton et al. 2004; A. G. N. Agusti et al. 2003; Steuten et al. 2006). The 
most obvious clinical expression of these nutritional abnormalities is unexplained weight loss, 
which is particularly prevalent in patients with severe COPD and chronic respiratory failure. It has 
been estimated that weight loss occurs in ~50% of severe to very severe COPD patients, but it 
may be seen also in ~10–15% of patients with mild-to-moderate disease (A. G. N. Agusti et al. 
2003; Bolton et al. 2004; Steuten et al. 2006; Lainscak et al. 2011). Weight loss and a low BMI 
are considered independent poor prognostic indicators for survival (A. G. N. Agusti et al. 2003; 
Steuten et al. 2006; GOLD 2013). Loss of skeletal muscle mass, i.e. FFM, is the main cause of 
weight loss in COPD and it is more important as a poor prognostic factor for survival, whereas 
loss of fat mass contributes to a lesser extent. Importantly, alterations in body composition may 
occur in COPD also in the absence of clinically significant weight loss. Indeed, even with a normal 
BMI, loss of FFM is associated with increased morbidity, poor QoL and reduced exercise 
tolerance (A. G. N. Agusti et al. 2003; Bolton et al. 2004).  Patients with COPD may suffer from 
cachexia rather than malnourishment, i.e. the caloric intake of patients with COPD is normal or 
even greater than normal, not lower, as in malnourishment. Indeed, COPD patients metabolic 
rate is usually increased, whereas it is decreased in malnourished patients, and their response to 
nutritional support is often poor. The causes of these nutritional abnormalities are unclear and 
decreased caloric intake does not appear to be very prominent in these patients, except during 
episodes of exacerbation of their disease. In contrast, most patients with COPD exhibit an 
increased basal metabolic rate, which is not met by a parallel increase in caloric intake. Also 
causes of increased basal metabolic rate are yet unclear. Traditionally, it has been explained on 
the basis of an increased oxygen consumption, i.e. V’O2 of the respiratory muscles due to the 
increased work of breathing. Recently, it has been shown that COPD patients skeletal V’O2 non-
respiratory muscle is higher at any given load than in age-matched HC, suggesting presence of 
bioenergetic abnormalities in non-respiratory muscles as contributor of increased metabolic rate 
in COPD. Also, several mechanisms such as drugs, systemic inflammation, tissue hypoxia and  
congestive heart failure, could conceivably contribute to the increased metabolic rate in COPD (A. 
G. N. Agusti et al. 2003). DXA or bioelectrical impedance measurements were able to assess 
differences in body composition (A. G. N. Agusti et al. 2003).  Interestingly, by these measures, it 
was observed that some COPD patients show the so-called “Obesity Paradox” phenomenon 
defined as an inverse association of good health, survival and obesity. Overweight COPD 
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patients seem to have better survival rates than normal weight, a lower FEV1 annual decline than 
normal BMI patients. However, this is an unknown mechanism which need further investigation 
(Table 2.3) (Franssen et al. 2008; Blum et al. 2011). 
 
Table 2.3 – Prevalence of severe dyspnea, underweight, obesity and muscle wasting by COPD stages 
% (no.) of patients GOLD 1 GOLD 2 GOLD 3 GOLD 4 
 overall overall overall overall 
MRC≥3 9.7 (9) 28.1 (43) 53.7 (29) 82.4 (14) 
BMI<21 6.5 (6) 10.5 (16) 16.7 (9) 47.1 (8) 
BMI>30 16.1 (15) 23.5 (36) 9.3 (5) 5.9 (1) 
FFM ≤15♀  
or 
 ≤16♂ 
11.8 (11) 16.3 (25) 11.1 (6) 52.9 (9) 
 
(adapted from Steuten et al. 2006) 
   
Skeletal Muscle Dysfunction in COPD 
The extrapulmonary effects of COPD, especially the higher values of systemic inflammation, are 
associated with a reducted share of PA (Watz et al. 2008). Initially, given its role as the primary 
inspiratory muscle and considering the increased work of breathing imposed on it, the diaphragm 
has been the topic of most publications on respiratory muscles in COPD; Observations have 
highlighted that the structure and the function of the diaphragm are affected during the course of 
COPD (Levine et al. 1997; Kim et al. 2008; Caron et al. 2009). This topic is clinically relevant 
because inspiratory muscle weakness is associated with dyspnea, hypercapnic respiratory failure 
and even premature mortality in COPD (Caron et al. 2009). The study of limb muscle alterations 
linked to COPD has also been a dynamic area of research: althought the association between 
cachexia and respiratory disease was formally reported more than 40 years ago, only during the 
last decade it has received more attention (Caron et al. 2009). Causes of peripheral muscle 
dysfunction have yet to be fully elucidated, but limb muscle dysfunction is a major concern in 
COPD. It is associated with decreased survival (Swallow et al. 2007; van der Vlist & Janssen 
2010), poor functional status, as in VO2max, 6MWD, inspiratory and expiratory muscle force, 
hand grip force (M.A. Spruit et al. 2002), a low QoL (Couillard & Prefaut 2005; Caron et al. 2009; 
Barreiro & Sieck 2013), and is present across all disease stages (Seymour et al. 2010), 
suggesting that limb muscle dysfunction is one of the main extrapulmonary manifestation 
affecting the exercise capacity (Table 2.4) (Mador & Bozkanat 2001).  
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Table 2.4 – Alterations in diaphragm and quadriceps muscles in COPD 
 Diaphragm Quadriceps 
 
Presence
? 
Description 
Severity 
of airflow 
limitation 
Presence
? 
Description 
Severity of 
airflow 
limitation 
↓Fiber CSA Yes 
↓30% MHC 
content 
↓40/60% CSA 
affected all fiber 
types 
Mild to 
severe 
Yes 
↓25/35% CSA 
affected all fiber 
types 
Mild to 
severe 
Contractility 
defect 
Unclear 
↓Force 
generation of 
isolated skinned 
fibers 
Mild to 
moderate 
No 
No difference in 
force generation of 
isolated fibers 
Moderate to 
severe 
Fiber shift Yes Type II → Type I 
Mild to 
severe 
Yes Type I → Type II Severe 
Capillarization 
alterations 
Yes 
↑Capillary 
contacts with 
every fiber type 
Mild to 
severe 
Yes 
↓Capillary contacts 
with type I and IIa 
fibers 
Moderate to 
severe 
Mithocondrial 
alterations 
Yes 
↑Respiratory 
chain capacity 
↑Oxidative stress 
production 
Moderate 
to severe 
Yes 
↓Mithocondrial 
density 
↑Oxidative stress 
production 
Mild to 
severe 
Shift in 
energetic 
metabolism 
Yes 
↑Oxidative/glycolit
ic enzymatic ratio 
Mild to 
severe 
Yes 
↓Oxidative 
enzymes (HADH, 
CS) 
↓Oxidative/glycolitic 
enzymatic ratio 
Moderate to 
severe 
 
CSA, cross-sectional area; MHC, myosin heavy chain; HADH, 3-hydroxyacyl-CoA dehydrogenase;  
CS, citrate synthase 
 
(from Caron et al. 2009) 
 
Other potential systemic effects of COPD 
Others organ systems might also be affected by the systemic influences of COPD. Indeed, COPD 
often coexists with other diseases, called comorbidities, that may have a significant impact on 
prognosis. Some of these arise independently of COPD whereas others may be causally related. 
Comorbid diseases could be increased by the sequelae of COPD and are common at any 
severity of COPD, so the differential diagnosis can be often difficult (Barnes & B.R. Celli 2009)  
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Cardiovascular disease 
Cardiovascular disease is the major comorbidity in COPD and probably the most frequent 
disease coexisting with COPD (GOLD 2013). Usually there are features of Coronary artery 
disease, Ischemic heart disease,  Heart failure, the Atrial Fibrillation and Hypertension (A. G. N. 
Agusti et al. 2003; GOLD 2013).  
 
Nervous system effects  
“ Various aspects of the nervous system may be abnormal in patients with COPD. For instance, 
the use of nuclear magnetic resonance spectroscopy has shown recently that the bioenergetic 
metabolism of the brain is altered in these patients. Whether this represents a physiological 
adaptation to chronic hypoxia, as occurs at altitude, or whether it may be considered another 
systemic effect of COPD mediated by other unknown mechanisms is unclear. Another potential 
systemic effect of COPD upon the central nervous system relates to the high prevalence of 
depression reported in these patients. It is possible that this may simply represent a physiological 
response to chronic debilitating disease. However, it is equally plausible that it may bear some 
relationship to the systemic inflammation that occurs in COPD, since TNF-α and other cytokines 
and molecules, such as nitric oxide, have been implicated in the pathogenesis of depression in 
several experimental models.” (A. G. N. Agusti et al. 2003 pp.354). 
  
Osteoskeletal effects  
Prevalence of osteoporosis is increased in patients with COPD (Figure 2.b) (Bolton et al. 2004; A. 
G. N. Agusti et al. 2003), is often under-diagnosed and is associated with poor health status and 
prognosis (GOLD 2013). Osteoporosis can have multiple causes, singly or in combination, 
including malnutrition, sedentary behavior, smoking, steroid treatment and systemic inflammation. 
Since most of them are already considered potential pathogenic factors of skeletal muscle 
dysfunction in COPD, they could theoretically also contribute to osteoporosis, and, in this context, 
excessive osteoporosis in relation to age could also be considered a systemic effect of COPD. It 
is interesting to note that emphysema and osteoporosis are both characterized by net loss of lung 
or bone tissue mass and, pictorially, an osteoporotic bone looks quite similar to an 
emphysematous lung, may contribute to palliating its symptoms and reducing the associated 
healthcare costs (A. G. N. Agusti et al. 2003; GOLD 2013). 
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Figure 2.b – Bone mineral density at the lumbar spine and hip regions in COPD patients and healthy patients; 
 
Data shown as means with 95% confidence interval; 
( □ ) healthy;  ( ■ ) COPD with FEV1 greater than 50% predicted; (     ) COPD with FEV1 less than 50% predicted 
 
(from Bolton et al. 2004) 
 
Others comorbid disease 
Anxiety and Depression are common in COPD and are both associated with a poor prognosis. 
Also are both often associated with younger age, female gender, smoking, lower risk, cough, 
lower QoL and history of cardiovascular disease.  Another comorbid condition is lung cancer that  
is frequently seen in patients with COPD and has been found the most frequent cause of death in 
patients with mild COPD. Moreover, studies have shown that the presence of metabolic 
syndrome and manifest diabetes are more frequent in COPD and the latter is likely to impact 
prognosis. Patients with diabetes and severe COPD are not advised to aim for a BMI less than 21 
kg/m2  (GOLD 2013). 
 
Exacerbations 
 
Exacerbation of COPD is an event in the natural course of the disease characterized by acute 
changes in symptoms, such as cough, dyspnea and sputum production, beyond what is 
considered normal variability in a patient. Patients with exacerbation often require modifications in 
COPD treatment regimens and hospitalization for effective management. Frequency of COPD 
exacerbation increases with disease severity and could affect patients ADL and QoL, increasing 
mortality rates. In patients with moderate to severe COPD, prospective data collection revealed 
that patients report only 50% of the exacerbations that they experience and have a median 
exacerbation rate of 3 per year with a range of 1–8.  Although the cause of approximately one-
third of severe COPD exacerbations is unknown, they are commonly associated with infections of 
the tracheobronchial tree and with air pollution. Patients who experience acute exacerbations 
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commonly present with increased breathlessness, wheezing, tightness in the chest, increased 
cough sputum production, change in color and tenacity of sputum, and fever. Also tachycardia, 
tachypnoea, malaise, insomnia, fatigue, depression and confusion were reported. Before the 
onset of an exacerbation, patients may have decreased exercise tolerance and fever (P. W. 
Jones 2001; B.R. Celli, MacNee, et al. 2004; Fromer & C. B. Cooper 2008; GOLD 2013). 
 
Health Status Scale to assess Quality of Life in COPD  
 
At the light of the multi-causal nature of COPD symptoms, it’s justified the development of several 
health status scales that sum the effects of the different and multiple processes, in order to 
measure the health-related quality of life, evaluate and compare the overall effectiveness of the 
pulmonary rehabilitation program (Troosters et al. 2005). Indeed, the current methods for 
assessing clinical outcomes in COPD mainly rely on physiological tests combined with the use of 
questionnaires (Glaab et al. 2010). 
 
Major outcome measures in COPD 
 
Considered the different determinants of QoL in COPD patients, the major commonly used 
outcome measures regard the lung function, the health status, the exercise capacity and physical 
activity, the dyspnea symptoms, the number and severity of exacerbations, and  the mortality 
(Glaab et al. 2010). 
 
Pulmonary parameters 
Lung function: FEV1 
Relevance 
It is well established that patients with COPD lose lung function at a steeper rate than subjects 
without COPD. FEV1 is the single most important marker to determine severity and treatment 
algorithms in COPD. The decline of FEV1 over time has been traditionally used to indicate 
disease progression. 
Measures 
The diagnosis, staging and treatment of COPD in current guidelines is based on the fixed ratio of 
FEV1/FVC and the percentage predicted FEV1 value. The methodology for measuring forced 
expiratory maneuvers by spirometry has been standardized by ATS/ERS. Specific training to 
yield reproducible and reliable results is mandatory. 
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Strengths 
FEV1 and FVC measurements are highly reproducible if performed adequately. Reduction in lung 
function is a risk factor for all cause and cardiovascular mortality, and impaired health status. 
Spirometry supports confirmatory detection of early stages of COPD when respiratory symptoms 
are often absent, thus creating the opportunity of early intervention. 
Limitations 
FEV1 measurements are based on an artificial maneuver and do not always correlate with 
clinically relevant outcomes such as dyspnea, health status, exercise capacity, or exacerbations. 
Patients with similar FEV1 may represent different underlying phenotypes. Reference equations 
for lung function by European Community for Coal and Steel are disputed and limited in 
predicting lung function in the general population. Changes in lung volumes can occur without 
concomitant changes in FEV1 and are more closely related than FEV1 changes to exercise 
performance. No minimal important difference, i.e. MID, has been established yet. It was 
suggested that an appropriate range of values for the MID for FEV1 might be 100-140 mL but the 
MID for FEV1 remains poorly defined for COPD. 
Open Questions and Outlook  
FEV1, while a crucial marker, is far from being the only measure to comprehensively characterize 
patients with COPD. Additional outcome measures are usually needed to assess the clinical 
benefit of therapeutic agents. The relationships between changes in airway structure and 
measures of lung function require further investigation. 
 
Lung volumes 
Relevance 
Changes in absolute lung volumes can occur in COPD patients even in the absence of FEV1 
changes. Progressive hyperinflation due to airflow limitation and loss of lung elastic recoil not only 
increases the work required during inspiration but also profoundly decreases the ventilator 
reserve and increases the sense of effort and dyspnea. The assessment of absolute lung 
volumes has been standardized but is technically more demanding than simple spirometry. 
Specific training to yield reproducible and reliable results is essential. 
Measures 
Static lung hyperinflation and its increase during exercise, i.e. dynamic hyperinflation, are 
measured as elevations of total lung capacity, i.e. TLC, functional residual capacity, i.e. FRC, 
residual volume, i.e. RV, and as a decrease in inspiratory capacity, i.e. IC. 
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Strengths 
Indices of dynamic hyperinflation correlate better than FEV1 with activity limitation and exertional 
dyspnea and pharmacological and surgical lung volume reduction have been associated with 
improvements in exercise performance and dyspnea. A severely reduced IC/TLC ratio with a 
threshold value of 25% has been shown to predict mortality in COPD patients. 
Limitations 
Body plethysmography remains the gold standard for the measurement of lung volumes such as 
TLC, FRC and RV. Spirometrically derived assessments of lung hyperinflation are more difficult to 
interpret in the absence of simultaneous body plethysmographic volume measurements to rule 
out a concomitant restrictive ventilator disorder. The reproducibility of FRC, IC and RV in absolute 
values has yet to be demonstrated. Measurement of IC alone is not a reliable marker of lung 
hyperinflation and does not consistently reflect changes in FRC or TLC. Neither a standardized 
classification for the assessment of severity of hyperinflation nor a MID have been established 
yet. In practice, values of RV, TLC and FRC exceeding 120-130% of the predicted value are 
regarded to be clinically relevant, but these cut-offs are not validated. The natural course of 
dynamic hyperinflation in COPD is unknown and seems likely to be highly variable among COPD 
patients. 
Open Questions and Outlook 
In the absence of any consensus on the definition and/or severity of hyperinflation, it has been 
proposed that hyperinflation - preferentially expressed as % predicted should be specified in 
terms of the volume compartment referred to and the measuring method used. So far, there have 
been no studies aimed at exploring the longitudinal course of dynamic hyperinflation and its 
impact on the course of the disease in COPD patients. 
 
Exercise Capacity and Physical Activity 
Relevance 
Reduced exercise capacity is considered to be a consequence of airflow obstruction, primarily 
because of dynamic hyperinflation occurring during exercise. Moreover, leg fatigue has been 
shown to be as important as breathlessness in limiting peak exercise performance. Muscle 
weakness is a feature of COPD, particularly of the legs but also of the arms. This may not be due 
entirely to disuse atrophy since nutritional depletion occurs and there is evidence of circulating 
inflammatory cytokines in COPD. A reduced physical activity of patients is a result of COPD, but 
at the same time promotes worsening and progression of the disease. 
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Measures 
There are different approaches to determine the exercise capacity or activity levels of COPD 
patients. Higher exercise tolerance measured via laboratory or field tests can be translated to 
higher levels of activity. In addition, physical activity during daily life can be recorded directly by 
measuring energy expenditure or by mechanical assessment of movement. 
 
Exercise Capacity 
6-Minute Walk Test  or 6MWT 
Measurement of the distance walked during a 6-minute period on a level surface. The principal 
outcome of this self-paced test is the distance covered. The MID is estimated to be 54-80 meters.  
Strengths 
6MWT is relatively simple to perform and well tolerated. It reflects everyday life-like activity. It is 
validated and standardized. 6MWT results correlate with lung function, health status, and 
maximal VO2, and have shown to be predictive for mortality. 
Limitations 
There are many sources of variability, e.g. patient's motivation, weight, height, age, sex, co-
morbidities, and day to- day variability. 
6MWT was significantly reduced only in COPD patients with GOLD stages III and IV. 
Assessment of the 6MWT is associated with spatial requirements and is personnel- and time-
consuming. 
Standards of 6MWT are not always realizable. This might influence the results, e.g. shorter 
corridors reduce the distance covered because of time-consuming change in direction. 
Learning effect: Walking distance is up to 17% higher for a second test performed a day later. 
 
Shuttle Walk Test or SWT 
There are two forms of assessment. In the Incremental Shuttle Walk Test, walking speed is set by 
the frequency of an acoustic signal. The frequency increases progressively until patients can no 
longer pick up the pace. The principal outcome is the distance covered. The MID is estimated to 
be 47.5 meters. The Endurance Shuttle Walk Test has been developed to determine sub-
maximal exercise capacity with the acoustic signal frequency being constant throughout the walk. 
The principal outcome is the duration of exercise. No MID has yet been described.  
Strengths 
SWT is relatively simple to perform and well-tolerated. Learning effects are minimal.  Walking 
pace is externally controlled. 
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Limitations 
Instructions for SWT are time consuming. The test is less extensively validated than the 6MWT. 
Solid evidence for validity still has to be provided. SWT does not reflect common daily activities 
that require endurance and pacing. 
 
Ergometry 
To evaluate the exercise response, bicycle-ergometer or treadmill are commonly used in two 
different test modes. In incremental-workload tests, work-rate is increased progressively as a mild 
continuous ramp under computer control with the principal outcome being the distance covered. 
Alternatively, constant-workload tests have been performed at sub-maximal levels of exercise 
intensity which is typically set between 75% and 85% of the maximum workload during 
incremental tests. The principal outcome is the duration of workload. Reasons for break-off, e.g. 
leg discomfort vs. breathlessness, provide additional insights. 
Strengths 
For ergometry, standardized protocols are available. Treadmill walking reflects an activity of daily 
living. Cycle ergometer is less prone to introduce movement or noise artifacts into measurements 
than treadmill, and electrocardiogram and blood pressure are generally easier to measure. 
Additional physiological and clinical variables, such as peak O2 uptake, CO2 output, minute 
ventilation, heart rate, dyspnea, and leg discomfort can be determined in parallel. 
Limitations 
The workload not only depends on speed and inclination of the treadmill but also on the weight of 
the subject and pacing strategy. Body weight has much less effect on bicycle ergometry 
performance. Cycling is less closely related to the patient's activities of daily living. Resources: 
Ergometers are relatively expensive, treadmills require much space. No MID has been 
established yet. 
 
Physical Activity 
Sensors for physical activity 
Relevance 
The methods that are available to quantify physical activity in daily life include direct observation, 
assessment of energy expenditure, and the use of physical activity questionnaires or motion 
sensors. In particular, motion sensors are practical tools for clinical trials or practice. 
Accelerometers are electronic devices that record energy expenditure or mechanically assess 
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movement. The devices are usually worn on patients' arm or waist. Accelerometers read out 
stored data as movement intensity and as quantity and can also provide data on body posture. 
Strength 
Accelerometers generate objective data by determination of quantity and intensity of body 
movements. Significant limitations of physical activity can already be detected in patients with 
moderate COPD (GOLD stage II). 
Limitation 
Solid evidence for reliability, validity and responsiveness for different types of accelerometers still 
has to be provided. Some activity sensors are poorly accepted by patients. Variability in 
sensitivity among accelerometers of a given model has been detected. Accelerometers may be 
sensitive to artefacts like car vibrations. Activity sensors may actually fail to accurately capture 
the inactive life style of patients with COPD. Physical activity patterns vary from day to day and 
between week-days and weekend due to the patient's health, or external factors. In long-term 
studies, another source of variability may be seasonal climate changes, hours of daylight and 
weather. Observation bias: a greater level of activity may be induced during the measurement 
period that results in overestimation of the activity. On the other hand, underreporting bias may 
evolve from poor compliance. No MID has been established yet. 
Open questions and outlook 
Exercise capacity is an important clinical outcome in interventional trials of COPD, but it is still 
debatable what is the most valid, reliable, and responsive measurement of changes within 
subjects. Physical activity may become a key outcome measure not only in clinical trials of 
COPD, but also in rehabilitation programs and for patients' self-management. Even though the 
technical assessment of physical activity is improving rapidly, not all new techniques have been 
developed to the point where their clinical utility has been validated. Little is known about the 
agreement of exercise capacity as measured using different methods. Therefore, indirect 
comparisons of treatment effects on exercise capacity are obscured by different methods of 
assessment applied in various trials. 
 
Dyspnea 
Relevance 
For patients with COPD, dyspnea is the most frequent complaint for which they seek medical 
attention and is the characteristic symptom of COPD. However, dyspnea is a subjective measure, 
i.e. there are large inter-individual differences in the perception of breathlessness for a given level 
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of ventilation, that poorly correlates with objective assessments of lung function, exercise 
capacity, and other outcomes. 
Measures 
Different approaches have been used to measure dyspnea in clinical trials, amongst which the 
BDI/TDI, Borg- Scale, and MRC are applied most often.  
 
Baseline Dyspnea Index/Transition Dyspnea Index (BDI/ TDI)  
The BDI and TDI represent one of the most commonly applied instruments for dyspnea rating in 
clinical trials, describing symptoms at a single point in time, i.e. BDI, and measuring changes in 
breathlessness from this baseline state over time, i.e. TDI.  
BDI and TDI ratings are obtained in the course of an interview conducted by an experienced 
observer, who asks open-ended questions about the patient's experience of breathlessness 
during everyday activities, which are then translated into numerical values. 
Strengths 
BDI and TDI ratings provide multi-dimensional measurements of breathlessness, i.e. functional 
impairment, magnitude of task, and magnitude of effort, related to activities of daily living. In 
BDI/TDI, a MID with a difference of 1 unit for the mean total score being considered clinically 
meaningful is available though it is mainly based on retrospective data analysis. 
Limitations 
BDI/TDI Interviewer bias: Neither interviewer questions nor the translation of patients' answers to 
ratings are standardized, enforcing thorough interviewer training. BDI/TDI Recall bias: The patient 
has to recall BDI in order to answer questions regarding the TDI. BDI/TDI Assessment bias: 
Interviewer blinding to patients' clinical status is necessary to prevent assessment bias. 
 
Medical Research Council (MRC) Scale 
The MRC dyspnea scale was developed as a simple and standardized method of categorizing 
disability in COPD. The patient selects a grade on the self-applied 5-point instrument that 
describes everyday situations or activity levels provoking breathlessness and impairment. A MID 
has not been established. 
Strengths 
The MRC scale method has been widely used in the past. 
  
57 
 
Limitations 
In MRC scale, a possible underestimation bias due to avoidance of exertion has to be taken into 
account. The MRC is relatively insensitive to change, i.e. due to therapeutic intervention. In MRC 
scale, there are relatively scarce clinical data on validation, responsiveness, and sensitivity. 
 
Borg-Scale (CR-10) 
The CR-10 or Borg-Scale has been developed primarily as an objective tool to measure 
exertional dyspnea in COPD patients. Although the 10-point category ratio scale is easy to use, 
concise and detailed instructions for patients are indispensable for appropriate application. Based 
on retrospective analysis, a MID for the Borg- Scale in the range of 1 unit has been discussed. 
Open Questions and Outlook 
More research is needed to optimize and validate questionnaire items including direct patient 
involvement in instrument generation to improve their utility in clinical trials. Little is known about 
the impact of concomitant disorders on outcomes, i.e. if disorders such as anxiety or depression 
influence perceived dyspnea and, if so, to which extent those instruments applied today reflect 
that influence. Furthermore, studies are needed to show which of the existing methodologies, 
should be ideal in the context of COPD.  
 
Exacerbations 
Relevance 
Exacerbations of COPD indicate clinical instability and progression of the disease and are 
associated with increased morbidity, deterioration of comorbidities, reduced health status, 
physical and physiologic deterioration and an increased risk of mortality. The prevention or 
reduction of exacerbations thus constitutes a major treatment goal. 
Measures 
Verification by patient interview, healthcare databases or prospectively from diary cards. 
Endpoints: frequency of exacerbations, time to first exacerbation, severity and duration of 
exacerbations. 
Strength 
The event-based approach considers the need for systemic corticosteroids and/or antibiotics or 
hospitalization due to an exacerbation. This definition may be more robust and is relatively easy 
to record. The symptom-based definition of exacerbations considers individual patient's 
perception of clinical status. 
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Limitations 
There is no standardized definition of an exacerbation, making comparative evaluations of clinical 
study results difficult. The symptom- and event-based approach involves subjective and recall 
bias, particularly because patients often have a poor understanding of exacerbation symptoms, 
resulting in substantial underreporting of exacerbations. The definition by use of health care 
resources is health system specific and affected by many other factors (social support, 
comorbidities, baseline health status, clinical expert behavior). Differential diagnoses to 
exacerbations such as pneumonia, heart failure, ischemic heart disease, pulmonary embolism 
have to be taken into account. Seasonal variations in exacerbation frequency usually require 
long-term studies of at least one year duration. No MID has been established yet. 
Open questions and outlook 
There is a clear need to standardize the evaluation of the onset, frequency, severity and duration 
of COPD exacerbations as well as to assess therapeutic effects on exacerbations in COPD. 
Given the potential clinical relevance of even single exacerbations it appears quite difficult to 
determine exactly what cut-off levels should be used in terms of MIDs. In addition, more work is 
needed to develop simple feasible criteria for defining exacerbations in clinical practice and to 
analyze the multiple factors that contribute to decisions to assess the severity stage of 
exacerbations. In that context, the EXACT-PRO initiative began to develop and evaluate a novel 
patient-reported outcome tool to measure the rate, duration and severity of exacerbations of 
COPD. 
 
Mortality 
Relevance 
Long-term observations of large patient populations have shown an increased risk for all-cause 
mortality in COPD patients that rises proportionally to severity classes. Mortality can be recorded 
as all-cause mortality and cause-specific mortality. 
Strengths 
All-cause mortality is the most robust and reliable outcome of clinical trials in COPD and is 
relatively easy to follow-up. 
Limitations 
Standardized methods to accurately define the cause of death (e.g. respiratory versus 
cardiovascular mortality) have not been established yet. Moreover, the careful analysis of the 
cause of death requires substantial effort. Retrospective mortality data may be confounded by 
inherent statistical bias, and even prospective studies are susceptible to bias due to missing 
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follow-up of withdrawals. Adequately powered mortality trials require high patient numbers and 
extended study duration. It is as yet unclear, whether COPD-specific mortality is increased in 
patients with milder forms of COPD (GOLD stages I and II). Mortality tends to be lower in 
participants of clinical trials than is found in routine clinical care. 
Open Questions and Outlook 
One important issue is the statistical approach to analyze the events of death. Intent-to-treat 
(ITT)-analyses, aiming for complete follow-up of deaths are recommended for unbiased 
comparison between treatment groups and should be used preferentially as shown in major trials. 
For a confident, robust assessment, mortality should be the primary outcome of a prospective 
trial. Clinical trials evaluating death as a primary or secondary endpoint should have a data safety 
monitoring board and an independent adjudicating committee (P. W. Jones 2001; Glaab et al. 
2010). 
 
Multidimensional scoring systems in COPD 
 
BODE-Index 
Relevance 
So far the only multidimensional scoring system that has gained broader acceptance is the BODE 
index which has been developed as a prognostic marker for COPD patients in an attempt to 
integrate not only the respiratory but also the systemic expressions of COPD in a single grading 
system. 
Measures 
It comprises the four components nutritional state, i.e. BMI, airflow limitation, i.e. Obstruction; 
FEV1, breathlessness, i.e. MRC Dyspnea scale, and Exercise capacity i.e. 6MWD, distance 
walked in 6 min. Replacing the 6MWD with a component for exacerbation frequency, i.e. BODEx 
index, resulted in fully preserved power to predict the mortality risk in a prospective observational 
study, while expanding the BODE index with exacerbation frequency as a fifth component, i.e. e-
BODE index, did not further improve its predictive power. A truncated version of the BODE index 
has been presented in which the exercise component is omitted (BOD index). The validity of the 
BODE index as a prognostic marker to predict mortality in COPD patients has recently been 
challenged by a study demonstrating that the risk of all cause mortality over 3 years was 
considerably underestimated by the BODE index in a population of severe COPD patients, while 
on the contrary it was overestimated in another population with milder disease, indicating that 
important predictors may still be missing in this index. Nevertheless, the BODE index has been 
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used to assess therapeutic efficacy in interventional studies investigating effects of lung volume 
reduction surgery, pulmonary rehabilitation, and physical training, but so far not in 
pharmacological intervention trials. 
Strengths 
The BODE index integrates different facets of COPD and the risks associated with significant 
comorbidities. It provides better power than that of its individual components, i.e.  FEV1, to predict 
mortality and future exacerbations in patient populations with severe-to-very severe COPD. Its 
assessment is straightforward. 
Limitations 
The BODE index has not primarily been developed to assess effects of therapeutic interventions 
and a MID has not yet been defined. The BODE index has been optimized to predict one-year 
mortality. The factors most critically affecting short-term survival might differ from those 
determining survival over a longer term. Thus, its suitability for assessment of patients with mild-
to-moderate COPD is as yet less validated. The FEV1 categories in the airway obstruction 
component are not consistent with the current GOLD staging system. No published experience 
with BODE index as a clinical outcome parameter in pharmacological intervention studies is 
currently available. 
Open questions and outlook 
More widespread application of the BODE index as an outcome parameter in clinical trials is 
currently hampered by the lack of experience in pharmacological intervention studies. 
Furthermore, its validity as a prognostic marker in a population of patients affected by mild-to 
moderate COPD and its power to predict survival over longer periods of time as yet have to be 
proven (Glaab et al. 2010). 
 
Questionnaires for health status in COPD 
 
Relevance 
Health-status is considered one of the main patient-related outcomes in clinical trials. It is 
important to make a distinction between quality of life (QoL), which is unique to the individual, and 
health status measurement, which is a standardized quantification of the impact of disease. 
Measures 
Health-status as a concept of high complexity is assessed indirectly and requires the application 
of specially designed questionnaires (Glaab et al. 2010). Questionnaires used for assessment of 
QoL may be categorized as generic or disease-specific. Generic questionnaires were designed to 
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make standardized comparative assessments between populations of patients (P. W. Jones 
2001; Seemungal et al. 2009). Instead, disease-specific questionnaires include the Chronic 
Respiratory Questionnaire, i.e. CRQ, the St. George’s Respiratory Questionnaire, i.e. SGRQ, the 
Medical Outcomes Study short-form-36, i.e. SF-36, the Severe Respiratory Insufficiency 
Questionnaire, i.e. SRI, and the Maugeri Respiratory Failure questionnaire, i.e. MRF-26 (P. W. 
Jones 1995; P. W. Jones 2001; Duiverman et al. 2008; Seemungal et al. 2009; Glaab et al. 
2010). 
 
The St. George’s Respiratory Questionnaire  
The SGRQ was originally developed to measure health status in patients with respiratory 
disease, i.e. COPD or asthma. It was designed so that it may be used in long-term studies and is 
fully standardized (P. W. Jones 1995; Glaab et al. 2010). A COPD-specific version is available. 
The SGRQ covers domains of symptoms, i.e. frequency and severity of respiratory symptoms, 
activity, i.e. effects on and adjustment of everyday activities, and psychosocial impact, i.e. overall 
impact on daily life and well-being, from which a total score with a possible maximum of 100 
points is calculated. The MID was assessed by various methods. Changes of 2 to 8 points were 
considered clinically meaningful, with a value of 4 applied most often. 
Strengths 
The SGRQ has been widely used in clinical trials as a secondary endpoint to assess the effects 
of treatment and management interventions on health status in COPD. It may be considered a 
standard in clinical trials. It has standardized instructions. It appeared to be similar in different 
countries and languages. 
Limitations 
The instrument is time-consuming to implement and is therefore of limited applicability in day-to-
day clinical practice. There is a trend bias due to non-poled questions: first possible answer is 
usually "yes" and indicates worse health-status. The processing of missing answers is 
unsatisfactory. A missing answer is considered as if the patient had answered "no", indicating 
better health-status. SGRQ scores were shown to be influenced by subjects' sex, age, education, 
and by comorbidities. Suitability of MID for individual patients as opposed to patient group 
comparisons has yet to be shown. Linearity of differences between SGRQ values has not been 
shown, especially not in different stages of severity. Thus, it is unknown, whether a reduction in 
SGRQ total score by 4 points, i.e. from 44 to 40, represents a subjective improvement in health 
status equivalent to a reduction from 64 to 60. There is little published empiric evidence 
supporting the MID of four points (P. W. Jones 1995; Seemungal et al. 2009; Glaab et al. 2010). 
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Chronic Respiratory Disease Questionnaire  
The CRQ is widely used disease-specific questionnaire that has been shown to be reliable, valid 
and responsive in COPD patients (Duiverman et al. 2008). It was the first disease-specific 
measure developed for COPD and was designed especially to detect changes following therapy 
(P. W. Jones 1995). The CRQ measures physical-functional and emotional limitations due to 
chronic lung diseases including COPD. It refers to activity-related dyspnea with results covering 
dyspnoea, fatigue, emotion, and mastery. The questionnaire has primarily been applied in 
rehabilitation trials of COPD patients. The patient is asked to recall the five most important 
activities that caused breathlessness over the past two weeks. A total score as well as individual 
subscale scores can be calculated. A difference of 0.5 for the mean domain scores is considered 
clinically meaningful. 
Strengths and limitations 
A distinctive property of this instrument is the patient-specific selection of five activities, which 
cause dyspnea for the individual patient. This way the instrument adapts to the specific conditions 
of the patient and is sensitive to treatment. On the other hand, the instrument is less suitable for 
inter-individual comparisons, as it mirrors individual physical limitations. The questionnaire is not 
interchangeable with other disease-specific instruments and has not yet been shown to be 
responsive to long-term disease progression. (Duiverman et al. 2008; Seemungal et al. 2009; 
Glaab et al. 2010). 
 
Medical Outcomes Study Short Form-36  
The SF-36 is a generic health survey. The patient is asked to complete 36 items of the 
questionnaire. The instrument allows the patient to self-assess psychic, physical, and social 
aspects of his or her quality of life. 
Strengths and limitations 
SF-36 is the best-known questionnaire to measure health status. The instrument has been shown 
to be discriminative, responsive to long-term disease progression, easy to use, and has been 
validated in several languages. However, as a generic measure, it is considered less responsive 
than disease-specific instruments in COPD and is not consistently responsive to therapeutic 
effects. No MID has been established yet. 
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The Severe Respiratory Insufficiency Questionnaire  
The SRI was developed especially for patients with respiratory failure (Carone et al. 1999; 
Windisch et al. 2003; Duiverman et al. 2008). Questionnaire contains items on problems that 
patients with chronic respiratory failure experience and emphasizes different aspects of HRQL.  
Strength 
The SRI total score, like the CRQ total score, was most strongly related to anxiety and 
depression. In addition, the SRI total score was also substantially related to daily activity level. 
SRI contains 49 items and takes 20 min to complete. However, as answer possibilities were 
clearly indicated, the questionnaire is easy for the patients to complete. For the SRI, as for the 
CRQ, anxiety also accounted for a large part of the total variance in the summary scale. 
Limitations 
The SRI total score not contain items about memory, attention or concentration during daily living 
(Duiverman et al. 2008). 
 
The Maugeri Respiratory Failure Questionnaire  
MRF-26 was developed especially for patients with respiratory failure (Carone et al. 1999; 
Windisch et al. 2003; Duiverman et al. 2008). Questionnaires contain items on problems that 
patients with chronic respiratory failure experience and emphasize different aspects of HRQL.  
Strength 
The MRF-26 total score was more related to activities of daily living. The MRF-26 might be more 
attractive in the practical sense as it contains 26 items and took the patients ~10 min to complete. 
However, as answer possibilities were clearly indicated, both questionnaires were easy for the 
patients to complete. The MRF-26 adds the cognition domain, which contains four items on the 
effects of impaired memory, attention and concentration on daily living but not contain 
psychological domain. 
Limitations 
The MRF-26 total score was less correlated to psychological functioning such as anxiety or 
depression (Duiverman et al. 2008). 
 
Open questions and outlook 
Further development of user-friendly, inexpensive instruments to enable fast and easy health 
status assessment in clinical trials as well as in daily practice is clearly required. Ways to involve 
patients in questionnaire generation should be further explored. More information is needed on 
the time course of health-status alterations, i.e. induced by therapeutic intervention or secondary 
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to COPD exacerbations and on the utility and efficacy of health status instruments in less severe 
COPD (Glaab et al. 2010). 
 
Strategies to improve Quality of Life in COPD 
 
The multi-causal nature of symptoms and determinant of QoL in COPD patients justify the 
development of several different strategies for disease management. Indeed, after a diagnosis of 
COPD has been made, the goals of treatment should include different topics, such as relief of 
symptoms, amelioration of disease progression, improvement of patients’ exercise tolerance and 
health status, prevention and treatment of complications and exacerbations, and a reduction in 
the risk of death from by COPD (Fromer & C. B. Cooper 2008; D. E. O’Donnell et al. 2008; GOLD 
2013). While there are a number of aspects of disease management that may be standard for all 
patients, healthcare providers and patients need to establish realistic goals and understand that 
these goals will vary between patients (Fromer & C. B. Cooper 2008). Therefore, a stepwise, 
comprehensive management approach is required to achieve these goals (B.R. Celli, MacNee, et 
al. 2004; D. E. O’Donnell et al. 2008; Rabe et al. 2007; GOLD 2013). At the light of the different 
HRQL, treatment for COPD should depend on the severity of the disease and health status of the 
patient, which should be evaluated based on symptom severity and impact of these symptoms on 
QoL and not solely on the extent of airflow limitation. Components of treatment plans should 
include smoking cessation strategies, pharmacologic management of the symptoms of COPD 
and related complications and comorbid conditions, risk factor reduction, patient counseling, 
mechanical bronchial hygiene, pulmonary rehabilitation, oxygen therapy and, in some cases, 
surgery to improve lung mechanics. A planned care management and regularly scheduled 
physician visits should be encouraged to monitor disease, to prevent acute care visit, to limit 
exacerbations experienced by patients and to improve QoL, in order to reduce economic burden 
of hospitalizations and emergency visits. Therefore, a support team comprised of both physician 
and support-service personnel should regularly follow-up with the patient to provide education, 
reinforce medication adherence and smoking cessation when applicable, encouraging an healthy 
lifestyle (B.R. Celli, MacNee, et al. 2004; Rabe et al. 2007; D. E. O’Donnell et al. 2008; Fromer & 
C. B. Cooper 2008; GOLD 2010b; GOLD 2013). 
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Pharmacologic strategy to improve QoL in COPD 
 
Effective medications for COPD are available and all patients who are symptomatic merit a trial of 
drug treatment (B.R. Celli, MacNee, et al. 2004). The currently available pharmacologic therapy 
for COPD is used to prevent, reduce, control or abolish symptoms, reduce the frequency and 
severity of exacerbations and improve health status, exercise tolerance and capacity. At present, 
none of the existing medications for COPD has been conclusively shown to modify the rate of the 
long-term decline in lung function when this is tested as a primary or secondary outcome in 
clinical trials (B.R. Celli, MacNee, et al. 2004; Rabe et al. 2007; GOLD 2013). However, this 
should not preclude efforts to use medications to control symptoms (Rabe et al. 2007). The 
choice within each class of medication depends on the availability and cost of medications and 
the patient’s response. Optimal pharmacotherapy of COPD and each treatment regiments need 
to be patient-specific as the relationship between disease and symptoms severity, airflow 
limitation and frequency of acute exacerbations will differ between patients (D. E. O’Donnell et al. 
2008; GOLD 2013). 
 
Non-pharmacological therapy 
 
Although pharmacologic treatment is essential for effective management of COPD symptoms, 
several non-pharmacologic interventions are crucial for ensuring successful HRQL outcomes.  
Non-pharmacologic therapy is characterized by risk factor reducing interventions, pulmonary 
rehabilitation and oxygen therapy. The aims of no-pharmacologic therapy are to reduce the 
burden of COPD symptoms, improve QoL, and increase physical and emotional involvement in 
DPA. Pulmonary rehabilitation, i.e. PR, includes ExT, nutrition counseling, patient education, has 
been prove to be most beneficial for patients with stage II to stage IV COPD. It should address 
disease-specific aspects not sufficiently covered by medical therapy, such as depression, muscle 
wasting and social isolation. ExT should include aerobic and resistance exercises to improve 
aerobic capacity and muscle strength. Nutrition counseling should also be offered because 
nutritional status plays a key role in symptoms, disability and prognosis of COPD. Finally, patients 
education is important in order to better understand the disease and to improve compliance with 
various aspects of treatment. Adherence strategies should be developed not only for 
pharmacologic agents, but also for all of non-pharmacologic interventions in order to improve 
patients’ compliance with their management plan (B.R. Celli, MacNee, et al. 2004; Nici et al. 
2006; Fromer & C. B. Cooper 2008; GOLD 2010b; GOLD 2013).  
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PHYSICAL ACTIVITY & EXERCISE TRAINING IN COPD 
 
Definition of Physical Activity and Exercise Training 
 
It is important to distinguish physical activity from physical fitness, functional or exercise capacity. 
The latter three indicate what a person is capable of doing while physical activity reflects what 
someone actually does (Table 3.1).  
 
Table 3.1 – Physical Activity and Exercise definition 
PA definition Exercise definition 
Any bodily movement produced by the skeletal 
muscles that requires energy expenditure (Caspersen 
& Christenson 1985) 
 
Any PA done on purpose and carried out in a more 
structured manner with the aim of improving cardio-
respiratory or muscular fitness (Caspersen & 
Christenson 1985) 
 
 
Indeed, the measurement of PA is different from the measurement of physical fitness, functional 
or exercise capacity. Physical Activity can be investigated by direct observation, assessment of 
energy expenditure, i.e. calorimetry, or doubly labeled water technique, use of diaries and self-
reported questionnaires and performance-based motor sensors, such as pedometers and 
accelerometers (Pitta et al. 2006). The first two are time consuming and expensive and are 
therefore used less frequently. Performance-based motion sensors objectively quantify the 
amount of daily physical activity performed and is therefore more accurate as compared with 
questionnaires and diaries, which depend on a person’s memory and interpretation (Hartman J.E. 
2010). There is considerable literature supporting importance of habitual PA in primary and 
secondary prevention of varied chronic conditions. Routine PA is thought to be of benefit for over 
25 chronic conditions. Seven chronic diseases in particular have been associated with a 
physically inactive lifestyle including coronary artery disease, stroke, hypertension, colon cancer, 
breast cancer, type 2 diabetes and osteoporosis ( Warburton et al. 2010). Indeed, regular PA is 
well-recognized to improve body composition, automic tone, coronary blood flow, psychological 
wellbeing, glucose homeostasis and insulin sensivity, enhances lipid lipoprotein profiles and 
endothelial function, reduces blood pressure and systemic inflammation, decreases blood 
coagulation and augments cardiac function  (Figure 3.a) (Hartman J.E. 2010; Cress et al. 2006; 
Warburton et al. 2010) Physical inactivity is therefore a modifiable risk factor for cardiovascular 
disease and a variety of other disease such diabetes mellitus, cancer, hypertension and dementia 
(Hartman et al. 2010). 
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Figure 3.a – Health benefits of regular physical activity 
 
(from Cress et al. 2006) 
 
An adequate physical activity program is defined as a “Well-Rounded Program” and it is an 
integral part of a strong, overall, health wellness and fitness program (Jones C.J. & Rose, 2005). 
The “well-rounded PA programs” for adults and older adults focus on the key components of 
endurance, strength, balance and flexibility training, and posture and maintenance of a body 
composition in according with ACSM position stand (M. E. Nelson et al. 2007). The 
recommended minimum amounts and types of physical activity that promote health and prevent 
disease is 30 minutes of moderately/intense aerobic physical activity at least 5 days a week or 20 
minutes of vigorously intense aerobic physical activity at least 3 days a week, or an equivalent 
combination. Every adult should also perform muscular strength and endurance exercises at least 
2 days each week (W. J. Chodzko-Zajko et al. 2009; O’Donovan et al. 2010; D.E.R. Warburton et 
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al. 2010). For elderly adults, i.e. age ≥65, or ≥50 years with clinically significant chronic 
conditions and/or functional limitations, it is necessary to adjust the recommended intensity of 
aerobic activity to the elderly adult’s aerobic fitness. Moreover, activities that maintain or increase 
flexibility are recommended next to balance exercise for elderly adults at risk to fall (Figure 3.b) 
(M.E. Nelson et al. 2007; Hartman et al. 2010). 
 
Dimensions of Movement in COPD patients 
 
A chronic condition is consider ‘‘clinically significant’’ if a person receives or should receive 
regular medical care and treatment for it. Therefore, a functional limitation is ‘‘clinically significant’’ 
if it impairs the ability to engage in physical activity (M. E. Nelson et al. 2007). Strategies to 
promote health are advocated for patients with long-term conditions, as well as the general 
population (Wilson et al. 2005). As highlighted before, breathlessness, chronic cough with or 
without sputum production, and chronic fatigue are the main characteristic features of COPD 
(Woo 2000). These clinical manifestations vary according to disease severity, with general 
deterioration over a period of 10 to 40 years, leading to reduced mobility, functional and social 
activity, and impaired quality of life (V. Williams et al. 2011). The variety of symptoms highlight the 
importance of a multi-faceted approach to manage COPD, integrating both pharmacological and 
non-pharmacological interventions (Caress et al. 2010). Many patients recognized their condition 
as long-term and progressive and, coupling with their family members, consider really important 
to improve and carry out PA in order to enhance health (Caress et al. 2010; V. Williams et al. 
2011). Therefore, PR, defined as “a multidisciplinary program of care for patients with chronic 
respiratory impairment that is individually tailored and designed to optimize physical and social 
performance and autonomy” (B.R. Celli, MacNee, et al. 2004), is recognized to be the most 
interventions aimed at reducing symptoms and improving well-being entail health promotion 
behaviors (Caress et al. 2010). The promotion of an healthy lifestyle is a key elements of PR to 
stress therapy adherence and encouraging PA (B.R. Celli, MacNee, et al. 2004). 
 
Psychological dimension of movement in COPD 
 
The majority published research in relation to PA and COPD has predominantly focused on the 
quantitative assessment of activity, rather than the meaning of such activities for participants 
using qualitative methods (V. Williams et al. 2011). Instead, apart from physical impairment, 
patients with COPD carry substantial mental burden related to their disease and its symptoms 
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(G.-C. Funk et al. 2009). Rates of anxiety disorders in patients with COPD, particularly 
generalized anxiety disorder, i.e. GAD, panic disorder and depression, are much higher than in 
the general public (Brenes 2003; G.-C. Funk et al. 2009). Prevalence of GAD among COPD 
patients ranges from 10% to 15.8% when using standard diagnostic procedures compared with 
lifetime rates of 3.6% to 5.1% in the general public. Furthermore, rates of panic disorder are also 
higher in this population with a prevalence rate of 8%, which is 5.3-times as high as in the general 
population (Brenes 2003). Not only anxiety is highly common among COPD patients but the 
reverse is also true: the lifetime prevalence of respiratory disease is higher in people with panic 
disorder, ~47% than with other psychiatric diagnoses (Brenes 2003). At present, it’s well known 
that both anxiety and depression are risk factors for re-hospitalization in COPD, poorer survival. 
(G.-C. Funk et al. 2009) and provide negative impact on QoL of COPD adults, i.e. greater 
disability, impaired functional status, physical roles, emotional roles, social functioning, bodily 
pain, mental health function, and vitality. Even after statistically controlling for the effects of 
overall health status, COPD severity, dyspnea and anxiety remain significantly associated with 
decreased functional status (Brenes 2003). Although, in most studies, FEV1 and BODE index 
were observed as a bad predictors of anxiety and depression, on the other hand, the presence of 
respiratory symptoms causes substantial anxiety and depression (Figure 3.d) (G.-C. Funk et al. 
2009). Anxious symptoms were explained by dyspnea, while depressive symptoms were 
explained by both dyspnea and reduced exercise capacity (G.-C. Funk et al. 2009).  
 
 
 
Figure 3.d – Prevalence of anxious and depressive symptoms in COPD patients according to GOLD (a) 
and BODE index (b); 
 
(from Funk et al., 2009) 
 
A limited number of qualitative studies have been published exploring various aspects of 
experience PA in COPD including social, physical, and psychological aspects. The major 
a) b) 
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research was made by Williams and colleagues (2011) concerning the impact of stagnation 
indoor air on individual perceptions of breathlessness, identified as feelings of suffocation. This 
study confirmed previous findings about link between emotional component of the breathlessness 
and feelings of vulnerability, helplessness and loss of control. The perception of suffocation, with 
associated feelings of anxiety, panic, helplessness, and loss of control, is not only present during 
acute exacerbations, but is also linked to the perception of being confined indoors when COPD is 
stable. Williams and colleagues developed a theoretical model showing link between 
environmental aspects and perception of symptoms, which in turn have an effect on the 
experience of activity, i.e. “Stagnation–Movement model” (Figure 3.e) (V. Williams et al. 2011). 
 
 
 
Figure 3.e – Stagnation-movement model in COPD; 
 
(from Williams et al., 2011) 
 
Behavioral dimension of movement in COPD 
 
Although some discordances are present, several studies observed a positive relationship 
between PA, slower decline in pulmonary function and lower mortality (Cheng et al. 2003; 
Pelkonen et al. 2003; Prakash et al. 2007). Indeed, physical activity and non-smoking or smoking 
cessation are associated with a maintenance of cardiovascular and respiratory function (Figure 
3.f). At present, regular PA is considered a factor to prevent or delay onset or progress of 
different chronic diseases (Cress et al. 2006; M. E. Nelson et al. 2007; D.E.R. Warburton et al. 
2010; O’Donovan et al. 2010; Darren E.R. Warburton et al. 2011). Patients with COPD frequently 
report dyspnea related to everyday tasks (GOLD 2013) and may be in a downward spiral of 
symptom-induced inactivity, leading to deconditioning and muscle weakness (Pitta et al. 2005). 
The assessment of the amount and intensity of DPA is considered very important due to the close 
relationship between activity levels and health (Pitta et al. 2006). It is well-known that most of the 
patients with severe COPD are breathless even when performing simple DPA, ADL, or walking 
72 
 
around at home (Restrick et al. 1993), but a recent cross-sectional comparative study (Gouzi et 
al. 2011). 
 
 
 
Figure 3.f – Baseline characteristics of subjects by tertile of baseline physical activity 
 
(from Pelkonen et al. 2003) 
al. 2011)  
 
assessed the lifetime pattern of PA in COPD patients and sedentary HC subjects using a PA 
questionnaire. Interestingly, the study showed a PA reduction in COPD patients, at 45 years old, 
that occurred earlier than in healthy subjects. Furthermore, Gouzi and colleagues (2011) found 
that this reduction becomes before any clinical signs of the disease (Figure 3.g), suggesting that 
PA was reduced before diagnosis and the onset of breathlessness, thus, before the disease 
onset.  
 
 
 
Figure 3.g – Age of occurrence of physical activity peak, reduction, breathlessness and diagnosis for COPD 
patients. 
 
Box plot showing median; top and bottom edges of the box indicate 75th and 25th percentiles, respectively. The 
brackets above and below the boxes indicate the 90th and 10th percentiles, respectively. Additional symbols are the 
values that fall outside the 10th to 90th percentile range. *p<0.001. 
 
(from Gouzi et al. 2011)  
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Vorrink and colleagues (2011) reviewed several studies about COPD sedentary behavior in terms 
of duration, intensity, and counts of DPA, compared with HC subjects. It was observed that 
COPD patients are physically active for significantly less time of the day than HC (Coronado et al. 
2003; Pitta et al. 2005; Walker et al. 2008; Hernandes et al. 2009; Troosters et al. 2010). Pitta 
and colleagues (2005) showed that most COPD patients spend significantly less time walking and 
standing and more time sitting and lying in daily life when compared with sedentary HC elderly 
subjects (Figure 3.h). The degree of sedentary behavior in patients with COPD is further 
illustrated by the fact that they spent ~12% of the time during the day, or twice the walking time, 
in the lying position, as compared with ~4% in healthy elderly subjects (Pitta et al. 2005). 
Moreover, Hernandes et colleagues (2009) evaluated the characteristics of DPA in Brazilian 
COPD patients, estimating a mean walking time per day shorter than HC (55 ± 33 vs. 80 ± 28 
minutes per day; p = 0.001). The Vorrink’s review established a ratio of duration of being active 
for HC vs. COPD of 1:0.57 (Hernandes et al. 2009). 
 
 
 
Figure 3.h – Percentages of time spent in different DPA in healthy and COPD patients; 
Others, cycling or undetermined activity 
 
(from Pitta et al., 2005) 
 
Secondly, evidences of a reduction in intensity of DPA in COPD were found (Vorrink et al. 2011). 
Patients with COPD walk ~25% slower, i.e., at a lower movement intensity, when compared with 
age-matched HC (Pitta et al. 2005; Hernandes et al. 2009; Walker et al. 2008). In addition, it was 
observed by Troosters (2010) that the time spent in activity with mild, moderate and high intensity 
was significantly reduced in COPD patients compared to HC. Same findings were described in 
Coronado’s, Hernandes’s and Singh’s studies. Ratio of DPA intensity for HC versus COPD is 
1:0.75 (Vorrink et al. 2011). Lower levels of daily movement counts, lower activity count, less 
steps per day were observed in COPD patients than the average level recorded in age- and sex-
matched HC (Vorrink et al. 2011; Schonhofer et al. 1997; Walker et al. 2008; Troosters et al. 
2010). Ratio of DPA counts for HC versus COPD is 1:0.56 (Vorrink et al. 2011). Regarding the 
relation between DPA and disease severity, several studies found a moderate correlation but 
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certainly not strong (Vorrink et al. 2011). Pitta and colleagues (2008) correlated FEV1 with 
sedentary activities, moderate activities and vigorous activities. Only correlation with vigorous PA 
proved to be significant (Pitta, Takaki, et al. 2008; Vorrink et al. 2011). Hernandes (2009) and 
Singh & Morgan (2001) did not fount correlation between FEV1 and walking time or total activity 
count. Whereas, Steele found significant correlation between DPA and FEV1 and GOLD stage 
(Steele et al. 2003). Finally, Pitta study (2005) indicated that, in patients with COPD, DPA are 
better predicted by a global or integrative test, such as 6MWD, rather than by tests focused on 
single components of physical functioning, such as lung function and muscle force. In fact, the 
study showed that 6MWD was capable of identifying patients with COPD who had low walking 
time during daily life: patients with a 6MWD of less than 400 m, or ~ 60% predicted, had an 
average walking time of less than 30 minutes/day (Figure 3.i) (Pitta et al. 2005).  
 
 
 
Figure 3.i – Plot of 6MWD and walking time in daily life in patients with COPD (closed circles)  
and healthy elderly subjects (open circles); 
 
(from Pitta et al., 2005) 
 
Therefore, this study showed that if the 6MWD is severely reduced, patients are markedly 
inactive in daily life and a 6MWD is the best surrogate marker of inactivity during daily life in 
patients with COPD (Pitta et al. 2006; Pitta et al. 2005). Furthermore, recently, Jehn and 
colleagues (2012) have evaluated the accelerometer based walking intensity as a measure of 
functional capacity and its association with health COPD related quality of life. They were able to 
demonstrate that patients with lowest accelerometer based daily walking intensity had worst 
outcome in terms of HRQL and highest disease severity, GOLD classification and BODE index 
(Jehn et al. 2012). Evidences about COPD sedentary behavior (Vorrink et al. 2011), correlation 
between disease severity, HRQL, and performance of usual DPA, (Pitta et al. 2005; Jehn et al. 
2012), and early reduction of DPA (Gouzi et al. 2011), support potential effectiveness of ExT to 
break downward spiral of symptom-induced inactivity, also for at-risk populations, i.e. smokers, 
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which should be more fully integrated into public health care policies and for the timing of 
pulmonary rehabilitation (Pitta et al. 2006; Gouzi et al. 2011; GOLD 2013). 
 
Physiological dimension of movement in COPD 
 
Patients with COPD are disabled by their inability to carry out many ADL caused by exercise 
limitation. This leads to increasing social isolation, depression, and dependence. Improving 
physical performance is therefore an important therapeutic goal in these patients (Steiner & M. D. 
L. Morgan 2001). For many years it was believed that COPD patients were only limited by their 
ability to adequately increase ventilation to match the demands of exercise and, thus, exhibit a 
ventilatory limitation to exercise. Only recently, researchers have identified evidence that factors 
other than ventilation limitation can be very important in limiting exercise (Butcher & R. L. Jones 
2006; Steiner & M. D. L. Morgan 2001). Patients with COPD exhibit several peripheral muscular, 
cardiac, haemodynamic and metabolic deficiencies that contribute to exercise limitation (Figure 
3.j) (Bernard et al. 1998; Serres et al. 1998; Polkey 2003; Polkey 2002; W.D-C Man et al. 2009a; 
van der Vlist & Janssen 2010). V’O2max is considered the present gold standard for measurement 
of cardiovascular fitness and is a useful parameter for determining aerobic capacity (I. M. 
Weisman et al. 2003). In patients with COPD, average V’O2max ranges from 0.5 to approximately 
1.6 L/min in most exercise tolerance studies with peak work rates of only 60–120W. Although 
V’O2max is not adequately explained by measures of lung function, V’O2max is typically lower in 
patients with more severe disease (Butcher & R. L. Jones 2006). However, there is considerable 
variability in V’O2max and exercise performance between patients, suggesting that when 
comparing patients of similar severity of lung dysfunction, factors other than V’O2max are more 
important in determining exercise performance (I. M. Weisman et al. 2003; Butcher & R. L. Jones 
2006). Therefore, much attention has been given in recent literature to determining the limitations 
to exercise capacity in patients with COPD and several excellent reviews of traditional and 
contemporary views have been published. 
 
Ventilatory limitations 
Exercise ventilation in patients with COPD, as in healthy subjects, is a direct consequence of the 
metabolic demands of exercise. However, a greater minute ventilation, i.e. VE, is required to 
achieve a given level of alveolar ventilation. This greater ventilation is due primarily to an increase 
in the physiological dead space and the resulting ventilation-perfusion mismatch. The result is a 
reduction in the ventilatory efficiency as indicated by a high VE/VO2 or VE/work rate; however, 
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peak exercise ventilation is decreased. This reduction at peak exercise reflects the reduction in 
total work rate and has been attributed to a reduced ventilatory capacity or ceiling. There are also 
significant differences in the way that ventilation is achieved.   
 
 
Figure 3.j – Schematic diagram of the important mechanisms of exercise intolerance in patients with COPD. 
 
(from Butcher & R. L. Jones 2006) 
 
Patients tend to increase tidal volume to only approximately the volume equivalent to their FEV1 
and this increase occurs early in exercise. The major increase in ventilation that occurs later in 
exercise is due to a disproportional increase in respiratory rate. However, because peak 
respiratory rate is only slightly greater than normal and there is a marked reduction in peak tidal 
volume, the net effect is an overall reduction of peak ventilation. The traditional view of ventilatory 
limitation to exercise is that a combination of a reduced ventilatory capacity and an increased 
ventilatory demand result in an eventual ceiling effect. That is, the inability to adequately increase 
ventilation to meet the  metabolic demands of exercise was thought to be due to a reduced 
maximal potential for ventilation. Ventilatory demand is measured by an in increasing VE with 
exercise and ventilatory capacity is most frequently measured by maximal voluntary ventilation , 
i.e. MVV, or surrogates of MVV such as FEV1×35 or 40. The closer VE approaches MVV, the 
greater the chance of a ventilatory limitation to exercise. Problems with this approach were 
identified as it became apparent that measures of resting lung function do not correlate well with 
ventilatory patterns during exercise. Recently, other measures of ventilatory limitation have been 
discussed, but a consensus regarding the most appropriate measure has yet to be reached. One 
such measure is the determination of inspiratory capacity during exercise. Inspiratory capacity is 
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an easy, non-invasive method of determining the degree of dynamic hyperinflation that occurs in 
patients with COPD. Dynamic hyperinflation seriously affects ventilatory mechanics, inspiratory 
muscle function and cardiac function. As ventilation increases, end expiratory lung volume 
increases, i.e. dynamic hyperinflation, which, in turn, decreases the potential increases in tidal 
volume. As we know that total lung capacity does not increase with exercise, tidal volume can 
only increase to the volume that inspiratory capacity allows. Thus, a reduced ventilatory capacity 
is more a rising floor than a low ceiling. The degree of dynamic hyperinflation correlates very well 
with exercise tolerance as has been demonstrated in both maximal and sub-maximal exercise. 
Dynamic hyperinflation is also associated with increasing sensations of dyspnoea and an 
increased work of breathing. Although examination of dynamic hyperinflation is emerging as a 
promising method of determining ventilatory limitations to exercise, the exact measurement and 
interpretation of when a true limitation occurs has yet to be demonstrated (Butcher & R. L. Jones 
2006; I. M. Weisman et al. 2003; Truwit 2003). 
 
Cardiac limitations 
During incremental exercise, the rise in oxygen consumption, i.e. VO2 , with increasing work rates 
appears to be relatively normal; however, there is often a higher resting VO2 in more severe 
patients, reflecting the increased ventilatory cost of breathing. VO2 is determined by cardiac 
output, i.e. heart rate and stroke volume, and oxygen extraction at the tissue level. Systemic 
oxygen extraction is not normally considered to be a major limiting factor in patients with COPD, 
but has been found to be reduced in some patients and not in others. Cardiac output and stroke 
volume are reduced at peak exercise likely as a result of a reduction in peak work rate occurring 
because of other limitations, such as ventilatory, muscular or symptom limitations, and not 
because of a primary limitation in cardiac output. Peak heart rate is usually reduced, especially in 
studies using patients with more severe COPD. If cardiac output were the primary limiting factor 
to exercise, one would expect a maximal or near maximal heart rate at peak exercise. Because 
this does not occur, exercise ceases prior to attaining a maximal, limiting cardiac output. Sub-
maximal cardiac output, on the other hand, appears to be normal, with the decreased stroke 
volume being offset by an increased heart rate. Reduction in stroke volume at all exercise 
intensities is a consistent finding in most patients with COPD. This reduction is primarily caused 
by reductions in right ventricular output due to lung hyperinflation, increased pulmonary vascular 
resistance and reduced venous return as a result of increased intrathoracic pressure. The effects 
of lung disease on right ventricular dysfunction also extend to the left ventricle. Increased right 
ventricular pressure and volume induce a septal shift, which reduces left ventricular filling. The 
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overall effect is reduced left ventricular stroke volume. Patients with COPD are typically able to 
sustain relative constant load work rates that are much higher, ~82%, than healthy subjects , 
~68%, when expressed as a percentage of peak work rate obtained in an incremental test to 
exhaustion. The sustainable work rate achieved, i.e. critical power, in patients is directly related to 
measures of ventilatory function and dyspnoea. The fact that the relative critical power is much 
higher in patients is likely reflective of an abnormally low peak work rate during the maximal test. 
This fact provides further evidence that VO2max, and therefore maximal cardiac output, are not 
likely attained in patients, and suggests that symptoms or limitations in ventilation determine both 
the critical power and the duration of exercise in work rates above the critical power (I. M. 
Weisman et al. 2003; Butcher & R. L. Jones 2006). 
 
Peripheral Muscle Limitations 
Recent evidence has pointed to skeletal muscle dysfunction as a potential limiting factor to 
exercise tolerance in patients. Documented skeletal muscle abnormalities that affect exercise 
performance in patients with COPD include decreased lower extremity skeletal muscle mass, 
strength, endurance, capillarity, muscle oxidative enzyme capacity and proportion of type I fibers. 
The net effect of these abnormalities is a greater dependence upon anaerobic metabolism, an 
early rise in lactate during low levels of exercise and a markedly reduced lactate threshold. There 
is also direct evidence that skeletal muscle strength is correlated with exercise tolerance and that 
skeletal muscle training increases exercise tolerance. Also, administration of a bronchodilator, 
which increases FEV1 and raises the potential to increase ventilation, does not improve exercise 
tolerance in all patients. After exhausting exercise, contractile fatigue of the quadriceps occurs in 
some patients limiting exercise tolerance. These findings together provide evidence that skeletal 
muscle abnormalities contribute to exercise limitation in certain patients and may be due to any 
combination of deconditioning, muscle wasting, malnutrition, corticosteroid myopathy, hypoxia or 
electrolyte disturbances (Gosselink et al. 1996; Bernard et al. 1998; Serres et al. 1998; ATS & 
ERS 1999; F. Maltais et al. 2000; W.D-C Man et al. 2009a; W.D-C Man et al. 2009b; H.R. Gosker 
et al. 2007; Kim et al. 2008; Couillard & Prefaut 2005; Butcher & R. L. Jones 2006). 
 
Limitation to oxygen delivery 
During exercise, respiratory muscle VO2 required approximately ~40% of the total body peak 
oxygen consumption, i.e. VO2peak, in patients with COPD compared with 10–15% in HC. It was 
hypothesize that this increased respiratory requirement would reduce available oxygen for the 
exercising leg muscles, leading to early exercise limitation. Recently, it has been found that 
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increasing respiratory muscle loads during exercise reduces exercise performance and leg blood 
flow at maximal exercise in healthy subjects. In some patients with COPD, a plateau in leg 
muscle blood flow, oxygen delivery, VO2 and oxygen extraction occurs during incremental 
exercise, despite further increases in work rate and whole-body VO2. Although this plateau is 
present in HC, it occurs at a much lower work rate in patients. It was speculated that increases in 
work of breathing in patients who demonstrate a plateau might be a reason for reductions in 
exercise tolerance, due to redistribution of blood flow to the respiratory muscles during exercise. 
Also, when reducing the effect of central cardio-respiratory limitations during whole-body 
exercise, a significant metabolic reserve is demonstrated in COPD skeletal muscle. This reserve 
disappears when performing single limb exercise, i.e. repeated knee extension, with heliox and 
hyperoxia. It is likely that this finding demonstrates that skeletal muscle may not be the cause of 
exercise limitation, but that a deficiency in the oxygen delivery system is. Also, it is quite possible 
that a limitation in oxygen delivery is partly responsible for some of the skeletal muscle 
abnormalities demonstrated in these patients. Although the exact mechanisms of exercise 
intolerance vary across individuals, most patients with COPD come very close to reaching, if not 
reach, their pulmonary mechanical limits during heavy exercise. Other limitations, such as 
peripheral muscle fatigue may occur prior to reaching a ventilatory limitation; however, ventilation 
is usually close to maximal. Importantly, however, these limitations appear to be different than 
healthy age matched control subjects in type and magnitude, making exercise prescription much 
more complex (Bernard et al. 1998; Butcher & R. L. Jones 2006). 
 
Exercise training in pulmonary rehabilitation 
 
Movement is an important aspect of COPD patients daily life despite their limitations (V. Williams 
et al. 2011). In fact, patient's satisfaction with physical functioning, i.e. SPF, is considered a 
component of HRQL. More specifically, decreased satisfaction with physical abilities is associated 
with greater physical impairment, greater disability in valued activities, and depressive symptoms 
(Katula et al. 2004). Therefore, encouragement to be more active in daily life to improve the level 
of DPA is a major goal in the care of COPD patients and should be an important part of the 
management of patients with COPD because inactivity may influence their clinical evolution 
(Roche 2009). In fact, the GOLD guidelines (2013) indicates pulmonary rehabilitation as a 
recommended standard of care and management for COPD patients. A comprehensive 
pulmonary rehabilitation program is a multi-component intervention which include patient 
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assessment, exercise training, education, and psychosocial support (Nici et al. 2006; Ries et al. 
2007).  Its definition focuses on three important features of successful rehabilitation: 
 Multidisciplinary: Pulmonary rehabilitation programs utilize expertise from various healthcare 
disciplines that is integrated into a comprehensive, cohesive program tailored to the needs of 
each patient. 
 Individual: Patients with disabling lung disease require individual assessment of needs, 
individual attention, and a program designed to meet realistic individual goals.  
 Attention to physical and social function: To be successful, pulmonary rehabilitation pays 
attention to psychological, emotional, and social problems as well as physical disability, and 
helps to optimize medical therapy to improve lung function and exercise tolerance (Nici et al. 
2006). 
At current, of all the pulmonary rehabilitation programs topics, ExT is the major component and is 
considered an established safe and effective intervention for improving physical capacity and 
quality of life in COPD patients (Dressendorfer et al. 2002). Any patient with moderate to severe 
COPD and exercise or activity limitation who lacks contraindications should undergo ExT, 
particularly of the lower limbs (Ries et al. 2007). However, some studies highlighted importance of 
ExT also in the early stages of COPD in order to improve fitness of patients with mild to moderate 
COPD (Chavannes N.H. et al., 2001). Persons who lack access to formal comprehensive PR or 
supervised ExT should be given a home-based exercise program to follow (Thomas et al. 2010). 
Evidence suggests that expected gains in endurance are less when patients are given only 
education and verbal advice and guidance about exercise, as compared to participating in a 
supervised exercise program (C. L. Rochester 2003). Although exercise and education sessions 
are conducted twice weekly in many outpatient programs, one recent study highlighted that twice 
weekly exercise may not be sufficient to achieve gains in walking distance and health status 
(Ringbaek et al. 2010). The recommendations for exercise training in the above-noted current 
clinical guidelines are summarized in the Figure 3.k. 
 
Clinical benefits of Exercise Training in Pulmonary Rehabilitation 
 
Many physiological and psychological benefits have been reported in COPD patients after 
participation in randomized controlled trials of prescribed exercise involving upper and lower body 
endurance and/or resistance training. Major benefits include increased physical capacity, 
decreased anxiety about breathlessness, greater independence in ADL, reduced fatigue and 
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Figure 3.k – Evidence-based guidelines for ExT in COPD. 
 
(C. L. Rochester 2003). 
 
improved QoL (C. L. Rochester 2003; N. H. Chavannes et al. 2002; Dressendorfer et al. 2002; 
Butcher & R. L. Jones 2006). These positive outcomes occur even though impaired lung function 
continues to persist after ExT (Dressendorfer et al. 2002) despite discordance about benefits 
duration and maintenance over the time (C. L. Rochester 2003). However, regular ExT thus 
enables COPD patients to do more recreational and vocational activities despite their lung 
disease (Dressendorfer et al. 2002). Finally, since both aerobic fitness/endurance training and 
weight training can be beneficial and are safe for patients with COPD most rehabilitation 
programs currently use both types of training (C. L. Rochester 2003; Butcher & R. L. Jones 
2006). 
 
Effects of Endurance Training in COPD patients 
In general, endurance ExT improves one’s ability to sustain an exercise task at a given work load. 
Walking, running, cycling, stair climbing and swimming are examples of endurance training 
exercise (C. L. Rochester 2003). Recently, it was suggested that also Nordic Walking could be an 
effective ExT to improve endurance capacity of COPD patients (Breyer et al. 2010). Endurance 
training is regarded as a fundamentally important component of any pulmonary rehabilitation 
program (C. B. Cooper 2001). Evidence-based guidelines for PR, published jointly by ACCP and 
AACVPR, identified two modalities of treatment that have been shown by well-designed, 
prospective, placebo-controlled, clinical trials to be of value in pulmonary rehabilitation (Ries 
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2008; Ries et al. 2007). These modalities are endurance training, using large muscle groups and 
strategies to assist with the mastery of dyspnea. Interestingly, aerobic exercise per se might be 
one of the most efficacious and time-efficient means of achieving mastery of dyspnea (C. B. 
Cooper 2001). There is little doubt that endurance training, especially for lower extremities, is 
beneficial and an important components of PA programs for COPD patients (Butcher & R. L. 
Jones 2006; B.R. Celli, MacNee, et al. 2004). As breathless and fatigue are the major limiting 
symptoms, improvements in endurance may contribute to greater sustainability of task 
performance, and lower levels of perceived fatigue, which, clinically, have been associated with 
improved functional performance, exercise tolerance and health status (Casaburi et al. 1997; C. 
B. Cooper 2001; Salman et al. 2003; Langer et al. 2009). Randomized controlled trials about 
endurance ExT effectiveness reported significant improvements in maximal exercise capacity, 
walking distance and endurance capacity after respiratory rehabilitation (Troosters et al. 2000; 
Casaburi et al. 1997; M.A. Spruit et al. 2004; van Helvoort et al. 2010). Bicycle ergometry training 
at workloads of at least 60% of maximal workload, showed improvements in maximal workload, 
~30%, and endurance time, ~70% (M.A. Spruit et al. 2004). Moreover, increases in endurance 
time and in time to fatigue at identical pre- and post- training work rates were observed, with a 
range from 70% to 100% (M.A. Spruit et al. 2004; Butcher & R. L. Jones 2006). Similar 
improvements were observed in ExT program incorporating both treadmill and walking exercise 
or combined walking and cycling programs (Casaburi et al. 1997; Nici et al. 2006; Lacasse et al. 
2006; Troosters et al. 2000; M.A. Spruit et al. 2004). Improvements in 6MWD by 10–25%, in 
HRQOL, in activities of daily living and reduced symptoms of dyspnea and fatigue were observed 
(Troosters et al. 2000; M.A. Spruit et al. 2004; Butcher & R. L. Jones 2006). Increases in VO2peak 
are not as commonly observed (Butcher & R. L. Jones 2006). 
 
Intensity Training in COPD patients 
Many low- and moderate intensity show non-significant increases in VO2peak after training 
(Butcher & R. L. Jones 2006) although gains in exercise tolerance were demonstrated (C. L. 
Rochester 2003). Striking gains in treadmill endurance were observed without increases in 
VO2max (Ries 2008). Low-intensity multimodality ExT also led to increased exercise tolerance for 
patients undergoing inpatient PR. The mechanisms by which exercise tolerance/endurance 
improves following low-intensity exercise, where in no specific improvements in aerobic fitness 
are noted, are not fully elucidated. However, gains in peripheral or respiratory muscle strength, 
increased mechanical efficiency of performing exercise due to improved neuromuscular coupling 
and coordination, reduction in hyperinflation/ improved lung emptying, reduced anxiety and 
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dyspnea, and improved motivation may all play a role. Different combinations of mechanisms 
likely result in the improvements noted in individual persons. In general, high-intensity exercise is 
considered to be that which takes place at greater than 60 percent of the patient’s VO2max or 
Wmax, whereas lower intensity exercise is conducted at lower work rates (C. L. Rochester 2003; 
Butcher & R. L. Jones 2006). High to near maximal intensity studies tend to show more 
consistent increases in VO2peak Interestingly, peak ventilation also increase with training, 6-11%, 
with slightly greater change likely after higher intensities of training, 9-11%, compared with lower 
intensities, 6-8%, although this is not consistent across all studies. Greater peak of ventilation 
may be explained by reductions in dynamic hyperinflaction and by increases in ventilator 
efficiency that occur as a result of training (Butcher & R. L. Jones 2006). Characteristic 
physiologic changed provided by high intensity training indicating improvements in aerobic fitness 
following ExT include increased muscle fiber capillarization, mitochondrial density and oxidative 
capacity of muscle fibers, and delay of the onset of anaerobic metabolism during exercise, i.e., 
ability to exercise to a higher work rate before reaching the anaerobic/lactate threshold. These 
factors in turn lead to reduced ventilatory requirement for a given exercise task, increased VO2max 
and decreased HR for a VO2. The demonstration of improvements in one or more of these 
variables following exercise training in patients with COPD is evidence of physiologic 
improvement in aerobic fitness (C. L. Rochester 2003; Casaburi et al. 1997; C. B. Cooper 2001; 
Butcher & R. L. Jones 2006). 
 
Guidelines for Endurance Training 
“ The evidence-based guidelines for pulmonary rehabilitation indicate scientific support in favor of 
aerobic exercise training using the large muscle groups of the legs. Arm endurance training is 
less effective than leg endurance training in improving functional capacity. Furthermore, when 
time for supervised endurance training is limited, it is clearly advantageous to focus on leg 
exercise. […]  Treadmill exercise is usually preferred by patients and rehabilitation therapists 
because of the readiness with which patients adapt to treadmill exercise and with which it 
translates to activities of daily living. Cycle ergometry can be used as a means of varying the 
exercise mode, provided intensity criteria are matched between the treadmill and cycle. In some 
cases, such as patients with arthritis, joint deformities, or morbid obesity, the cycle ergometer will 
be preferred because of its low impact on the musculoskeletal system. Cycle ergometry might 
also be chosen if therapists find difficulty with monitoring, such as pulse oximetry or 
electrocardiography during treadmill exercise. […] Pulmonary rehabilitation should aim for an 
accumulation of 30 min of aerobic exercise on at least 3 d/wk for at least 6–8 wk. […] Perhaps the 
most contentious of all issues regarding exercise prescription in chronic pulmonary disease is the 
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question of an appropriate exercise intensity. Several studies have indicated, as with normal 
subjects, that higher exercise intensity results in better training responses […]. Despite these and 
similar findings, it has never been proven that there is a threshold exercise intensity above which 
it is necessary to train in order to obtain benefit. By contrast, low-intensity training induces 
worthwhile training responses both in asthmatic subjects and in those with COPD. 
Notwithstanding this knowledge, in order to obtain the most favorable response, patients in 
pulmonary rehabilitation should be encouraged to train at as high an intensity as tolerated with 
due consideration for various safety aspects. The obvious concern is that unsupervised training is 
less likely to achieve and sustain the exercise intensity required to elicit a clinically meaningful 
improvement in functional capacity. Determination of the optimal exercise intensity is the essence 
of the aerobic exercise prescription. An arbitrary approach (i.e., guessing the exercise intensity 
and making empirical adjustments) is unlikely to be the most effective strategy. However, 
unfortunately this is how many pulmonary rehabilitation programs operate. In order to advance 
the discipline of pulmonary rehabilitation and in order to optimize outcomes, the aerobic exercise 
prescription needs a firmer scientific basis. […] First, exercise intensity should have a “target” that 
represents the minimum intensity needed to produce a clinically meaningful response. This does 
not imply that exercise intensities below the target are ineffective but rather that any such effect 
would be insufficient to translate into clinical benefit. Second, exercise intensity should have a 
“range,” the upper limit of which is typically defined by patient acceptance and safety 
considerations. Third, an effective exercise prescription must take into account “progression,” 
necessitating careful adjustment of the exercise prescription to maintain the desired intensity in 
the presence of training adaptations. Again, it is self-evident that in order to attain these goals 
with any degree of precision requires some physiological measurement or monitoring. […] 
Patients with COPD are known to be able to achieve greater than 80% of their initial maximum 
work rate as a training intensity. […] The diverse nature of limitation in COPD is likely to make it 
more difficult to predict what percentage of achieved maximum work rate constitutes an 
appropriate exercise prescription. Similar considerations are likely to apply to a percentage of 
measured V˙ O2max. The traditional and probably the commonest approach to aerobic exercise 
prescription for normal subjects uses a percentage of predicted maximum heart rate or heart rate 
range calculated from measured or predicted maximum heart rate. Again, in patients with chronic 
pulmonary disease, measured heart rate often does not bear the same relationship to exercise 
intensity that one expects with normal subjects. Furthermore, predictions of maximum heart rate 
are subject to errors. […] One way around these difficulties is to use RPE rather than heart rate 
as a measure of exercise intensity. When using the RPE scale, it is helpful to establish some idea 
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of the relationship between RPE and heart rate for a given individual. For a given subject in 
pulmonary rehabilitation, this can be achieved simply by making paired observations of heart rate 
and RPE during submaximal exercise. Also, the RPE scale (range, 6–20) is preferred to the CR-
10 (range, 1–10) scale […].  Regular use of the RPE scale in the manner Borg intended leads to 
an appreciation of the appropriateness of RPE compared with the cardiovascular response to 
exercise. […] When RPE is used to determine the aerobic exercise prescription for pulmonary 
rehabilitation, the desired threshold is likely to be 12 and the upper limit 16. Many rehabilitation 
programs use a rating of breathlessness rather than perceived exertion as an intensity target for 
patients with chronic pulmonary disease. This approach seems understandable on the basis of 
the fact that breathlessness is often the dominant limiting factor in these patients […]” (C. B. 
Cooper 2001, pp. 673-674). Finally, current knowledge supports prescription of low to moderate 
endurance intensity training to increase COPD patients ability to sustain tasks currently able to 
perform, and High endurance intensity training in order to enhance ability to perform tasks that 
are above the current level (C. B. Cooper 2001; C. L. Rochester 2003; Butcher & R. L. Jones 
2006) 
 
Effects of Resistance Training in COPD patients 
Resistance training is an exercise modality in which small muscle groups are trained by 
repetitively lifting heavy weights. This training modality has been successfully used in the 
rehabilitation of elderly subjects and in patients with chronic heart failure to improve peripheral 
muscle force, exercise capacity and ambulation (Spruit et al. 2004; C. L. Rochester 2003). A 
recent review (2009), O’Shea and colleagues analyzed the results from 18 controlled clinical trials 
and confirmed progressive resistance exercise with isotonic and/or free weight as an appreciable 
modality of training in order to improve several important COPD patients PR therapy outcomes, 
such as muscle strength, 6MWD and mass. Despite these findings, improvements in body 
composition, psychological function, societal participation and maximal exercise capacity 
remained inconclusive (O’Shea et al. 2009) confirming previous studies (Bernard et al. 1999). “ 
Progressive resistance exercise can lead to appreciable increases in arm and leg muscle 
strength for people with COPD. Given that muscle weakness is a common problem in this 
population, progressive resistance exercise represents a beneficial treatment for improving 
muscle strength. Moreover, improvements in muscle strength can be obtained when progressive 
resistance exercise is conducted alone or in combination with aerobic training, indicating that it 
can be successfully performed in conjunction with other training modalities during pulmonary 
rehabilitation. Despite improvements in muscle strength after progressive resistance exercise, 
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inconclusive evidence was found for changes in skeletal muscle structure. Minor structural 
adaptations may reflect the small number of investigations, small sample sizes, or variations in 
training type and intensity utilized. Furthermore, disease-related factors, such as chronic hypoxia, 
long-term corticosteroid use, altered endocrine hormone concentrations, systemic inflammation, 
or nutritional status, may influence the rate or degree of muscle remodeling occurring during 
progressive resistance exercise for people with COPD. A primary goal of rehabilitation 
interventions for people with COPD is to optimize function. Therefore, it is important to determine 
whether increases in muscle strength after progressive resistance exercise translate into 
meaningful changes in activity performance and societal participation. Improved endurance in 
healthy young persons, and older adults has been reported after progressive resistance exercise. 
As fatigue is a major symptom identified by people with COPD, improvements in endurance may 
contribute to greater sustainability of task performance, and lower levels of perceived fatigue, 
which, clinically, have been associated with improved functional performance. When compared 
with no intervention, the findings […] suggest an apparent trend toward improved endurance after 
progressive resistance exercise for people with COPD. However, when progressive resistance 
exercise is compared with aerobic training, improvements in cycling endurance favor aerobic 
training; highlighting the importance of aerobic training modalities for increasing endurance in 
people with COPD. Moreover, no additional benefit was demonstrated by adding progressive 
resistance exercise to a program of aerobic training. Concurrent progressive resistance exercise 
and aerobic training has been recommended during pulmonary rehabilitation for people with 
COPD; but it remains unclear which participants and which outcomes will benefit most and how 
combined training is best implemented in the clinical setting. […] Improvements in muscle 
strength may carry over to improved daily task performance, such as stair-climbing, sit-to-stand, 
and arm elevation activities. […] However, it has been reported  […] that participants reported 
improvements in measures of impairment, i.e. muscle strength, in the context of activity 
performance, despite no change being detected with quantitative measures of activity. Future 
investigations of rehabilitation interventions, such as progressive resistance exercise, should 
place greater emphasis on measures of activity and participation, as clinically meaningful benefits 
for people with COPD are likely to be associated with improvements in tasks and roles that are 
important in the context of daily life […]” (O’Shea et al. 2009). 
 
Intensity and Modality Training in COPD patients 
Fewer studies have evaluated the impact of strength training as a sole exercise modality for 
persons with COPD. The relative advantages and disadvantages of high- versus low-intensity 
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strength training for persons with COPD are as yet unknown (C. L. Rochester 2003). The typical 
progressive resistance exercise protocols used in PR were similar to guidelines for healthy adults  
and those that have been applied to healthy older adult populations (M. E. Nelson et al. 2007; W. 
J. Chodzko-Zajko et al. 2009; Haskell et al. 2007) and very few adverse events were reported,  
suggesting that progressive resistance exercise is generally safe and appropriate for people with 
COPD (O’Shea et al. 2009). However, prevention of muscle tears is of paramount importance, 
particularly for persons on chronic steroid treatment who may be at risk for muscle rupture, i.e. 
biceps, when exposed to a high-intensity load. Clearly, such rupture can lead to prolonged, if not 
permanent, additional functional disability (C. L. Rochester 2003). Despite moderate withdrawal 
rates from trials, high levels of training adherence were reported with short-term interventions 
(O’Shea et al. 2009). 
 
Effects of Eccentric Exercise Training in COPD patients 
Many COPD patients do not tolerate high exercise intensities during whole body exercise 
because of breathlessness (C. B. Cooper 2001). Dynamic exercise can be accomplished by 
either concentric , i.e. positive work, or eccentric muscle contractions, i.e. negative work. During 
eccentric exercise, such as lowering a weight or walking downstairs, the contracting muscle 
lengthens in a controlled way, whereas during concentric exercise, i.e. lifting a weight and walking 
upstairs, the muscle shortens (Asmussen E. 1953). It was observed that eccentric exercise is 
associated with a reduced oxygen cost and ventilator requirement both in HC subjects and 
patients with COPD (Rooyackers et al. 2003) compared to concentric exercise at the same 
absolute workload (Roig et al. 2008; Rooyackers et al. 2003). It is generally accepted that 
exercise protocols in which eccentric actions are emphasized produce more important gains in 
strength (Hilliard-Robertson et al. 2003) muscle mass (Seger et al. 1998) and neural adaptations 
(Hortobabyi et al. 1996) than regimens consisting of concentric actions only. Moreover, when 
eccentric and concentric contractions are performed at the same metabolic level eccentric-biased 
interventions result in greater strength gains and muscle fiber hypertrophy (LaStayo et al. 2000). 
The lower metabolic, neural, and cardio-respiratory cost of eccentric actions (Hortobabyi et al. 
2000) combined with the relative preservation of eccentric force expression during ageing 
(Hortobabyi et al. 1995) has led to the prescription of this type of training programm for individuals 
with reduced tolerance for physical activity (Krishnathasan et al. 2000). Despite evidences of 
musculoskeletal dysfunction in COPD patients (Couillard & Prefaut 2005; Kim et al. 2008; W.D-C 
Man et al. 2009b; W.D-C Man et al. 2009a), only one study explored the use of eccentric-biased 
programs in exercise COPD patients’ prescription (Roig et al. 2008). Rooyackers and colleagues 
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(2003) applied eccentric training in a COPD patients PR trial, establishing that eccentric exercise 
training is enabled the patients to achieve high intensities in terms of strength and endurance 
without being short of breath and while maintaining SaO2 above 90%. Moreover, they found that 
non-contractile components of the muscle and elastic elements contribute to the force generation 
during eccentric contractions and higher forces were generated during negative work as 
compared to positive work. Also, at similar work-loads, electromyographic activity and perceived 
exertion were lower, whereas mechanical efficiency was higher during negative work. Finally, 
despite all patients experienced some muscle soreness during the first 4 weeks of eccentric ExT, 
due to muscle damage provided by the negative work, this was well tolerated, did not influence 
the exercise intensity achieved during the training, reporting patients enjoyment to perform this 
type of exercise because of the low impact of exercise-limited symptoms, i.e. dyspnea and 
breathlessness during a conversation (Rooyackers et al. 2003). In conclusion, the relative 
conservation of eccentric force in older individuals (Hortobabyi et al. 1995)  and in COPD patients 
(Mathur et al. 2007)  by comparison to either isometric or concentric force makes this contraction 
a potential tool for restoring muscle function in COPD patients, also because the great capacity of 
eccentric contractions to induce muscle gains and neural adaptations (LaStayo et al. 2000) at a 
reduced metabolic level has been demonstrated (Roig et al. 2008).  
 
Effects of Exercise Training on Balance in COPD patients 
Impairments in peripheral muscle function, mobility, and exercise capacity are well established in 
COPD patients (ATS & ERS 1999; Bernard et al. 1998). However, emerging evidence also 
suggests that older adults with COPD show important reductions in balance control that may be 
associated with an increased fall risk in this population (Roig, Eng, D. L. Macintyre, J. D. Road, et 
al. 2010; Beauchamp et al. 2011). Although information regarding postural control in persons with 
lung disease is limited, evidence suggests that balance deficits constitute an important secondary 
impairment in older adults with COPD (Beauchamp et al. 2010). Two studies have shown 
reduced balance performance and coordination in subjects with COPD compared with healthy 
controls (Eisner et al. 2008; Butcher et al. 2004). One study examining the impact of fatigue on 
physiologic measures of postural sway found that patients with COPD showed impaired static 
postural control after a 6MWT in the absence of visual input, i.e. eyes-closed condition (Chang et 
al. 2008). In addition, it was reported that standard clinical balance measures discriminated 
between fallers and non-fallers with COPD, despite similar pulmonary function and 6MWT 
distances in the 2 groups (Beauchamp et al. 2009). ACSM recommends exercise with balance 
training as an essential component of a multifactorial falls intervention strategy for community-
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dwelling older adults who are at risk for falling (M. E. Nelson et al. 2007). Although the exercise 
component of PR is considered the cornerstone of rehabilitation for patients with COPD, it is 
directed predominately to training peripheral muscles. Balance training and fall prevention 
strategies are not included in international guidelines for PR, and very few programs include 
standardized balance assessment (Ries et al. 2007). Beauchamp and colleagues (2010) 
described effects  PR on balance in persons with chronic obstructive pulmonary disease (COPD) 
in order to determine whether any observed changes in balance were associated with change in 
exercise tolerance or health-related quality of life. They observed that PR was associated with 
minor changes in results of standard clinical tests of balance, without effects on balance 
confidence in patients with COPD. Also, they highlighted that measures of exercise tolerance and 
HRQL could not be used as surrogate measures to derive balance information. Finally, they 
emphasized the value of including a balance assessment and specific balance training in PR 
program, especially in patients with moderate and severe COPD, particularly if they have a 
history of falling (Beauchamp et al. 2010; Beauchamp et al. 2011). 
 
 
 
  
90 
 
 
 
 
 
 
 
 
 
  
91 
 
SEDENTARY BEHAVIOR, EXERCISE & MUSCLE WASTING IN COPD 
 
Evidence of Skeletal Muscle Dysfunction in COPD patients 
 
DPA, HRQL, muscle strength and performance are likely intimately interlinked. At present, 
skeletal muscle weakness is recognized to contribute to poor health status, increased health 
utilization and even mortality. Therefore muscles seems to represent a potential site to improve 
COPD patients level of function and their QoL, in contrast with the irreversible lungs impairment 
(W.D-C Man et al. 2009b). Initially, this dysfunction has been tried to be explain by the sedentary 
lifestyle commonly observed in COPD patients. Then, in light of the most recent research, 
evidence has suggested that a sedentary lifestyle is unlikely to be the only explanation for this 
muscle weakness. Therefore, it was assumed that an intrinsic muscle disease, i.e. myopathy, 
may play an important role in reducing muscle strength performances of COPD patients (M. P. 
Engelen et al. 2000; Couillard & Prefaut 2005; Kim et al. 2008).  Myopathy is defined as a 
“disease of the muscle unrelated to any disorder of innervations or the neuromuscular junction”, 
implying that muscle is affected by a pathological condition and couldn’t function normally. There 
are different forms of myopathy, such as hereditary, metabolic, inflammatory, endocrine, and toxic 
causes. Whatever its form, myopathy is usually characterized by several metabolic, 
morphological and/or structural muscle abnormalities that lead to dysfunction (Couillard & Prefaut 
2005).  Literature indicates that corticosteroids, inflammation, hypoxemia and oxidative stress are 
the major factors contributing to COPD muscle dysfunction, although their relative contributions 
have not been fully elucidated (Couillard & Prefaut 2005; Kim et al. 2008). 
 
Functional characteristics of Skeletal Muscle Dysfunction  
 
In patients with COPD, peripheral muscle dysfunction is clearly evidenced by a significant 
reduction in both strength and endurance in the patients ambulatory muscles compared with 
healthy subjects (Couillard & Prefaut 2005; Kim et al. 2008; van der Vlist & Janssen 2010; W.D-C 
Man et al. 2009a)  
 
Depressed muscle strenght 
 
Muscle strength is the muscle capacity to develop maximal force. Alterations in muscle strength 
performances of COPD patients are not homogenous between various muscle groups (Mador & 
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Bozkanat 2001; Kim et al. 2008). Gosselink and collegues (1996) have found that COPD upper 
limb strength was relatively preserved when compared to lower limbs (Mador & Bozkanat 2001). 
Diaphragm, adductor pollicis and abdominal muscles are relatively preserved in COPD patients 
compared with age-matched healthy control (Gosselink et al. 1996; Bernard et al. 1998; ATS & 
ERS 1999; Kim et al. 2008; W.D-C Man et al. 2009b) (Figure 4.a). Reasons behind differences 
between various skeletal muscles remain unclear, althought many investigators have proposed 
daily muscle recruitment and activation as determinant factors (Kim et al. 2008). In general, 
depressed muscle strenght appears to be particularly localized in to lower arms or, however, 
seems to involve primarly the lower limbs (Mador & Bozkanat 2001). The amount of the decrease 
was estimated about 20-30%, than compared with age-matched HC (Gosselink et al. 1996; 
Bernard et al. 1998; Serres et al. 1998; van der Vlist & Janssen 2010), althought these 
differences disappear when quadriceps strength is normalized to the mid-thigh cross-sectional 
area (Bernard et al. 1998; W.D-C Man et al. 2009b). The  degree of the strength decrease seems 
to be correlated with the disease stage severity (Bernard et al. 1998; Mador & Bozkanat 2001). 
Depressed muscle strenght in COPD lower limbs is an important topic of research because it 
seems to be a relatively predictor of mortality, affecting the exercise capacity, increasing 
symptoms as dyspnea and deteriorating patients QoL (Gosselink et al. 1996; Swallow et al. 2007; 
Kim et al. 2008) 
 
 
Figure 4.a – Localization of skeletal muscle weakness in COPD patients 
 
(from W.D-C Man et al. 2009) 
 
Reduction in muscle endurance 
 
Muscle endurance is defined as the muscle capacity to maintain a certain force over the time and, 
together with the muscle strength, it’s a determinant of the strength performance in COPD 
patients (Couillard & Prefaut 2005; Kim et al. 2008; W.D-C Man et al. 2009a). Information about 
the limb muscle endurance in patients affected by COPD is still conflicting (Mador & Bozkanat 
2001). No homogenous reduction was observed in endurance COPD patients muscle capacity: 
93 
 
for instance, ventilatory muscles, particularly diaphragm, present different workloads than do the 
lower limb muscles. Caused by an increased work of breathing brought on by airflow obstruction 
and hyperinflation, ventilatory muscles are in a chronically overload state. Instead, lower extremit 
muscles are in a chronically underloaded state due to a chronic inactivity and disuse (Kim et al. 
2008). Comparison bnetween quadriceps and diaphragm showed seems the last relatively 
fatigue-resistant to exhaustive exercise; also it has been showed that COPD diaphragm fibers are 
metabolically more efficent than those from HC (W.D-C Man et al. 2009b). These findings 
suggest that dissimilar loading patterns could the likely cause of biochemical and structural 
adaptations in ventilatory muscles, not present in lower limb muscles (Kim et al. 2008). Newell 
and collegues (1989) did not found any changes in endurance capacity of the elbow flexors, but 
in Zattara-Hartmann study (1995) it was observed a significant reduction in adductor pollicis 
endurance (W.D-C Man et al. 2009b).  However, several studies have confirmed the presence of 
alterations in endurance capacity of the lower limb skeletal muscle of COPD, due by a 
morphological and enzymatic deficiencies (Maltais, 1996; Whittom, 1998) and a change in 
mitochondrial oxidative capacity (Allaire et al. 2004; Kim et al. 2008).These alterations reduce 
endurance approximately of 30/50%, in patients with moderate COPD (Serres et al. 1998; ATS & 
ERS 1999; Kim et al. 2008) and increase quadriceps fatigability for equivalent workload (Mador et 
al. 2003; W.D-C Man et al. 2009b). Finally, this impairment seems to be positively correlated with 
physical activity index, FEV1, and resting PaO2 (Serres et al. 1998; Mador et al. 2003; Kim et al. 
2008). 
 
Structural characteristics of skeletal muscle dysfunction  
 
In addition to the functional skeletal muscle abnormalities, loss of muscle performance is due also 
by a muscle structure changes, i.e. muscle atrophy, and a dysfunction of the remaining muscle 
tissue, as changes in fiber type size, fiber type distribution, muscle section, type of fiber oxidative 
capacity and metabolic capillary distribution (Couillard & Prefaut 2005; Kim et al. 2008; van der 
Vlist & Janssen 2010). 
 
Muscle fiber atrophy 
 
As in other chronic inflammatory condition, it has long been observed that a proportion of severe 
COPD patients develop a “cachexic” state with significant weight and muscle mass loss (E. F. M. 
Wouters 2002; W.D-C Man et al. 2009b). In 1993, Shols and collegues demonstrated that about 
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of the 45% of stable COPD patients were either underweight or have a depletion in FFM, mainly 
in muscle mass (W.D-C Man et al. 2009b). Althought there aren’t results regarding the direct 
measurement of muscle mass of individual muscles, in several studies, radiological tecniques 
have demonstrated that the lower limb muscles of COPD patients show a significant muscle 
atrophy, caracterized by a reductions in mass, in mid-thigh and in calf muscle cross sectional 
area compared with matched HC (Wuyam et al. 1992; H.R. Gosker et al. 2000; H.R. Gosker et al. 
2003; Hopkinson et al. 2007; W.D-C Man et al. 2009b; Mador & Bozkanat 2001). The amount of 
thigh muscle mass loss is relatively greater than the whole body weight, indicating a preferential 
loss of muscle tissue over other body tissues in COPD (Bernard et al. 1998; Kim et al. 2008). The 
degree to which fiber atrophy contributes to reduce the lower muscle strength in this patients 
remains yet unclear and is still on debate. 
 
Fiber type shift 
 
The latest results in research suggest that besides atrophy, dysfunction of the remaining muscle 
also contributes to the loss in COPD muscle function (Van der Vlist & Janssen 2010). The 
diaphragms of patients in severe disease stage showed an increased proportions of type I fibers 
as compared with HC. This was documented firslty by Levine and collegues (1997), reporting that 
the proportion of type I fibers averages 64% of total fibers whereas the proportion of these fibers 
averages only 45% in control diaphragms (Levine et al. 1997). This rise in proportion of type I 
fibers in the diapragm is evident only in severe COPD (Kim et al. 2008). Moreover, fiber type 
switching toward an increase in proportion of type I fibers can also be observed in other 
inspiratory muscles, such as parasternal intercostals (Kim et al. 2008). Instead, several studies 
about quadriceps muscles of patients with severe COPD found a significant redistribution of fiber 
type ratios, with a reduction in the proportion of the type I, i.e. slow-twitch oxidative, and an 
increase of the proportion of type IIb, i.e. fast-twitch glycolytic, fibers (H.R. Gosker et al. 2003; 
Mador & Bozkanat 2001). Whittom’s study (1998) showed a 20% of decrease in fiber type I and 
an increase of 10% in fibers type IIb of COPD patients compared to healthy subjects (ATS & ERS 
1999). Several studies reported oxidative fibres averaged at ~23% (even down to 19%) in the 
patients, whereas they average, as expected, 44% in the healthy sedentary subjects (Allaire et al. 
2004; Remels et al. 2007; H.R. Gosker, van Mameren, et al. 2002; Couillard et al. 2003; Couillard 
& Prefaut 2005). These results clearly indicate a two-thirds reduction in the proportion of type I 
fibres in the peripheral muscles of COPD patients, which is unlikely to be accounted for by 
muscle disuse alone (Figure 4.b) (Couillard & Prefaut 2005; Mador & Bozkanat 2001). 
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Studies about histochemical composition of the vastus lateralis muscle in patients with moderate 
to severe COPD, found correlation between proportion of type I fibers , lung function and BMI. In 
addition, several investigators reported also an atrophy of the type I, IIa and IIx fibres (H.R. 
Gosker, M. P. K. J. Engelen, et al. 2002; W.D-C Man et al. 2009b). The findings suggest an 
increase in early fatigabable type II fibers proportion leading to an increased muscle fatigue, with 
a consequently reduction in lower arms endurance performances (H.R. Gosker et al. 2000). 
Moreover, a lower oxidative enzyme activity (H.R. Gosker, Van Mameren, et al. 2002; F. Maltais 
et al. 2000; Wuyam et al. 1992) and mitochondrial density (Picard et al. 2008) have been shown 
in the vastus lateralis muscle of COPD patients comparing with HC (H.R. Gosker et al. 2007). 
 
 
 
Figure 4.b – Histochemical proportion of type I (      ) and type II (      ) fibres observed in vastus lateralis of healthy 
active, long-term sedentary and COPD subjects. 
 
(Couillard & Prefaut 2005) 
 
Changes in fibre type distribution, low levels of oxidative enzyme activities and a low 
mithocondrial density suggest a reduced oxidative capacity of skeletal muscle in COPD, which is 
associated with an early increase in intracellular acidosis occurring at lower work rates when 
compared to HC (Van der Vlist & Janssen 2010). Lower capillary to muscle fiber ratio in vastus 
lateralis were found on COPD patients compared to HC (Eliason et al. 2010). In conclusion, the 
lower limb skeletal muscle of people affected by COPD do not function appropriateley (Table 4.1). 
 
Consequences of skeletal muscle dysfunction in patients with COPD 
 
Exercise intolerance and dyspnea on exertion are considerated the most common symptoms in 
patients with COPD (Kim et al. 2008), which reduced the QoL and incresed the risk of premature 
death (Mador & Bozkanat 2001; Kim et al. 2008). These complaints cannot be explained entirely 
on the basis of a decline function and impaired gas excanghed: in fact, lung function impairments  
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Table 4.1 – Quadriceps muscle abnormalities in COPD 
Abnormality 
Clinical Reduced strength 
 Increased fatigability 
 Reduced endurance 
 Reduced mid-thigh CSA 
Structural Reduced fiber type I proportion and increased fiber type IIx proportion 
 Reduced fiber CSA 
 Reduced capillary contacts to fiber CSA 
Metabolic Reduced oxidative enzyme capacity and increased glycolytic enzyme activity 
 Increased intracellular acidosis 
 Increased lactic acid 
 Reduced PCr/Pi ratio 
 
(from W.D-C Man et al. 2009b) 
 
shows only a weak relation to exercise capacity, suggesting that other factors could play an 
important role in exercise tolerance in these patients (M.A. Spruit et al. 2004; Kim et al. 2008).  
Indeed, association between skeletal muscle function, FFM and exercise capacity (E. F. M. 
Wouters 2002; W.D-C Man et al. 2009b), improvements in muscle function and exercise 
tollerance (M.A. Spruit et al. 2004; Kim et al. 2008), and significant relationship between mid-thigh 
cross sectional area and mortality (Marquis 2002) suggest that muscle wasting may play 
important roles in exercise capacity in COPD patients.  Decramer et collagues (1997) shown also 
that a reduction in exercise capacity and the quadriceps weakness lead to disability and correlate 
with higer utilization of helath care resources (Kim et al. 2008). 
 
Mechanisms of skeletal muscle dysfunction in COPD patients 
 
Skeletal muscle dysfunction in COPD patients can be attributed to a set of complex interactions 
between many factors, both systemic and local (Figure 4.c). 
 
Inflammation 
 
At present, it is clearly established the association between COPD and both systemic and local 
inflammation, characterised by an enhanced activation of circulating inflammatory cells, i.e. 
neutrophils and lymphocytes, a greater expression of surface adhesion molecules in circulating 
neutrophils, and an increased plasma level of cytokines, including tumor necrosis factor-alpha 
(TNFα), interleukin-8 (IL8), IL6 and its receptors tumour necrosis factor, as sTNF-R55 and sTNF-
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R75, and C-reactive protein. This increased circulating levels of inflammatory cells induces a 
systemic oxidative stress (Couillard & Prefaut 2005; Kim et al. 2008; van der Vlist & Janssen 
2010).  
 
 
Figure 4.c – Potential mechanisms of skeletal muscle dysfunction in COPD patients 
UPP, ubiquitin/proteosomal pathway 
 
(from Kim et al. 2008) 
 
One likely source of inflammation is the lungs, but no direct correlations have been found 
between sputum and plasma concentrations of inflammation markers in patients with mild to 
moderate COPD, suggesting contribution provided by other organs, such as the skeletal muscle. 
Some studies indicated association between systemic inflammation, abnormal body composition 
and muscle dysfunction, observing that serum levels of TNFα seem to be higher in COPD 
patients with reduced body mass, BMI and FFM (Van der Vlist & Janssen 2010). Moreover, 
several studies confirmed both ventilatory muscle, i.e. diaphragm and intercostal muscles, and 
lower limb muscle, such quadriceps, as sources of systemic inflammation. Inflammatory 
mediators involvement in skeletal muscle dysfunction is suggested by the observation that 
systemic inflammation markers correlate with poor muscle contractile performance in COPD 
patients. In Spruit’s study (2003), quadriceps muscle strength correlates negatively with serum 
IL8 levels in COPD patients during exacerbations and with IL6 and TNF-α in aged COPD patients 
(Kim et al. 2008). Although the exact mechanisms have not yet been complitely elucidated, the 
muscle dysfunction in COPD seems to be caused by alterations in both degradation and the 
syntesis rate of muscle proteins (Figure 4.d). 
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Figure 4.d – The possible effects of inflammation on muscle protein degradation and synthesis. 
 
(from Van der Vlist & Janssen 2010) 
  
Several studies shown that systemic inflammation may trigger a catabolic/anabolic imbalance that 
results in skeletal muscle wasting and reduced strength (Jagoe & M. P. K. J. Engelen 2003; 
Couillard & Prefaut 2005). Therefore, inflammation seems to have a negative impact on muscle 
protein catabolism, affecting the growth and the contractile muscle performances of patients with 
COPD, via different cytockine-mediated pathways, particularly TNF-α (Couillard & Prefaut 2005). 
In fact, TNF-α promotes muscle wasting by enhancing the activity of the ubiquitin proteasome 
pathway and inducing apoptosis and muscle atrophy. Moreover, TNF-α might also reduce the 
oxidative capacity of the muscles through the inhibition of mitochondrial biogenesis and exerts 
acute inhibitory effects on acute muscle contractility, depressing sensitivity of myofilament 
proteins to Ca++ and to enhanced generation of  ROS and RNS (Kim et al. 2008; van der Vlist & 
Janssen 2010). Although the involvement of systemic inflammation in pheripheral muscle wasting 
and weakness of COPD has never been directly demonstrated, all the findings highlighted before 
strongly support a causal relationship. 
 
Malnutrition 
 
Reduction in BMI and a loss of FFM significantly correlate with an increased morbidity, a poor 
QoL, a reduced exercise performance and an high mortality in COPD patients (Bolton et al. 
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2004). It was established that over 30% of COPD patients undergoing pulmonary rehabilitation 
experience nutritional depletion. Whereas malnutrition is the result of an imbalance between 
energy intake and energy expenditure, nutritional status could be an important systemic factor 
that may affect the exercise performance and skeletal muscle dysfunction in COPD patients. A 
reduced dietary intake in these patients has been attributed to symptoms such as postprandial 
dyspnea, early satiety, fatigue and loss of appetite. Instead, elevated energy expenditure has 
been attributed to increased work of breathing, thermogenic effects of bronchodilators and 
systemic inflammation. An impairment of nutritional status could affect the skeletal muscle 
structure and contractile performance, as seen in patients with anorexia nervosa (Kim et al. 
2008). 
 
Corticosteroid use 
 
Patients affected by COPD are usually treated with corticosteroids either as ‘‘short-burst’’ therapy, 
for acute exacerbations, or as long-term low-dose ‘‘maintenance’’ therapy, for controlling chronic 
symptoms. Therefore, several authors have investigated the possibility that COPD peripheral 
muscles experience a toxic myopathy, i.e. ‘‘steroid-induced myopathy’’. Firstly it was observed 
that a long-term high doses of steroids mediate detrimental effects on the structure and function 
of COPD peripheral muscle, reducing strength and atrophy of both ventilator and limb muscles of 
COPD patients (Kim et al. 2008). In subsequent studies, others studies reported a significant 
reduction in quadriceps strength, strongly associated with quadriceps atrophy (Bernard et al. 
1998; Couillard & Prefaut 2005; Kim et al. 2008). Deleterious effects of corticosteroids on skeletal 
muscle function have been attributed to inhibition of signaling pathways involved in protein 
synthesis, as well as to augmented protein degradation, which itself is a result of increased 
expression and activity of the ubiquitin proteasome pathway, including upregulation of pathway 
regulators known as “Forkhead transcription factors” (Kim et al. 2008). However, it was 
established that a short-term corticosteroid treatment did not affect quadriceps muscle strength or 
metabolic parameters during exercise, suggesting that this treatment does not in and of itself 
cause skeletal muscle weakness in COPD patients (Hopkinson et al. 2004; Couillard & Prefaut 
2005; Kim et al. 2008). 
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Inactivity 
 
PA is an important clinical parameter related to lung function, hospitalization and mortality in 
COPD patients (W.D-C Man et al. 2009a). In fact, active COPD people have lower risk of both 
COPD-related hospital admissions and mortality (Garcia-Aymerich et al. 2006; Watz et al. 2008). 
Several studies confirmed that both current PA level, i.e. planned and structured regular ExT 
performed deliberately, and DPA, i.e. workplace and household physical activity, in COPD are 
lower than those in sedentary healthy subjects control group (Mador M.J., 2011; Gouzi et al. 
2011). The fact that a great proportion of COPD patients show a sedentary lifestyle (Chapter 3) 
led many investigators to attribute skeletal muscle dysfunction in these patients to physical 
deconditioning (Pitta et al. 2005; Couillard & Prefaut 2005; Kim et al. 2008; W.D-C Man et al. 
2009a; van der Vlist & Janssen 2010). This concept was supported by observations that a longer 
duration of inactivity (Serres et al. 1998) in COPD causes greater alterations due to the dose-
response effect of PA (Steele et al. 2000). Physical inactivity induces adaptive changes in 
skeletal muscles, including reduction in proportions of type I fibers, attenuation of oxidative 
enzyme capacity, regulators of mitochondrial biogenesis (PPARs and PGC-1α), fiber atrophy, 
reduction of antioxidant enzyme levels and lower capillary density (Kim et al. 2008). However, 
recent trials suggested that physical inactivity alone does not sufficiently to explain COPD skeletal 
muscle dysfunction. First of all, these muscle alterations are more severe in COPD patients than 
sedentary HC (Pitta, Troosters, et al. 2008; Gouzi et al. 2011). Secondly, reductions in 
quadriceps muscle endurance was observed between COPD and HC whit similar level of PA 
(Kim et al. 2008). Indeed, while sedentary lifestyle is associated with reduction of quadriceps 
muscle type I fiber proportion, from 60%–65% in healthy active control subjects to about 40% in 
inactive subjects (Proctor et al 1995; Houmard et al 1998), the proportion of type I fibers in 
quadriceps muscles of COPD patients reaches as low as 19% (H.R. Gosker, Van Mameren, et al. 
2002; Allaire et al. 2004; Couillard & Prefaut 2005; Kim et al. 2008; Richardson et al 2004). 
Moreover, it has been shown that prolonged periods of Ext exerts a relatively small influence on 
the proportion of type I fibers in quadriceps muscles of COPD patients, and only partially reverses 
reductions in oxidative enzyme activities in the muscle (F. Maltais et al. 2000). Finally, several 
studies found contradictory results regarding relationship between PA and limb muscle 
endurance in COPD. Serres and collegues (1998) described a positive correlation while Gosker 
and collegues (2003) did not observe any relationship between these parameters (Kim et al. 
2008). Therefore, physical inactivity is almost certainly an important factor in skeletal muscle 
dysfunction of COPD patients, but the most recent data indicate that disuse only partly explains 
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the severe morphological, metabolic and functional abnormalities observed in COPD peripheral 
muscle (Couillard & Prefaut 2005; Kim et al. 2008; van der Vlist & Janssen 2010). 
 
Aging 
 
The well-recognized presence of a systemic inflammation may be considered as a contributor to 
the development of comorbid conditions and these disorders can be seen as manifestations of 
COPD or vice versa. Moreover, aging is characterized by a progressive, generalized impairment 
of function and amplification of the inflammatory response that results in an increased 
vulnerability to environmental challenge and an increased risk of disease. Therefore, an 
accelerated aging is a further process that could account for both the local lung effects of COPD 
and its comorbidities (Han et al. 2010). In fact, Lopez and collegues (2006) have reported the 
importance of aging in relative risks of COPD-related mortality (Figure 4.f) (A. D. Lopez, Shibuya, 
et al. 2006) 
 
 
 
Figure 4.f – Comparison of relative risk of COPD-related mortality by age  
in different gender for a) males and b) fameles. 
▲USA burden of disease study; ● Global Burden of Disease Study; ■ Model estimates 
 
(from Lopez et al. 2006) 
 
 “It has been well established that limb muscles of older individuals are significantly smaller and 
have significantly more fat and connective tissues than those of younger individuals. In addition, 
limb muscle strength, particularly that of the quadriceps muscle, has been reported to be about 
39% lower in men in their seventies as compared to men in their twenties. Furthermore, declines 
in muscle strength with aging correlate with the degree of atrophy of type II fibers and are not 
limited to limb muscles. Indeed, maximum transdiaphragmatic pressure (Pdimax) measured at 
various lung volumes is reportedly to be approximately 25% lower in elderly subjects as 
compared to that measured in young subjects. Similarly, 13% and 23% reductions in sniff Pdi and 
twitch Pdi (generated by phrenic stimulation) have been observed in elderly subjects, as 
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compared to young subjects. These studies clearly indicate that aging contributes to poor skeletal 
muscle contractile performance in COPD patients.” (Kim et al. 2008, pag. 645). 
 
Hypoxemia 
 
Several studies about healthy subjects have established that exposure to high altitude hypoxia 
over a few months is associated with significant detrimental effects on specific skeletal muscle 
properties: functional, i.e. reduced strength and endurance (Caquelard et al. 2000), 
morphological, i.e. atrophy, and metabolic, i.e. reduced Krebs cycle enzyme activity. Many COPD 
patients develop chronic moderate-to-severe hypoxemia or may present repeated episodes of 
hypoxemia due to exercise-induced desaturation or sleep apnoea (Couillard & Prefaut 2005; Kim 
et al. 2008). Although there is no direct proof of hypoxemia involvement in reducing skeletal 
muscle functionality, there are circumstantial evidences suggesting the role of hypoxemia as a 
contributor factor in deterioration of COPD skeletal muscle performance. For instance, the 
proportion of type I fibers in quadriceps muscles of COPD patients was reported to be 
significantly lower in hypoxemic as compared with non-hypoxemic patients (H.R. Gosker, Van 
Mameren, et al. 2002) and strongly correlated with their resting Pa,O2 (Jakobsson et al. 1990). 
Serres et colleagues (1998) confirmed correlation between quadriceps endurance capacity and 
resting Pa,O2 in COPD patients (Serres et al. 1998; Couillard & Prefaut 2005; Kim et al. 2008). 
Greater levels of exercise-induced lipid peroxidation and oxidized proteins in hypoxemic COPD 
patients quadriceps muscles than non-hypoxemic (Koechlin et al. 2005). Also maximum 
diaphragm force and diaphragm endurance are both significantly reduced in COPD patients with 
chronic hypoxemia, although inhalation of O2 for 15min elicits an increase in diaphragm strength 
and endurance (Couillard & Prefaut  2005; Kim et al. 2008). Despite molecular and cellular 
mechanisms underlying hypoxemia deleterious effects on skeletal muscle still need to be 
elucidated, literature data strongly indicate hypoxemia as a  direct and indirect factor on 
contractile processes, eliciting skeletal muscle dysfunctions (Couillard & Prefaut 2005; Kim et al. 
2008). 
 
Smoking 
 
“ Most COPD patients are current or previous smokers, making smoking the main risk factor for 
COPD. However, the potential effects of smoking on skeletal muscle function remain unclear. A 
recent study by Montes de Oca and colleagues (2008) suggests that smoking per se, 
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independent of the presence of COPD, elicits skeletal muscle atrophy, as indicated by a reduction 
in the cross-sectional areas of both type I and II fibers, a reduction in the expression of 
constitutive nitric oxide synthases and augmentation of the number of low oxidative and highly 
glycolytic muscle fibers. The deleterious effects of smoking on muscle metabolism have been 
further analyzed by Petersen and colleagues (2007), who have reported that heavy smoking (≥20 
cigarettes/day for ≥20 years) elicits no change in whole body protein breakdown but significantly 
attenuates quadriceps muscle protein synthesis and augments the expression of both myostatin 
(inhibitor of muscle growth) and atrogin-1 (E3 ligase). These results suggest that smoking 
induces skeletal muscle fiber atrophy as a result of inhibition of protein synthesis, rather than as a 
result of increased protein degradation. These deleterious effects of smoking on skeletal muscle 
function may be mediated directly by nicotine or by other toxic byproducts of cigarette smoke, or 
indirectly as a result of changes in lifestyle and physical activity ” (Kim et al. 2008, pag.646). 
 
Local factors 
 
Skeletal muscle dysfunction in COPD patients has also been attributed to local factors within 
skeletal muscle fibers. These local factors include oxidative and nitrosative stress of muscle fibers 
and changes in balance between protein synthesis and degradation, eliciting changes in protein 
expression, protein function, reduction of muscle mass and depression of contractile functions 
(Couillard & Prefaut 2005; Kim et al. 2008).  
 
Oxidative stress 
There is now considerable evidence of both local and systemic oxidative stress in COPD patients, 
which is involved in the pathogenesis of local lung inflammation as well as in systemic 
phenomena, such as skeletal muscle dysfunction, increasing cardiovascular risk of mortality 
(MacNee 2005). Cachexia and loss of FFM of COPD patients may involve oxidative stress. 
Skeletal muscle is exposed continuously to changes in the redox environment as occurs during 
exercise (MacNee 2005). Although in normal skeletal muscle fibers, ROS are produced at 
relatively low levels and play a positive role in maintaining muscle contractility, patients affected 
by COPD show a significant higher level production of ROS and RNS (MacNee 2005; Couillard & 
Prefaut 2005; Kim et al. 2008). Development of oxidative and nitrosative stress has been 
documented in COPD skeletal muscles both at rest, in DPA and after ExT (Couillard et al. 2002; 
Couillard et al. 2003; Couillard & Prefaut 2005; Kim et al. 2008).  In resting quadriceps muscles of 
severe COPD, disturbed redox homeostasis was observed, i.e. glutathione levels and 
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concentrations of glutamate are reduced whereas the levels of lipid peroxidation products are 
significantly higher than those detected in control subjects. The impairment of glutathione 
metabolism and the increased lipid peroxidation suggest an oxidative damage in skeletal muscle 
of COPD patients (MacNee 2005; Kim et al. 2008). Moderate to severe COPD patients show 
elevated ROS-induced DNA damage in peripheral blood mononuclear cells, plasma uric acid, 
blood oxidized glutathione and lipid peroxides levels at the end of whole body ExT. These 
evidences suggest systemic oxidative stress in COPD patients, even during DPA (Kim et al. 
2008). The excessive ROS and/or NOS produced within muscle fiber lead to develop oxidative 
stress state, affecting mitochondrial and myofilaments, leading to apoptosis, mitochondrial 
respiratory chain dysfunction, and/or an alteration in myofilament contractile properties (Figure 
4.g) (MacNee 2005; Couillard & Prefaut 2005; Kim et al. 2008).  
 
 
 
Figure 4.g – Molecular mechanisms that may underlie oxidative stress-induced  
peripheral muscle dysfunction.  
 
(from Couillard & Prefaut 2005) 
 
Regulation of protein synthesis/degradation 
Regulation of muscle mass is a dynamic process involving a delicate balance between 
hypertrophic, i.e. protein synthesis, and atrophic, i.e. degradation, signaling pathways. Generally 
it assumed that COPD peripheral muscle atrophy is due to imbalance between protein synthesis 
and degradation, in favor of the latter (Kim et al. 2008). Increased protein degradation activated 
by inflammatory factors seems to be partly responsible of muscle wasting in COPD, although 
some studies suggest also role of inflammatory cytokines to affect protein synthesis (Van der Vlist 
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& Janssen 2010). “ Debigare and colleagues (2003) have shown that limb muscle atrophy in 
COPD patients may be due to an increase in the ratio of catabolic factors, such as IL6 and 
cortisol, to anabolic factors, i.e. testosterone, dehydroepiandrosterone and insulin-like growth 
factor-1 [IGF-I]. Increased IL6, ROS and RNS levels are expected to upregulate the ubiquitin-
proteasome components, while increased anabolic factors are expected to downregulate these 
components. […] Debigare and colleagues (2008) employed microarray technology to compare 
gene expression profiles in quadriceps muscles of four patients with moderate or severe COPD to 
those of control subjects. They reported significant upregulation of FoxO1 and FoxO3 
transcription factors in quadriceps muscles of COPD patients. Both transcription factors promote 
muscle atrophy through inhibition of IGF-I-mediated muscle growth and by upregulating the 
expression of atrogin-1 and MuRF-1 […]. Activation of the ubiquitin-proteasomal pathway is not 
limited to the limb muscles of COPD patients. Activity of the 20S proteasome and atrogin-1 
expression have recently been shown to be upregulated by 3-fold in the diaphragms of patients 
with mild to moderate COPD (Ottenheijm et al. 2006). While these studies imply that the 
proteasomal pathway contributes to proteolysis of skeletal muscle proteins in COPD patients, no 
information is as yet available about the relative contributions of the lysosomal, calpain and 
caspase pathways to the atrophy process. Systematic and thorough investigations of how, where, 
and when these pathways are activated, and thus contribute to muscle protein degradation, are 
clearly needed in relation to patients with COPD. ” (Kim et al. 2008, pag. 651). 
 
Vascular density and capillarization 
An adequate capillarization is essential for maintenance of adequate oxygen supply required for 
normal muscle function (Eliason et al. 2010). However, little information is available about 
changes in capillary density in skeletal muscles of COPD patients. Some studies reported a lower 
capillarity to muscle fiber ratio in COPD patients vastus lateralis muscle compared to HC. 
Decreased capillarity was estimated about ~47% lower than those measured in the same muscle 
of age-matched HC (Kim et al. 2008). Additionally, Eliason and collegues (2010) highlighted a 
positive correlation between degree of muscle capillarization and degree of airflow obstruction. 
Considered evidences of increased proportion of type IIa fibers, decreased proportion of type I in 
tibialis anterior muscle, attenuation of oxidative enzymes activities, and presence of hypoxemia, 
the reduction of muscle capillarization seems to be due to a rearrangements of capillary fiber 
geometry which affect the exercise capacity in COPD patients (Eliason et al. 2010).  Reduction in 
skeletal muscle mitochondrial density and volume are also been observed in vastus lateralis 
muscle of COPD patients (H.R. Gosker et al. 2007). In conclusion, both capillary and 
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mithocondrial densities reduction in COPD skeletal muscles seem to provide deleterious effects 
on muscle oxidative capacity since it is associated with augmentation of serum and muscle lactic 
acid levels during exercise and an early onset of contractile fatigue (Kim et al. 2008). 
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PROMOTING ACTIVE LIFESTYLE & CHANGE BEHAVIOR IN COPD 
 
Promotion of Active Change Behavior in Adults and Elderly people 
 
Considered the evidences about the benefits of PA in order to improve health and QoL in several 
target populations, the PA on prescription has attracted attention in recent years (US Preventive 
Services Task Force, 2002; Sørensen et al., 2006; Kallings 2008) and the role of community-
based interventions to promote physical activity has emerged as a critical piece of an overall 
strategy to increase active behaviors among worldwide populations (Kahn et al. 2002). Indeed, in 
1995, the Centers for Disease Control and Prevention, i.e. CDC, and the American College of 
Sports Medicine, i.e. ACSM, published a preventive recommendation that every adult should 
accumulate 30 minutes or more of moderate-intensity physical activity on most, preferably all, 
days of the week (Pate et al. 1995). Subsequently, in 2007, ACSM and the American Heart 
Association, i.e. AHA, provide an update to this recommendation (Haskell et al. 2007). The 
update was more inclusive and provided recommendations for moderate-intensity aerobic activity, 
vigorous-intensity aerobic activity, and muscle-strengthening activity. Moreover, it was highlighted  
that many adults should exceed the minimum recommended amount of activity. Furthermore, 
ACSM deemed that it would appropriate to issue a separate recommendation between adults and 
older adults. Therefore, specific guidelines for men and women age ≥65 years and adults age 50 
to 64 years with clinically significant chronic conditions and/or functional limitations were provided 
(M. E. Nelson et al. 2007). Differences between adults and older adults PA recommendation were 
highlighted before, i.e. chapter 3. However, as recommended by ACSM guidelines, the promotion 
of physical activity in adults, older adults and people with chronic diseases should avoid ageism 
that discourages from reaching their potential in order to became more physically active (M.E. 
Nelson et al. 2007; Haskell et al. 2007). Considered also that adults and older adults with a 
medical condition for which PA is therapeutic should engage in ExT in order to treats their 
conditions and reduce risk of developing other comorbidities, several interventions that promote 
the adoption and maintenance of lifestyle physical activity are being developed (M. E. Nelson et 
al. 2007; Haskell et al. 2007; Heesch et al. 2003). 
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Motivations to engaging in a physical activity 
  
Although physical activity is a primary factor that contributes to health and to an healthy aging 
(Haskell et al. 2007; M. E. Nelson et al. 2007), the majority of adults and elderly people do not 
meet current recommendations of moderate activity for 30 minutes on most days of the week 
(AARP et al. 2001; Heesch et al. 2003; Rhodes et al. 2009). Given the aging demographics, an 
examination of the adults and elderly people motivational aspects to engage in a PA is required to 
implement the interventions effectiveness on behavior change (Dacey et al. 2008). Indeed, 
motivation represents one of the most important analyzed variables in the assessment of the 
behavior change. Motivation has been the subject of attention from a host of individual, including 
philosopher and psychologist. Psychologist, in particular, have provided some general definitions 
of the construct. A widely accepted definitions of motivation is that it represents the hypothetical 
construct used to describe the internal and/or external forces that lead to the initiation, direction, 
intensity and persistence of behavior. Thus motivation leads to actions (Vallerand 2004). One of 
the difficulties in defining motivations is that it is not directly observable. Over the year, 
psychologists have come to realize the experience of different type of motivation. Self-
determination theory, i.e. SDT (Ryan & Deci 2002) provides an excellent framework for examining 
physical activity motivation: SDT posits that motivation exists along a continuum that includes 
Amotivation, Nonself-determined Extrinsic Motivation, Self-determined Extrinsic Motivation, and 
Intrinsic Motivation (Vallerand 2004; Dacey et al. 2008). Research studies with younger adults 
reported that Self-determined Extrinsic and Intrinsic forms of motivation distinguish those who are 
regularly active from individuals who are sedentary or less active (Mullan et al. 1997; Ingledew et 
al., 1998). In terms of gender, studies with younger adults suggest that women are more likely to 
report higher levels of Nonself-determined Extrinsic motives to body image and appearance 
(Frederick et al. 1996; Ryan et al. 1997) as well as self-determined extrinsic motives of fitness 
and social affiliation (Gill et al. 1996). In older adults, an increase of intrinsic and self-determined 
extrinsic motives seems to be positively associated with more physical activity behavior (Dacey et 
al. 2008). 
 
Intrinsic Motivation 
 
Intrinsic motivation is represented in behaviors that are performed for their inherent interest and 
enjoyment of the activity itself. Indeed, it refers to engaging in an activity for itself and for the 
pleasure and satisfaction derived from participation. Therefore, more an individual will be likely to 
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engage a particular activity, more that behavior will be persisted. It was proposed three types of 
intrinsic motivation: 
 Intrinsic motivation to know, i.e. engaging in the activity for the pleasure of learning; 
 Intrinsic motivation toward accomplishments, i.e. engaging in the activity for pleasure to trying 
to surpass oneself; 
 Intrinsic motivation to experience stimulation, i.e. engaging in the activity out of sensory and 
aesthetic pleasure (Vallerand 2004; Dacey et al. 2008). 
 
Extrinsic Motivation 
 
When extrinsically motivated, individuals do not engage in the activity out of pleasure but rather 
do so to derive some kind of reward that are external to the activity itself. Avoiding punishment 
also pertains to extrinsic motivation. In 1985, Deci and Ryan proposed the existence of a number 
of types of extrinsic motivation that vary in terms of their inherent levels of self determination.  
Nonself-determined Extrinsic Motivation is characterized by controlled behavior that is performed 
to avoid immediate negative consequences or to obtain ego enhancements. Self-determined 
Extrinsic Motivation is present when an individual performs a behavior for an extrinsic reason, but 
for personally valued and endorsed outcomes. Therefore, from the lowest to the highest level of 
self determination, these types of extrinsic motivation are: 
 External regulation, i.e. regulated through external means such as obtaining rewards and 
avoiding constraints; 
 Introjected regulation, i.e. referred to start to internalize the reasons of the action; 
 Identified regulation, i.e. referred to identification of extrinsic motives; 
 Integrated regulation, i.e. referred to engaging in an activity from an extrinsic perspective in a 
“choiceful” manner (Vallerand 2004; Dacey et al. 2008). 
 
Amotivation 
 
Besides intrinsic and extrinsic motivation, Deci and Ryan (1985) have proposed a third 
motivational concept namely, Amotivation, to fully understand human behavior. When amotivated, 
individuals experience a lack of contingency between their behaviors and outcomes. Their 
behaviors are neither intrinsically nor extrinsically motivated. Amotivated behaviors are the least 
self-determined because there is no sense of purpose and no expectations of reward or 
possibility of changing the course of events. Amotivation can thus be seen as similar to learned 
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helplessness where the individual experiences feelings of incompetence and expectancies of 
uncontrollability (Guay et al. 2000; Dacey et al. 2008). 
 
Determinants of Intrinsic and Extrinsic Motivation 
 
Motivation is present in people at the three levels of generality, i.e. global, contextual and 
situational level. Research reveals that several types of variables produce important effects onto 
the levels of generality. This variables could be identified in Individual, Environmental and Task 
variables (Vallerand 2004; Hemmingsson et al. 2001). 
 
Individual Variables 
 
Individual variables could be subdivided into several subcategories, i.e. intrapersonal, 
interpersonal and socio-cultural determinants. The intrapersonal determinants are influenced by 
biologic, i.e. genetic differences, health status, chronic diseases, obesity, demographic, i.e. age, 
gender, education, occupation, ethnicity, cognitive, i.e. self-efficacy, self-health perception, stress, 
enjoyment, perceived benefits, expectations, attitude, perceived barriers and risk, and behavioral, 
i.e. successful chance and transferability, factors (Vallerand 2004; Schutzer & Graves 2010; 
Stiggelbout et al. 2006). Indeed, the elderly most frequently cite poor health as the leading barrier 
to both physical activity and exercise: perceived health problems, illness, injuries and pain 
emerged as the most common barriers to exercise. Also, lack of knowledge and understanding of 
the relationship between moderate exercise activity and health is an especially relevant barrier 
(Schutzer & Graves 2010). One of the most potent and frequently mentioned psychological 
mediators of successful behavior change is self-efficacy. Self-efficacy is highly situational, i.e. one 
can have high self-efficacy for weight training and, conversely, low self-efficacy for aerobic dance. 
McAuley and colleagues (1994) found that previously sedentary middle-aged adults significantly 
improved adherence to a 20-week walking program with a relatively simple information program, 
specifically aimed at increasing self-efficacy. Also it was found that self-efficacy enhancement 
was particularly important in the early phases of behavior change, and less important as physical 
activity become less psychologically demanding. Interpersonal determinants are influenced by 
emotional, instrumental, informational and appraisal support. Receiving support and 
encouragement from other people, such as family members, general practitioner and specialist 
could be reduced anxiety and enhanced motivation (Hemmingsson et al. 2001; Cress et al. 2004; 
Cress et al. 2006; Kahn et al. 2002; Vallerand 2004). Moreover, it was observed that a 
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prescription of PA in primary care seems to increase patients’ behavior change (N. H. Williams et 
al. 2007; Kallings et al. 2008) and that the attitude and knowledge of general practitioners, 
specialists and nurses on health and PA promotion could influence the acquisition process of an 
healthy lifestyle (Geense et al. 2013; Schutzer & Graves 2010). Therefore, according to Deci and 
Ryan’s self-determination theory, social factors influence motivation through their impact on one’s 
perceptions of competence, autonomy and relatedness. Because individuals experience the 
needs to feel competent, autonomous, and related to significant others in their interaction, activity 
that allow people to satisfy these needs will be engaged in choicefully and on a regular basis. 
Variables that nurture those needs help intrinsic motivation and identified regulation to flourish. 
Variables that thwart those needs produce negative effects on the latter types of motivation and 
facilitate the development of external and introjected regulation and amotivation (Vallerand 2004)   
 
Environmental Variables 
 
The physical environment can also present as a potential barrier to exercise adherence.  
Environmental variables could be influenced by both by climatic and seasonal influences, 
available PA structures, and socio structural context (Vallerand 2004). Environments with 
available and convenient resources used both for exercise and physical activity performance, 
such as sidewalks, parks, recreation centers, and fitness facilities, make it easier for people to be 
exercise. Conversely, environments with high crime decrease the likelihood of people becoming 
more active (Schutzer & Graves 2010). Several studies, investigating the adherence at ExT 
programs of obese people (Jakicic et al. 1999 ; Perri et al. 1997) found that a more easily access 
to PA equipment and structures improved significantly the activity levels, the weight loss 
maintenance and/or loss, recordering also a lower drop-out rate (Hemmingsson et al. 2001). 
 
Task Variables 
 
A part from the many psychological, behavioral, social and environmental influences of physical 
activity, there is also research indicating that activity bout adaptations of volume, type, intensity, 
duration and frequency may influence behavior change. Indeed, task differ in terms of their 
intrinsic properties in that certain task are more enjoyable than others. Thus, it is not surprising 
that certain tasks generate higher levels of situational intrinsic motivation than do others. 
Moreover, individual differences and environmental variables may affect perceptions of task in 
such a way that even dull task may, at times, be experienced as enjoyable.  
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For example, Chao and colleagues (2000) pointed out that many elderly deem the adoption of 
moderate physical activity as time consuming. Time commitments include the time needed to 
perform activity and the time required for travel to an exercise facility. This time commitment 
increases substantially for those who rely on public transportation. Furthermore, these 
investigators maintained older adults tended to view exercise as a recreational pursuit instead of 
necessary medical therapy (Schutzer & Graves 2010). Therefore, incorporating a comprehensive 
and individualized behavioral management strategy in physical activity interventions can help 
maximize recruitment, increase motivation for exercise progression, and minimize attrition 
(Hemmingsson et al. 2001; Vallerand 2004; Cress et al. 2006; Rhodes et al. 2009). 
 
Models of Behavior Change 
 
Encouraging and supporting patients to embark on PA lifestyle changes is an everyday challenge 
faced by many health professionals. Although many public health intervention are developed 
without explicit reference to theory, evidence suggests that the explicit use of theory will 
significantly improve chances of effectiveness (Hutchison et al. 2009). During the years, several 
theory were developed in order to lead interventions to be more effective in changing physical 
activity behavior, such as the Health belief model, i.e. HBM (Houchbaum, 1958), the Theory of 
Reasoned Action, i.e. TRA, and the Theory of Planned Behavior, i.e. TPB, (Ajzen 1975; Ajzen, 
1991), the Precaution Adoption Process Model, i.e. PAPM, (Weistein, 1988), the Socio-cognitive 
theory, i.e. STC, (Bandura 1986) and the Ecologic model (Sallis & Owen, 1996). However, the 
most commonly adopted theoretical frameworks for PA behavior change interventions are the 
Transtheoretical Model, i.e. TTM (Prochaska & DiClemente, 1983) and the Stages of Motivational 
Readiness for Change Model, i.e. SOC  (Marcus, Rossi, Selby et al. 1992). 
 
The Transtheoretical Model 
 
The TTM is an integrative model of behavior developed from a comparative analysis of leading 
theories of psychotherapy and behavior change (Lowther et al. 2007; Hutchison et al. 2009). 
Since its conception, the model has been applied to a variety of behavior change contexts such 
as substance abuse, diet and PA (Hutchison et al. 2009). In 1983, Prochaska and DiClemente 
reported that smokers who ‘self-changed’ their behavior used the processes to progress through 
a series of stages. Initially it was thought that progress through these ‘stages of change’ was 
linear, but subsequently a spiral pattern of change has been reported, recognizing that people 
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may relapse on several occasions while trying to change behavior. The TTM evolved to 
encompass two further constructs: decisional balance and self-efficacy. Decisional balance 
relates to individuals weighing up of the benefits and costs of changing behavior. The benefits 
and costs appear to be particularly relevant for understanding and predicting movement in the 
first three stages, but during the action and maintenance stages, these decisional balance 
measures are far less prominent predictors. Self-efficacy is the situation-specific confidence 
people have that they can maintain a behavior change. This construct was integrated into the 
TTM from Bandura’s (1977, 1982) self-efficacy theory. In general, as progression is made 
through the stages of change, self-efficacy is seen to increase (Prochaska & Marcus, 1994). 
(Lowther et al. 2007). Therefore, the TTM has evolved in a multidimensional design model 
including the facets of the stages of change, the processes of change, self-efficacy, and 
decisional balance. When applying the TTM as a theoretical framework to develop behavior 
change interventions, a good understanding of each dimension and how they interact with one 
another needs to be demonstrated (Hutchison et al. 2009). 
 
The Stages of Motivational Readiness for Change Model 
 
The stages of change identified by the TTM have been applied to physical activity to form the 
Stages of Motivational Readiness for Change Model  (Marcus, Rossi, Selby et al. 1992). 
Specifically the stages include Precontemplation, Contemplation, Preparation, Action and 
Maintenance (Marcus et al. 2003). In the Precontemplation stage, individuals are sedentary and 
have no intention of becoming more active in the next six months. In Contemplation, individuals 
are also sedentary but are considering being more active in the next six months. The Preparation 
stage signifies that the person is intending to become more active in the very near future, usually 
the next month. They may also have actually started some activity but not enough to meet current 
recommendations (Pate et al., 1995). Individuals in the Action stage are physically active to 
recommended levels but only in the last six months. Action is the least stable stage and is also 
when people are at most risk from relapse (Prochaska & Marcus, 1994). The Maintenance stage 
occurs when the individual has been active to recommended levels for longer than six months. In 
comparison to action, maintenance is stable, but there is still risk of relapse (Lowther et al. 2007; 
Marcus et al. 2003). Marcus and Simkin (1993) have developed a four-item self-report 
questionnaire that categorizes individuals into one of the five stages of change (Figure 5.1). 
Moreover, as with the stages of change, Marcus and colleagues (1992) showed that the 10 
processes of change, i.e. five behavioral processes and five cognitive processes, could be 
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generalized to exercise behavior and suggested that these processes can be organized in a 
hierarchical manner consisting of two higher-order constructs, experiential and behavioral (Figure 
5.2). Marcus and colleagues (1992) went on to show that the experiential processes are more 
important in understanding and predicting progress in the early stages of change but the 
behavioral processes appear to be more important in the latter stages. Thus it was argued that 
successful behavior change depends upon engaging the right process at the right stage and if the 
key processes of change can be identified that facilitate movement from one stage to the next, 
interventions can be designed to target those key processes (Lowther et al. 2007; Marcus et al. 
2003; Marcus, Simkin, Rossi & Pinto, 1996).  
 
 
 
 
 
Figure 5.2 –The Physical Activity Stages of Changes Questionnaire, i.e. PASC-q 
 
 (from Marcus et al. 2003) 
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Figure 5.3 –The process of Change 
 
 (from Marcus et al. 2003) 
 
Criticisms to Transtheoretical and Stages of Motivational Readiness for Change models 
 
Despite the popularity of the TTM as a theoretical framework used to develop and guide PA 
behavior change interventions, previous reviews have questioned the effectiveness of TTM-
based health promotion and PA interventions (Hutchison et al. 2009). Adams and White (2003) 
produced evidence to suggest that TTM-based PA promotion interventions are reasonably 
effective in promoting PA adoption but have little influence on long-term adherence to increased 
activity levels. Bridle and collegues (2005) included seven PA behavior change interventions in 
their review, and in only one of these did the effect favor the TTM-based intervention compared to 
usual care. On the basis of these findings, it was concluded that TTM-based activity promotion 
interventions may be less effective than originally proposed. A number of arguments have been 
presented to explain the lack of support for TTM-based interventions (Hutchison et al. 2009). 
First, it has been suggested that PA behavior is more complex than single behaviors such as 
smoking and that individuals could be in a number of different stages of change depending on the 
type of activity being considered (Adams & White, 2005). Second, the importance of accurately 
determining current stage of change was highlighted, and it was demonstrated that many of the 
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previously reviewed interventions lacked validated algorithms to assess this (Adams & White, 
2005; Bunton et al., 2000). Third, it was suggested that exercise behavior may be influenced by a 
number of factors not considered by the TTM. Finally, it has been suggested that many of the 
previously reviewed interventions may not have been complex enough to do justice to the 
multidimensional nature of the TTM (Adams & White, 2005). Moreover, regarding the Stages of 
Motivational Readiness for Change model, a meta-analysis by Marshall and Biddle (2001) 
questioned the relevance of the processes of change in physical activity. Although the meta-
analysis found that, in general, individuals use all 10 processes when trying to modify exercise 
behavior and that the predictions for the higher order constructs were partially supported, it also 
found similar patterns of change for individual process use across all stage transitions, which 
argues against a stage by process interaction. Marshall and Biddle (2001) call for further work in 
this area, particularly studies employing a longitudinal (as opposed to cross-sectional) design 
(Lowther et al. 2007) 
 
Behavioral measures of motivation 
 
Situational measures of motivation were developed to assess participants’ immediate or current 
reactions toward a specific activity in which they were engaged. For two decades, two types of 
measures have been used: behavioral and self-report indices. 
 
The Behavioral Measure of Intrinsic Motivation 
 
“ The behavioral measure, namely the free-choice measure, has been extensively used in 
laboratory research in psychology. […] Free-choice measure consists of calculating the time 
spent on the activity when external contingencies are no longer operative. More precisely, the 
experimenter declares that the experiment is officially over and presents a pretext for leaving the 
participant alone for a period of time (typically 8 minutes). During that period, the participant is 
surreptitiously observed through a one-way mirror. The participant then has the opportunity to 
work on the experimental task, to read some magazines, or to do something else. The rationale 
underlying the free choice measure is that the more an individual persists at the experimental 
activity, the more he or she should be intrinsically motivated. This operationalization of the 
measure is in line with the usual definition of intrinsic motivation, which states that intrinsically 
motivated behavior typically occurs in the absence of any apparent external rewards. […] 
Although this measure is useful for laboratory research it nevertheless has two important 
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limitations. First, this measure is unidimensional and consequently cannot assess other important 
motivational concepts derived from self-determination theory, namely identified regulation, 
external regulation, and amotivation. Second, the free-choice measure can hardly be used in field 
settings. This seriously limits the type of research that can be conducted with this measure” 
(Guay et al. 2000, pp.178-179). 
 
Self-Report Measures of Intrinsic Motivation 
 
“ In addition to the free-choice measure, self-report measures have also been used to assess 
intrinsic motivation at the situational level. A review of the literature reveals that two main scales 
were developed and validated: The Mayo Task Reaction Questionnaire (TRQ; Mayo, 1977) and 
the Intrinsic Motivation Inventory (IMI; McAuley, Duncan, & Tammen, 1989). We will also briefly 
discuss a third one that has been developed by Conti, Amabile, and Pollack (1995). The TRQ is 
formed of 23 items assessing different aspects of intrinsic motivation (i.e., concentration, 
interest/enjoyment, achievement, challenge, competence, and autonomy), which are rated on a 
7-point Likert scale. Although the scale measures many conceptual aspects of intrinsic motivation 
(e.g., challenge, enjoyment, etc.), the TRQ has been constructed in a way to capture overall 
intrinsic motivation (i.e., the scale is unidimensional). The psychometric properties of the TRQ 
have been supported in some studies. […] Evidence for the construct validity of the TRQ has 
emerged in line with predictions stemming from self-determination theory. […] It should be noted 
that although the TRQ has some interesting psychometric properties, there are some problems 
with this measure. First, the scale is relatively long (23 items) for a situational measure. Second, 
no evidence has been reported on the factor structure of the scale. It is thus difficult to determine 
if the TRQ is unidimensional or multidimensional. Third, the TRQ does not assess different types 
of motivation postulated by self-determination theory, namely identified regulation, external 
regulation, and amotivation. Finally, as pointed out by Vallerand and Fortier (1998), the TRQ 
includes items that refer to some determinants (e.g., perceived competence) and consequences 
of intrinsic motivation (e.g., concentration). Inferring motivation from motivational determinants 
and consequences seriously compromises the construct validity of the scale. […] The Intrinsic 
Motivation Inventory (IMI; McAuley et al., 1989) represents another self-report instrument that 
was developed to assess situational intrinsic motivation. This scale was designed to assess four 
underlying dimensions of intrinsic motivation in a specific situation, namely interest-enjoyment, 
perceived competence, effort-importance, and pressure-tension. Studies have revealed high level 
of internal consistency for the subscales. Moreover, the construct validity of the scale has been 
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supported by results in line with existing theories. However, data on the factorial validity of the IMI 
are much less impressive. […] In addition, the IMI displays some of the limitations found with the 
TRQ. More specifically, the instrument does not assess other forms of motivation besides intrinsic 
motivation. Further, it also evaluates determinants (e.g., perceived competence) and 
consequences of intrinsic motivation (e.g., effort) rather than motivation per se. […] Conti et al. 
(1995) have developed a scale that measures two types of intrinsic motivation: (1) interest, (2) 
willingness to partake in future activities like the experimental task for intrinsic reasons; and three 
types of extrinsic motivation: (1) concern with the performance, (2) pressure and tension, and (3) 
concern with the experimenter’s opinion. However, these subscales have not been fully validated 
and have low levels of internal consistency. […] In sum, although some of these traditional 
measures of situational motivation have provided results in line with hypotheses derived from 
existing theories, none of them assesses the types of extrinsic motivation proposed by Deci and 
Ryan (1985) as well as amotivation. Furthermore, the free-choice measure is difficult to use in 
field studies. ” (Guay et al. 2000, pp.179-180). 
 
The Situational Motivation Scale  
The Situational Motivation Scale, i.e. SIMS, was developed and validated as a measure of 
situational motivation that overcomes the limitations of the free-choice measure and self-report 
questionnaires. This measure scale was designed to assess a more diverse range of the types of 
motivation postulated by selfdetermination theory, namely intrinsic motivation, identified 
regulation, external regulation, and amotivation. This measure would thus represented a 
multidimensional measure of ongoing self-regulatory processes that could be used in laboratory 
and field settings, offering the possibility to address questions related to other types of regulation 
( i.e., identified regulation and external regulation) (Figure 5.4) (Guay et al. 2000). 
 
The Exercise Motivation Inventory  
The Exercise Motivation Inventory-2, i.e. EMI-2, was developed by Markland & Hardy (1997) in 
order to assess a range of physical activity motives. It was based upon self-determination theory 
and was used to study younger adults’ physical activity motivation. Although Guay and 
colleagues (2000) has criticized that a self-report measure of motivation could not assess 
determinants and consequences of intrinsic motivation, a Dacey’s study (2008) examined the 
feasibility of using with older adults a modified version of the EMI-2 to assess a range of physical 
activity motives based upon self-determination theory. The resultant factor structure 
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demonstrated a good psychometrics, with an high alpha reliability and good predictive validity 
based on concepts from self-determination theory. 
 
 
Figure 5.4 –The Situational Motivation Scale questionnaire 
 
(from Guay et al. 2000) 
 
 
Psychometrics also accounted for gender invariance and an assessment of a range of physical 
activity behaviors, from sedentary to regularly active for over a year. This revised instrument was 
used as a measure of intrinsic motivation and certain forms of self-determined and nonself-
determined extrinsic motivation toward physical activity participation in older adults. Results 
demonstrated that motivation differentiates activity levels and that an increase of intrinsic and 
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self-determined extrinsic motives is positively associated with more physical activity behavior in 
older adults (Dacey et al. 2008; Markland & Ingledew 1997). 
 
 
 
 
Figure 5.5 –Adjusted menas of motive measures as a function of exercise activity levels,  
controlling for gender and age category (N=632) 
 
(from Dacey et al. 2008) 
 
 
Strategies to increase physical activity behaviors 
 
The role of community-based interventions to promote physical activity has emerged as a critical 
piece of an overall strategy to increase physical activity behaviors among population. Therefore, 
several organizations, associations, and agencies, with expertise in health, medicine, social and 
behavioral sciences, epidemiology, gerontology/geriatrics, clinical science, public policy, 
marketing, medical systems, community organization, and environmental issues, developed 
guides, such as The National Blueprint (2001), to plan strategies in order to help adults and 
elderly people to increase their physical activity (AARP et al. 2001). An independent, nonfederal 
Task Force on Community Preventive Services, i.e. the Task Force, developed in 2002 The 
Guide to Community Preventive Services (the Community Guide) with the support of the U.S. 
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Department of Health and Human Services, of the Centers for Disease Control and Prevention, 
and in collaboration with other public and private partners (Kahn et al. 2002). This guide 
highlighted three categories of interventions in order to increase physical activity behavior:  
 Informational approaches to change knowledge and attitudes about the benefits of and 
opportunities for physical activity within a community; 
 Behavioral and social approaches to teach people the behavioral management skills 
necessary both for successful adoption and maintenance of behavior change and for creating 
social environments that facilitate and enhance behavioral change; 
 Environmental and policy approaches to change the structure of physical and organizational 
environments to provide safe, attractive, and convenient places for physical activity (Kahn et 
al. 2002). 
 
Promoting Active Lifestyle and Change Behavior in COPD patients 
 
The variety of symptoms and comorbidities, the functional impairment caused by the disease, and 
the high level of sedentary behavior, reported by COPD patients, and described in the chapters 
before, enforce the need to find realistic and effectiveness long-term strategies to promote health 
and active lifestyle in these patients, as well as the general population (Wilson et al. 2005; Caress 
et al. 2010). A large body of evidence shows that PR programs and ExT are beneficial to patients 
with COPD in order to improve exercise capacity, muscle force, symptoms, and health-related 
quality of life (GOLD 2013; Lacasse et al. 2006; Troosters et al. 2005). Moreover, it well 
recognizes that a comprehensive PR should include elements of an healthy lifestyle promotions 
in order to stress adherence to therapy, encourage behavior change, engage physical activity in 
daily routine and prevent patients from re-entering the vicious circle of inactivity (B.R. Celli, 
MacNee, et al. 2004; M.A. Spruit et al. 2004). Considered that it has been shown that COPD 
patients who perform some level of regular physical activity have a lower risk of both COPD 
admission and mortality (GOLD 2013), an active lifestyle should be considered as a therapeutic 
priority in this populations. Indeed, making the patients more active in daily lifestyle should be a 
goal of PR programs, and strategies specifically aimed at improving active time, i.e. behavior 
strategies, should be considered as components to be added to the program (Pitta, Troosters, et 
al. 2008; Nici et al. 2006; Ferreira et al. 2009; Lacasse et al. 2006; Ries et al. 2007). 
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Recruitment and Adherence of COPD patients in Exercise Training Programs 
 
Encouraging and supporting adults, elderly and chronic disease patients to embark on PA 
lifestyle changes is an everyday challenge faced by many health professionals (Hutchison et al. 
2009). In fact, health promoters find it challenging to recruit people into ExT and PA programs 
(Hildebrand & Neufeld 2009). However, several guides and behavior change programs were 
established worldwide in the last years, for example “Get fit for Active Living” by Canadian Center 
for Activity and Aging (CCAA) and “The Rural Route to active Aging” by Alberta Center for Active 
Living (for more details and program see ACSM 2002). These programs approached to meeting 
the challenge of promoting physical activity in adults and elderly people, also with chronic 
condition, including evidenced-based strategies of behavior change (Hildebrand & Neufeld 2009). 
With regard on the recruitment of COPD patients in ExT and PA programs, the situations is more 
challenging than that observed for healthy adults, elderly and/or people with others chronic 
disease. Indeed, it is well documented that a considerable proportion of eligible patients decline 
participation and/or drop out from PR (Keating et al. 2011; Faulkner et al. 2010; Fischer et al. 
2007; Goldstein et al. 1994), especially if these initiative are clinical trials (Bell-Syer at al. 2000). It 
has been estimated that in the United Kingdom, less than 1.5% of patients with COPD access 
into PR each year (Yohannes & Connolly 2004). In a recently Faulkner’s study (2010) it was 
established that to recruit 100 patients it would be necessary to approach approximately 7000 
patients on a COPD register. Moreover, an high rate of drop out to COPD rehabilitation program 
was often observed (Faulkner et al. 2010; Fischer et al. 2007; Young et al. 1999). In the 
prospective controlled study of Goldstein and colleagues (1994) it was recorded an adherence to 
complete PR program rate of ~34%, confirmed by than recorded in Ries and colleagues (1995) of 
~36%. More recent trials showed the same trend: 29.26% Pitta’s study (2008), 27.92% Steele’s 
study (2008), 46.87% Ringbaek’s study (2010). Furthermore, considered that the positive effects 
of exercise decline over the time (Ries et al. 1995; Berry et al., 2003), the long-term adherence to 
an exercise prescription is critically important (Donesky-Cuenco et al. 2007; M.A. Spruit et al. 
2004). In healthy adults it was estimated a rate of ~50% adherence to an exercise prescription 
(Dunbar-Jacob et al. 2000). In the available studies about adherence to an exercise training and 
prescription in COPD, data vary considerably due to differences in definition of adherence, units 
of measurement and data analysis strategies. However, Berry and colleagues (2003) estimated a 
rate of ~55% of COPD patients who continued to attend prescribed exercise maintenance 
sessions after pulmonary rehabilitation at 12 months. The ACSM states that individuals of all 
ages should maintain a minimum of 30 minutes of moderate exercise, i.e. walking, per day to 
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maintain or develop fitness (Pate et al. 1995). Pitta and colleagues (2005) showed objective data 
on PDA of COPD patients and highlighted that ~30% of patients involved in the study did not 
reach the recommended amount of walking time per day, whilst all the healthy group subjects met 
these goals. In addition, even in those patients with walking time exceeding 30 minutes per day, 
the movement intensity was ~17% significant lower than the movement intensity observed in 
healthy elderly subjects. This finding shows that even the most active patients with COPD 
probably walk at an intensity insufficient to bring benefits in terms of fitness maintenance. 
Furthermore, considered that inactivity is a risk factor for hospital readmission in COPD, 
according to the threshold, i.e. walking at least 60 minutes/day every day, ~74% of the patients 
included in the Pitta’s study can be considered “at risk” (Pitta et al. 2005). Subsequently, in 
another study, Pitta and colleagues (2008) investigated the effects of 3 and 6 months of PR on 
the time spent by COPD patients in different activities and body postures in daily life and 
examined whether PR leads to a change in the duration of bouts of continuous walking. In this 
study it was observed that changes in PA in daily life were limited only to an improvement in 
movement intensity during walking in daily life, suggesting that more time was needed to 
introduce important lifestyle changes. Also it was observed that an improve in functional exercise 
capacity and functional status seems to not suffice to introduce a more active lifestyle (Pitta, 
Troosters, et al. 2008). This results are according with previous findings observed by Spruit and 
colleagues (2004). This study reported that short programs, i.e. 2-3 months, might not be able to 
permanently change physical behavior in COPD patients, suggesting the need to emphasize 
general training principles into aftercare programs (M.A. Spruit et al. 2004). 
  
Predictor of Non-adherence in COPD patients 
 
Considered that a careful exercise prescription and a close supervision of patients during 
exercise training are important to elicit training effects, it seems of great importance to offer 
COPD patients an extensive PR that is linked up perfectly with an aftercare program to preserve 
the brought about changes in physical behavior and to prevent patients to revert again to a 
sedentary lifestyle (M.A. Spruit et al. 2004). Although several studies focused their attention to 
understand the predictor of adherence to ExT and PA program among adults and elderly people 
(Hemmingsson et al. 2001; Kahn et al. 2002; Heesch et al. 2003; Stiggelbout et al. 2006; 
Bergman et al. 2008; Dacey et al. 2008; Schutzer & Graves 2010; Geense et al. 2013), the 
reasons for non-attendance of COPD patients at PR and ExT programs are not well-documented. 
Most studies are small and may be influenced by local health system characteristics and program 
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organization, as much as by individual patient characteristics. Moreover, the factors that influence 
whether people choose to attend their initial appointment may be different to the factors that 
influence program completion (Young et al. 1999; Fischer et al. 2007; Keating et al. 2011). In a 
recent review of Keating and colleagues (2011) it was highlighted that patients with COPD have 
difficulty attending and completing pulmonary rehabilitation programs. This review found that 
patients who fail to attend pulmonary rehabilitation at all may do so because of personal 
perceptions such as disruption to routine, influence of their doctor and inconvenient timing. In 
contrast, failure to complete a program is related to illness, depression and current smoking. 
Travel to the pulmonary rehabilitation centre, difficulties with transportation, mobility, distance and 
location of programs influenced both attendance and completion (Keating et al. 2011). The 
standard recommended PR program runs over a period of 8-12 weeks and people are required to 
attend at least twice weekly (Nici et al. 2006). Accessing the program may be a significant burden 
for this group of people who have limited mobility and financial resources. At present, pulmonary 
rehabilitation guidelines do not make strong recommendations regarding transport. Whilst it is 
stated that transport may make programs more accessible, its impact on the cost of the service is 
also recognized (BTS 2010).  Moreover, also lack of perceived benefit influences both failure to 
attend and failure to complete PR programs. Limited data were available to assess the reasons 
that people with COPD fail to attend pulmonary rehabilitation at all. The small studies that were 
available (N= 11) suggest that negative perceptions of pulmonary rehabilitation from the patients 
themselves or medical professionals are important factors influencing the decision to attend. 
(Keating et al. 2011).  These findings are according with results observed in others study among 
general population (Karapolat et al. 2012; Geense et al. 2013). Pulmonary rehabilitation was not 
perceived as important enough to warrant disruptions to important personal routines (Fischer et 
al. 2007; Keating et al. 2011). This is consistent with other literature suggesting that if participants 
cannot perceive the benefit of an intervention, they will be less likely to adhere  (Keating et al. 
2011). Young and colleagues (1999) observed that divorced or widow, and living alone were also 
predictive of non-adherence (Young et al. 1999). Illness related to lung disease or comorbid 
conditions was linked to non-completion PR. Considered these findings, a qualitative study by 
Fischer (2007) about patients’ pretreatment beliefs and goals with regard to participation in 
pulmonary rehabilitation proposed an explanation model about reasons for drop out or decline PR 
(Figure 5.6). 
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Figure 5.6 - Attitudes of referred patients with COPD  
towards participation in a pulmonary rehabilitation program. 
 
(from Fischer et al. 2007) 
 
Although quantitative data did not indicate a greater non-completion rate in patients who 
experienced an exacerbation during their program, it did increase the risk of dropout in at-risk 
groups such as smokers. This is also reflected in qualitative studies analyzed by the review, 
where patients consistently identified exacerbations as important contributors to non completion.  
Comorbid conditions are present in over half of COPD patients who undergo pulmonary 
rehabilitation (Crisafulli et al. 2008) and are associated with increased mortality and social 
isolation (GOLD 2013). Given the common nature of both comorbidities and exacerbations, 
strategies to support completion in this large group of patients should be considered. These 
findings are well related to previous studies’ results in which non-adherence was strongly 
associated whit deficient disease-specific social support. Management programs should be to 
provide support persons with the skill to provide better quality disease-specific support and 
should be regarded to improve social activity (Young et al. 1999). Current smoking and 
depression were the only two baseline demographic factors that clearly increased the odds of 
non-completion (Young et al. 1999; Keating et al. 2011).  Commonly used measures of disease 
severity such as lung function, dyspnea and BMI were not consistently related to uptake or 
completion (Keating et al. 2011). In conclusion, COPD patients non-adherence in PR is not 
homogeneous and the factors affecting patient’s decision and ability to engage in pulmonary 
rehabilitation are a complex mix of physical and personal factors. Differences in barriers to uptake 
and completion suggest that different strategies may be needed to enhance program attendance 
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in these two groups of patients (Young et al. 1999; Fischer et al. 2007; Caress et al. 2010; 
Keating et al. 2011). 
 
Supporting health behavior change in COPD 
 
As highlighted before, permanent lifestyle changes are needed to ensure long-term maintenance 
of treatment effects. Therefore, in order to improving compliance with therapy and encouraging 
permanent changes in PA behavior, several specific COPD strategies in the PR field were 
individuated.  
 
Maintenance and follow-up 
There is currently debate concerning the follow-up care that should be provided to patients with 
COPD after graduation from pulmonary rehabilitation programs. However, after a 6-month 
program, Troosters and colleagues (2000) observed prolonged i.e. more than 1 year after 
stopping the program, benefits without rigorous maintenance programs. After shorter programs, 
more intensive follow-up care seems important (Troosters et al. 2005). Usual care, regular 
telephone support, and once-monthly follow-up visits were insufficient to maintain benefits of an 
8-week outpatient or 6-week inpatient rehabilitation program (Ries et al. 2007; Ries 2008; 
Troosters et al. 2005; Langer et al. 2009). Brooks’ study (2002) showed that compliance with 
maintenance home exercise therapy was relatively low. Continued three-times weekly outpatient 
rehabilitation up to 15 months after graduation was superior to exercise advice during the follow-
up (Berry et al. 2003). However, the current knowledge advise once-weekly high-intensity 
maintenance exercise training sessions (M.A. Spruit et al. 2004; Troosters et al. 2005). 
 
Patient education interventions to increase physical activity 
Atkins and colleagues (1984) investigated the effects of strategies to improve adherence to a 
home-based walking program. Despite their promising findings little attention has been paid so far 
to the incorporation of behavior modification strategies into the treatment plan for patients with 
chronic obstructive pulmonary disease. A pilot study by de Blok (2006) looked into the effects of 
lifestyle physical activity counseling, using physical activity self-monitoring, with pedometers, as 
an adjunct to pulmonary rehabilitation. They found a non-significant increase in daily steps in 
comparison to a control group at the end of a nine-week pulmonary rehabilitation program. Two 
recent trials using feasible, alternative, cheap and easy accessible physical training modalities, 
based on Nordic Walking activity (Breyer et al. 2010) and use of a metronome in order to 
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maintain the rate of walking during home ExT (Pomidori et al. 2012), resulted effective PA training 
modalities to impact the DPA pattern of COPD patients under short- and long-term observation. 
 
Other considerations 
Several studies showed that intense physical exercise training as part of a multidisciplinary 
rehabilitation program had only modest effects on participation in physical activities in daily life 
(Pitta, Troosters, et al. 2008; Steele et al. 2003). Simply advising patients to do more physical 
activity without-more specific assistance and follow-up seems to be ineffective (Langer et al. 
2009). COPD education requires a physical activity intervention that is feasible, acceptable and 
effective in a variety of settings. Studies with successful results in chronically ill adults had in 
common that they used physical activity self-monitoring, i.e. with pedometers or diaries, and 
applied behavioral strategies to increase patient’s self efficacy and self-regulatory skills (Conn et 
al. 2008). A systematic review of randomized controlled trials on physical activity self-monitoring 
with pedometers showed an average increase of 2491 steps per day, i.e. 95% confidence 
interval: 1098–3885 steps,  above control interventions (Bravata et al. 2007). Many of these 
interventions used two or more interventions; i.e. self-monitoring, goal setting, diaries or 
counseling. A recent trials, using a metronome in order to maintain the rate of walking during 
home ExT (Pomidori et al. 2012), resulted an effective PA training modality to achieve and 
sustain  an optimal exercise intensity. Although both classical training techniques of walking, i.e. 
walk a known distance in a given period, and alternative metronome method resulted in improved 
daily MET expenditure, peak MET level, and duration of PA more than 3 METS after 6 months, 
only the alternative techniques showed to maintain the results over the time, i.e. 12 months. 
Current knowledge recommended to implement interventions to initiate and maintain change of 
physical activity behavior. Short questionnaires or pedometers can be used during these 
interventions to facilitate follow-up assessment and self-monitoring of behavior change (Langer et 
al. 2009). 
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Background 
Despite lung function parameters don’t improve after PR, extensive knowledge reports positive 
effects of ExT on symptoms, physical capacity and HRQL in COPD patients (Ries 2008; D. E. 
O’Donnell et al. 2008; GOLD 2013). Unfortunately, there are few health-care structured programs 
of PA and ExT available (Valero et al. 2009; Dourado et al. 2009) and a considerable proportion of 
eligible COPD patients decline participation or drop out from the programs (Faulkner et al. 2010). 
Reasons for decline and drop-out in PR and ExT have seldom been investigated systematically 
(Keating et al. 2011; Fischer et al. 2007). 
 
Purpose 
The aim of this study is to outline motivation and barriers which reduced COPD patients 
recruitment in ExT and hindered an active lifestyle acquisition. 
 
Design 
A single-centre, multi-practice, randomized, parallel-group clinical trial was designed and 
recruitment steps (Glaser & Strauss in 1969) were recorded in order to assess patients’ motivation 
of decline or drop out.  
 
Subjects 
A total of 269 males COPD patients were established from the Respiratory Division of ULSS 20, 
but only 132 were considered eligible according to study inclusion criteria. Patients were contacted 
and invited to take part at 6 months of ExT program; participants were randomized and assigned to 
one of the three evaluation groups: Fitness Center based group (FC), Educational PA group (EDU) 
and Control group (CG). Ethical approval by Department of Neurological, Neuropsychological, 
Morphological and Movement Sciences, University of Verona, Medical Hospital Management 
approval of ULSS20, and informed consent by patients were obtained. 
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Measures 
The qualitative study was based on administration of a semi-structured interview and the EMI-2 
structured questionnaire (Markland & Hardy 1997). One way ANOVA was used to detect significant 
differences between groups and between variables. 
 
Results 
A total of 132 COPD males patients was established eligible to the ExT program but only the 70% 
(n=92) was possible contacted. Only the 59.8% of patients (n=55) demonstrated interest regarding 
the initiative and attended the initial meeting. The remaining 40.2% (n=37) reported immediately 
intention to not-participate caused by no-interest in practice ExT and PA (n=21), instable clinical 
conditions (n=11), difficulties in transportation (n=3) and lack of available time (n=2). After the initial 
meeting, the 69.1% (n=38) of subjects provided informed consent, while the 30.9% (n=17) decline 
participation due to lack of available time (n=17), recently onset of clinical condition (n=2) and 
difficulties in transportation (n=1). At the end of the 6-months ExT program, the 89.5% of patients 
(n=34) concluded the trial, instead the 10.5% of subjects (n=4) dropped out caused by onset of 
instable clinical conditions. Analysis of recruited COPD patients’ motivation of COPD recorded a 
low score (mean 81.69pt ±48.08; 44.27% of maximum total score). No significant differences were 
found at baseline between the 3 evaluations group. After 3 months of ExT and at the end of the 6-
months of PA program only the FC group showed a significant improvement in total score 
motivation (3 months= +43.99%, p<0.05; +47.42%, p<0.05). After 3 months of ExT, FC subjects 
showed significant increases in Socio/Emotional aspects (p<0.01), in Weight management 
(p<0.05) and Enjoyment items (p<0.01). At the end of the 6 months of ExT significant improvement 
in FC groups were observed in Socio/Emotional aspects (p<0.01) and in Enjoyment items (p<0.05).  
 
Conclusion 
Recruitment of COPD patients is very challenging and the major cause of not-participation are 
related to mismatched inclusion criteria. (65.53%) according to difficulties of recruitment in clinical 
trials reported by literature (Bell-Syer S. 2000). No-interest in ExT (8.94%), lack of available time 
(6.81%) and inability to access at the PA structures (1.7%) were the most commonly cited reasons 
to decline participation confirming previous literature’s findings (Keating et al. 2011). Compared to 
the literature, the study’s recruitment showed higher score (25.7% vs 6.5% of Faulkner’s study, 
2009), and lower number of drop out after 6 months of PA program (10.52% vs. 29.26% Pitta F. 
2008, 27.92% Steel, 2008, 25%, 46.87% Ringbaek, 2010) suggesting that a great effort practice of 
recruitment, managed by Exercise Specialist, characterized by persistence and flexibility 
strategies, seems to be more effective Improving level of liaison between Specialist Physicians and 
Exercise Specialist should be empathize. At baseline low total scores of motivation to practice PA 
were recorded in COPD patients. Significant short and long-term motivation items improvements , 
suggest that a, structured and constantly supervised PA program could positively influence COPD 
patients’ intrinsic and self-determined extrinsic motives to ExT. Analysis of subscales highlighted 
importance to design COPD ExT programs focused on patients’ needs and interests. 
 
 
Key words: COPD; recruitment; motivation; feasibility; exercise training; physical activity  
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Background 
 
At present, exercise training and physical activity are commonly recognized components of an 
healthy lifestyle and several professional societies and governmental agencies recommend that 
all adults and elderly people should participate in a regular and moderate exercise program. 
(Darren E.R. Warburton et al. 2011; Cress et al. 2006). Moreover, considered the positive effects 
of exercise and physical activity, people affected by chronic disease condition should be 
addressed to an healthy behavior changes in order to match international guidelines (M. E. 
Nelson et al. 2007; Harman J.E. 2010). COPD is one of a major global public health problem and 
it is one of  main cause of worldwide morbidity and mortality (GOLD 2013; Viegi et al. 2007). It is 
characterized by a progressive airflow limitation, not fully reversible, due to an abnormal lungs 
inflammatory response (B.R. Celli, MacNee, et al. 2004; GOLD 2013). Extra-pulmonary 
manifestations and several co-morbidities are present in more than 50% of COPD patients (Divo 
et al. 2012; Barnes & B.R. Celli 2009) who undergo in pulmonary rehabilitation (Crisafulli et al. 
2008) and they are associated with increased mortality (Sin et al. 2006). Indeed exercise 
intolerance and symptoms such as dyspnea and skeletal muscle wasting may contribute to 
increase patients disabilities, affecting their quality of life and reducing the maintenance of an 
active lifestyle (Kim et al. 2008; Caress et al. 2010; Glaab et al. 2010; Huertas & Palange 2011; 
Vorrink et al. 2011). Therefore, the financial cost of COPD is very high for the health system and 
there is a large impact on individuals, with loss of productive healthy years of life (GOLD 2013; 
Rabe et al. 2007). To attacking the problem of COPD, several international efforts (GOLD 2013) 
and a number of management approaches alongside conventional medical interventions have 
been deployed in order to reduce the COPD disease burden (Walters et al. 2012). Despite lung 
function parameters don’t improve, physical activity is considered the cornerstone of a 
comprehensive pulmonary rehabilitation (Nici et al. 2006) and the most effective non-
pharmacological intervention to improve COPD patients health, quality of life and exercise 
capacity (B.R. Celli, MacNee, et al. 2004; D. E. O’Donnell et al. 2008; Fromer & C. B. Cooper 
2008; GOLD 2013). Unfortunately, there are few health-care structured programs of physical 
activity for COPD (Valero et al. 2009; Dourado et al. 2009) and a considerable proportion of 
eligible patients declined participation or dropped out from pulmonary rehabilitation (Faulkner et 
al. 2010; Keating et al. 2011). Reasons for declining and dropping-out from pulmonary 
rehabilitation and exercise training programs have seldom been investigated systematically 
(Fischer et al. 2007; Keating et al. 2011). Therefore primary aim of this study is to describe every 
steps of recruitment patients into an ExT program in order to outline which motivations and 
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barriers reduced COPD patients participation in a PA initiative. Through this analysis and together 
with data about COPD patients’ adherence and drop out from the ExT program, the second 
purpose of the study is to assess which motivation variables hindered an active lifestyle 
acquisition for these chronic patients. 
 
Methods 
 
Design 
 
This study is a single-centre, multi-practice, randomized, parallel-group clinical trial. It was 
designed to assess every recruitment steps according with the Grounded Theory (Glaser & 
Strauss 1969) and to record the different COPD patients’ motivation to participate, decline and/or 
drop out from a secondary study, i.e. a 6-months longitudinal randomized controlled trial 
investigating the effects of two models of exercise training. Moreover, subsequently, the study 
analyzed the score obtained by the baseline administration of the Motivation Inventory-2 
questionnaire, i.e. EMI-2 (Markland & Hardy 1997), which is a validated instrument to assess a 
range of physical activity motives based upon Self-Determination Theory, i.e. SDT (Ryan et al. 
2002). The individual EMI-2 total score obtained by COPD patients was used as one of the three 
randomization criteria for the secondary longitudinal study and re-administration was performed 
after 3 and 6 months of exercise training.  Ethical approval by Department of Neurological, 
Neuropsychological, Morphological and Movement Sciences, University of Verona, Medical 
Hospital Management approval of ULSS20, and informed consent by participant patients were 
obtained (Figure S1.a). 
 
Procedures 
 
The data were obtained during the periods between September 2011 and February 2012, in 
which were singled out, contacted and recruited participants from eligible COPD patients, and 
between March and September 2012, in which COPD recruited patients were randomized in a 6 
months, longitudinal, controlled trial of the differential effects of varying type of supervised 
exercise prescription.   Evaluation sessions were provided at baseline, after 14 weeks and after 
28 weeks 
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Sample 
 
The convenience sample of 132 eligible patients enrolled in the clinical trial had the following 
criteria (Figure S1.a). 
 
 
 
Figure S1.a – Study 1 procedures 
 
Participants were recruited from the Cardiovascular and Thoracic Department, Respiratory 
Division, of ULSS 20, Verona, Italy. Over 6 months, i.e. March-August 2011, a database of 269 
COPD males patients, assessed by the Respiratory Division of the Cardiovascular and Thoracic 
Department, ULSS 20, was created. Subsequently, between the period of September and 
October 2011, 132 eligible patients, which matched the inclusion  criteria (Table S1.b) were 
singled out and advised about the initiative with an introduction mail at their home. Then, we 
were able to contact by telephone 92 subjects and we invited them at first introducing meeting at 
the Faculty of Science Sports of the University of Verona. During the meeting, COPD 
characteristics’ disease, positive effects of ExT and PA programs to improve health, quality of life 
and exercise capacity, and research’s purpose and details were provided to participants. After 
one week, patients were contacted a second time by telephone to verify their participation and to 
set another individual meeting in order to provide informed consent and to administrate 
questionnaires. As a result of this screening process, 17 subjects were excluded, 2 who did not 
meet clinically stable condition criteria and 15 who were dropped after the meeting because lack 
of available time to take part at the study (N=14), and difficulties with transportations (N=1). The 
remaining 38 patients were randomized in three different groups: Fitness Center based group 
(FC=13), Educational PA group (EDU=12) and Control group (CG=13). 
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Table S1.b – Study 1 participant inclusion and exclusion criteria 
Inclusion Exclusion 
65 years ±5 4 stage of COPD 
males Instable cardiac disease 
Stage 1 to 3 GOLD classification 
Pneumonia, pulmonary embolism, pulmonary 
vascular disease, respiratory infections 
Clinical stability for  at least  1 months Lung cancer, thoracic malignancy, malignancies 
 Bone fractures, fractures 
 
Randomization parameters were disease stage, according to GOLD classification (GOLD 2013), 
total recorded score motivation, assessed by EMI-2 and the share of practiced physical activity 
calculated by administration of the International Physical Activity Questionnaire-short form (IPAQ 
2005). COPD patients randomized into the FC group attended 3 time/wk,  90-minute of 
supervised APA, delivered by a qualified exercise practitioner, for 6 months, i.e. period between 
March and October 2012. Subjects of the EDU group were involved in 14 weeks of low 
progressive supervised ExT, in which they practiced different types of PA, and subsequently 14 
weeks of self-selected PA. CG patients were not involved in any type of treatment but only in 
evaluation sessions.. At the end of the 6 months 4 patients from FC (N=1) and CONT (N=3) 
groups dropped out caused by instable onset clinically conditions (Figure S1.c). 
 
 
 
Figure S1.c – Patients recruitment to the Study 1  
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Measurements 
 
Database information 
 
Through the analysis of all the physical examinations and pulmonary function evaluations 
performed by the clinicians of the Respiratory Division of ULSS 20, between March and August 
2011, all COPD males patients were collected in a database. Personal data, such as name, 
surname and date of birth were recorded. Also home address, telephone, mobile and eventually 
e-mail were included. Moreover, information about clinical conditions, i.e. last available %FEV1 
and %FEV1/FVC post-bronchodilator evaluation, disease stage diagnosis, co-morbidities and 
MRC scale were reported in the database, in order to acquire as much details as possible for the 
subsequent screening processes. 
 
First mail and telephone records    
 
After first screening process, COPD males eligible patients were contacted by mail. Then 
telephone contact was based on a semi-structured interview, for investigating their interest and 
their willingness to participate at subsequent introducing meeting. In such meeting, we provide 
more specific informations about training and its locations. All the answers and details provided 
by the subjects were collected and recorded in the database. 
 
First introducing meeting   
 
First meeting lasted about 90 minutes, and it was attended by 15-20 patients per time.. Patients 
family members, such as wife or sons, were invited at the meeting. Between December 2011 and 
February 2012, five introducing meetings were performed at the Faculty of Science Sports of the 
University of Verona. During each meeting, COPD subjects and family members could visit the 
University Fitness Center structures and they were involved in a presentation regarding the trial. 
Characteristics’ disease, positive effects of ExT and PA programs to improve health, quality of life 
and exercise capacity, and research’s purpose and details were provide to participants. The 
information model about trial details was delivered to each participants. Adherences to the 
meeting, questions and answers provided by or to the subjects were collected and recorded in 
the database. 
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Second telephone records    
 
After one week from the meeting, patients were contacted a second time by phone call. Even this 
second telephone contact was based on a semi-structured interview to verify their willingness to 
participate at the study and to set another individual meeting in order to provide informed consent 
and administrate questionnaires. All the answers and details provided by the subjects were 
collected and recorded in the database. 
 
Individual meeting 
 
Subsequent individual meeting was required to each patients that did show interest to the 
research project. During this meetings, that lasted 60 minutes, family members were invited. 
COPD patients were involved in the administration of the some questionnaires: the IPAQ short 
form, to assess the share of DPA, the EMI-2 questionnaire, to record the motivations to practice 
PA, and the Physical Activity Readiness questionnaire, i.e. rPAR-q (Thomas et al. 1992), to 
evaluate onset changes in clinical conditions from the evaluation made by the Respiratory 
division of ULSS 20. Scores of all questionnaires were collected and recorded in the database. 
 
Adherence, drop out and EMI-2 administration during the longitudinal randomized trial 
 
Adherence and/or drop out motivations from the secondary 6-months longitudinal randomized 
controlled trial were collected and recorded in the database. Moreover, EMI-2 re-administration 
were performed after 3 months and at the end of research in order to assess changes in the total 
and items PA motivation scores obtained by the different patients groups. 
 
Statistical methods 
 
To address the purpose of this analysis, we calculated descriptive statistics, such as means, 
proportions, and standard deviations for EMI-2 total score and each EMI-2 items score, i.e. 
Health and Fitness, Social/Emotional benefits, Weight management, Stress management, 
Enjoyment and Apparance, separated by treatment group, using routines in the Statistical 
Package for the Social Sciences version 16.0 (SPSS Inc., Chicago, IL). The statistical analysis 
plan for this study was developed together with the data analysis of the secondary 6-months 
longitudinal randomized controlled trial. Therefore, a two-way repeated measures ANOVA was 
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performed. Then, post hoc analysis using Bonferroni correction was used to compare difference 
among testing sessions and groups.  
 
Results 
 
Patients recruitment 
 
Preliminary records identified 269 males patients with COPD. 132 COPD (49%) patients 
appeared to match study inclusion criteria after inspection of patients record by the researchers, 
and they were established eligible to the ExT program. We were able to contact by mail 92 
patients the (70%). After the first telephone contact 55 patients (59.8%)  demonstrated interest 
regarding the initiative and attended to the initial meeting to present details. Instead, the 
remaining 37 patients (40.2%) reported immediately intention to not-participate caused by no-
interest in practice ExT and PA (n=21), instable clinical conditions (n=11), difficulties with 
transportation, mobility, distance and location of PA structures (n=3) and lack of available time to 
take part at the study (n=2). At the second telephone contact, after one week from the introducing 
meeting, 38 subjects (69.1%)  provided the informed consent, while the 17 (30.9%) decided to 
not-participate caused by lack of available time (n=14), which was considered too much 
challenging, recently onset of instable clinical condition (n=2) and inability to access easily at the 
PA structures (n=1). At baseline assessment no subject mismatch the inclusion criteria by the 
PAR-q analysis. During the 6-months ExT program, the 89.5% of patients (n=34) concluded the 
trial, instead the 10.5% of subjects (n=4) dropped out caused by onset of instable clinical 
conditions (Table S1.d).  
 
Motivation towards physical activity 
 
The analysis about the motivation of COPD recruited patients towards PA and ExT recorded a 
low score (mean 81.69pt ±48.08; 44.27% of maximum total score), although improving health 
(mean 32.5pt ±15.88; 59.09% of maximum item score), management of body weight (mean 
13.49pt ±6.65; 58% of maximum item score) and decreasing stress (mean 17.06pt ±7.24; 
58.52% of maximum item score) resulted the main reasons (Table S1.e and Figure S1.f). No 
significant differences were found at baseline between the 3 evaluations groups.  
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Table S1.d – Study 1 recorded variables of  decline, no-attendance and drop out  ( tot N subject  = 92) 
 N % 
   
Decline participation 37 40.2 
No interest 21 22.8 
Instable clinical condition 11 11.9 
Difficulties in transportation 3 3.4 
Lack of available time 2 2.2 
   
No-attendance 17 18.5 
No interest - - 
Instable clinical condition 2 2.17 
Difficulties in transportation 1 1.08 
Lack of available time 14 15.21 
   
Drop out 4 4.3 
No interest - - 
Instable clinical condition 4 4.34 
Difficulties in transportation - - 
Lack of available time - - 
 
Table S1.e – EMI-2 recorded score at baseline 
Variable Tot max score COPD score SD 
Total EMI-2 185 81.69 48.08 
Health 55 32.5 15.88 
Socio/Emotional 50 15.17 12.09 
Weight 20 11.6 12.09 
Stress 52 14.63 8.82 
Enjoyment 20 10.57 6.48 
Appearance 15 2.76 3.49 
  
139 
 
 
 
Figure S1.f – % of EMI-2 total score recorded and % of each variables recorded. 
 
After 3 months of ExT and the end of the 6-months longitudinal randomized controlled trial only 
the FC group showed significant improvement in total score motivation (3 months = +43.99%, 
p<0.05 ; 6 months= +47.42%, p=0.05) (Table S1.g).  After 3 months of ExT FC subjects showed 
significant increases in Socio/Emotional aspects (p<0.01), in Weight management (p<0.05) and 
Enjoyment items (p<0.01). At the end of the 6 months of ExT significant improvement in FC 
groups were observed in Socio/Emotional aspects (p<0.01) and in Enjoyment items (p<0.05) 
(Table S1.h).  
Table S1.g – EMI-2 total score in different ExT group 
mean (SD);   * p < 0.05;   # p = 0.05 
Groups baseline score at 3 months at 6 months 
FC 85.75 (52.45) 117.55 (35.39) * 123.67 (39.87) # 
EDU 85.18 (35.42) 111.17 (23.34) 117.33 (29.12) 
CG 72.00 (58.79) 85.86 (40.39) 105.00 (44.85) 
 
Table S1.h – Changes in 6 months of EMI-2 total score and variables (FC group)  
mean (SD);   * p < 0.05;  # p = 0.05;   § p < 0.01; 
Variable baseline score at 3 months at 6 months 
Total EMI-2 85.75 (52.45) 117.55 (35.39) * 123.67 (39.87) # 
Health 33.83 (14.75) 40.63 (7.49) 40.08 (10.46) 
Socio/Emotional 20.42 (13.49) 27.45 (11.68) § 31.33 (14.50) § 
Weight 11.25 (6.74) 13.72 (5.87) * 13.75 (7.25) 
Stress 15.58 (8.91) 16.36 (5.55) 17.75 (8.40) 
Enjoyment 11.25 (6.25) 13.63 (5.5) § 15.50 (5.84) * 
Appearance 3.33 (4.14) 5.72 (5.29) 5.25 (5.07) 
140 
 
Discussion 
 
It was observed that the recruitment of COPD patients becomes very challenging especially if 
ExT and PA programs are complex or have restrictive entry criteria (Bell-Syer at al. 2000). As 
expected, also this study have recorded difficulties to recruit high number of COPD patients. Our 
rate of recruitment, based on the number of eligible patients (132, i.e 25.75%), and the major 
cause of not-participation into the ExT program was related to mismatched inclusion criteria by 
COPD patients, i.e. 137 patients at the first screening process and 13 patients during the 
recruitment. Figure S1.i summarizes all the several motivation recorded to decline participation or 
drop out from the study. The recruitment of COPD patients in our study is higher than that 
observed in literature by Faulkner and colleagues, i.e. 6.5% (2010).  Moreover, the rate of drop 
out from our study, based on the number of patients recruited, is really low, i.e. 10.52%, and 
related to onset of instable clinic conditions, which are an exclusion criteria. Finally, the 
adherence to complete our trials shown by COPD patients (89.47%) is higher than that observed 
in literature by Pitta’s study (2008), i.e. 29.26%, Steele’s study (2008), i.e. 27.92%, Woo’s study 
(2009), i.e. 25%, Ringbaek’s study (2010), i.e. 46.87%. Considered the impossibility to modify 
inclusion/exclusion criteria into a trial of ExT, the rate of adherence and the number of drop out 
recorded suggest that our great effort practice of recruitment, managed by only one Exercise 
Specialist, and characterized by persistence and flexibility strategies towards patients, seems to 
be more effective to recruit and maintain adherence of COPD patients. We assume that the 
Exercise Specialist participation at the all recruitment phases could establish a positive 
relationship of confidence within the patients, according with the evidence that attitude and 
knowledge, about the health and PA promotion field, of specialists and people, involved at any 
level of the disease management, could influence the acquisition process of an healthy lifestyle 
(Geense et al. 2013; Schutzer & Graves 2010). 
 
 
Figure S1.i – All motivation recorded in decline participation and drop out from the trial. 
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Results from the analyses of the motivations recorded to not attempt in our ExT trial confirm 
literature’s findings that the most frequently barrier to engage older adults and COPD patients into 
a PA program is related to health, illness, pain and co-morbidities (Schutzer & Graves 2010; 
Keating et al. 2011). The second major recorded factor which obstructs our recruitment was 
related to mistakes and/or lack of patients’ personal data reported in medical records. However, 
in line with previously reported studies, we found that lack of interest in PA exercise program and 
lack of available time to engage into an ExT reduce COPD patients interest and motivation to 
take part in a PR program, probably due to a lack of perceived benefits and a disruption to usual 
routine (Keating et al. 2011; Fischer et al. 2007). These data acquire higher value considering 
that it was established that a low ratio of COPD patients have true knowledge about 
characteristics and benefits of PA in PR program (Karapolat et al. 2012). Finally, travel to the 
pulmonary rehabilitation centre, difficulties with transportation, mobility, distance and location of 
programs seems to influence recruitment, according to literature (Keating et al. 2011). In regard 
to the EMI-2 analysis, our study shows a low baseline total scores of motivation to practice 
physical activity in recruited COPD patients, confirming that the factors to attend initial 
appointment may be different to the factors that influence program completion (Young et al. 1999; 
Fischer et al. 2007; Keating et al. 2011). As expected, no significant differences in baseline total 
scores of motivation between the groups were found, considered that EMI-2 total score was one 
of the three randomization parameters. However, the significant improvements among motivation 
items, observed only in FC group, after 3 and 6 months of ExT suggest that an high, structured 
and constantly supervised PA program could positive influence COPD patients’ intrinsic and self-
determined extrinsic motives (Figure S1.j). According with Dacey (2008) about the positive link 
between high level of PA and increases of intrinsic and self-determined extrinsic motives in older 
adults, also COPD patients seems to modify their motivation through the regular practice of ExT. 
Significant modifications in motivation at short-term PA, i.e. after 3 months of ExT, were observed 
in Socio/Emotional benefits, Weight management and Enjoyment items, instead after a long-term 
PA it were observed significant improvement only in Socio/Emotional benefits and in Enjoyment 
items. In literature, Socio/Emotional benefits items are considered as self-determined extrinsic 
motives because they reflect personal values not typically dependent on external approval. 
Moreover, Socio/Emotional benefits seems to discriminate actives from sustained maintainers in 
older adults (Dacey et al. 2008). Therefore, at the light that was recorded only one drop out from 
the FC group, caused by illness, and that the FC group shows significant improvement in 
Socio/Emotional benefits items in both short- and long-term period, we assume that enhancing 
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 Figure S1.j – Changes in Intrinsic and self-determined extrinsic motives in FC group. 
 
level of self-determined extrinsic motivation are associated with increased engagement and 
commitment into an ExT. Dacey and colleagues (2008) observed that high Enjoyment score is 
related to high levels of PA, confirming previous study in which Enjoyment was considered a key 
factor in older adults PA adherence (Salmon et al. 2003; Bocksnick et al. 2001; Stead et al. 
1997). Considered that EMI-2 examines Enjoyment as an emotion and, thus, represents an 
intrinsic motivation (Ryan et al. 2002), the significant improvements in Enjoyment items at both 
short- and long-term period suggest that also COPD patients improve their intrinsic motivation 
when engaging in a structured and constantly supervised PA program. Moreover, these findings 
suggest that ExT and PA programs for COPD patients should be not only disease-specific 
tailored (Young et al. 1999) but also focused on patients’ need and interest in order to design a 
PA regiment that reflects their personal preferences and capabilities (Cress et al. 2006) and to 
improve satisfaction (Katula et al. 2004). Although Weight management item is related to nonself-
determined extrinsic motivation and it was the only motive measure that yielded no differences 
between activity levels in older adults (Dacey et al. 2008), we found a significant short-term 
improvement of this items. Considered the importance of weight management is PR (B.R. Celli, 
MacNee, et al. 2004; Rabe et al. 2007; GOLD 2013) we hypothesize that this improvement may 
be affected by an increase of knowledge regarding the disease, the management and the HRQL 
factors. Although several studies reported high rate of anxiety and depression among COPD 
patients and positive effects of PA to decrease these symptoms (Brenes 2003; G.-C. Funk et al. 
2009), in our study we did not record any significant improvement in Stress Management items. 
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We assumes that a more-specific instrument of investigation about depression and anxiety 
symptoms in COPD patients could be more effective to detect modification. Finally, COPD 
patients did not improve or change the Appearance subscale after participation into an ExT, 
according with previous studies that recognized Appearance as a nonself-determined extrinsic 
motivation, reflecting a desire to attain ego enhancement, social approval or feelings of self-
worth, which decreased as importance with age. 
 
Conclusion 
 
Recruitment of COPD patients is very challenging and the major cause of not-participation are to 
related to mismatched inclusion criteria. Rate of adherence and number of drop out recorded in 
this study suggest that a great effort practice of recruitment, managed by only one Exercise 
Specialist, characterized by persistence and flexibility strategies towards patients, seems to be 
more effective. Results from the analyses of the motivations recorded to not engage in ExT 
program confirm literature’s findings that the most frequently barrier reported in literature for older 
adults, i.e. instable clinic conditions, lack of available time, lack of perceived benefits and 
difficulties in transportation. Improving in level of liaison between specialist physicians and other 
healthcare professionals engaged in pulmonary management should be empathize. Significant 
improvements among motivation items, both at short and long-term, suggest that an high, 
structured and constantly supervised PA program could positive influence COPD patients’ 
intrinsic and self-determined extrinsic motives. The analysis of subscales highlighted the 
importance to design ExT programs for COPD considering patients’ need and interest in order to 
reflect personal preferences and capabilities. To our knowledge, there are no other studies that 
analyze intrinsic and self-determined extrinsic motivation in COPD patients based on EMI-2 
assessment. In order to increase COPD patients recruitment, to enhance the chances of 
treatment disease modalities and to promote maintenance of an active lifestyle, further 
investigations should be conducted to access both knowledge and intrinsic/extrinsic motivation to 
PA and ExT in PR at different disease stages. 
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Background 
PR is considered a recommended multi-component intervention (Ries et al. 2007), in which ExT is 
the most effective part to improve exercise capacity, muscle strength, symptoms and QOL (GOLD 
2013; Egan et al. 2012; D. E. O’Donnell et al. 2008). Sedentary lifestyle is recognized as one of the 
most important factor in physical deconditioning, worsening QoL, increasing disability and risk of 
death ( Pitta et al. 2005;Vorrink et al. 2011). Therefore Long-term strategies to promote health, 
increase active behaviors and stress adherence to therapy are advocated in COPD patients, as 
well as the general population (Kahn et al. 2002; Wilson et al. 2005; Roche 2009; Caress et al. 
2010). Unfortunately, there are few health-care structured programs of PA and ExT available 
(Valero et al. 2009; Dourado et al. 2009). 
 
Purpose 
The aim of the study is to evaluate modifications in body composition, health-related physical 
parameters, life style and QoL provided by two different and easily applied-field models of APA for 
COPD patients.   
 
Design 
A longitudinal, randomized controlled trial was designed  
 
Subjects 
Thirty-eight COPD males patients (mean post-bronch. FEV1=69.28±21.5% of predicted; post-
bronch. FEV1/FVC= 57.68±13.9% of predicted; age 66.63±4.6 years) were involved. Participants 
were randomized and assigned to one of the three evaluation groups: Fitness Center based group 
(FC), Educational PA group (EDU) and Control group (CG). Ethical approval by Department of 
Neurological, Neuropsychological, Morphological and Movement Sciences, University of Verona, 
and informed consent by patients were obtained. 
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Measures 
The differences between groups were assessed using two-way ANOVA was used. Post hoc 
analysis using Bonferroni correction was provide.  
 
Results 
No significant difference were found between groups at baseline in %FEV1, %FEV1/FVC, EMI-2 
total score (mean 115.62±37.95) and  met/min/set at IPAQ (2324.8±3805.42). Four patients 
dropped out during the 6 months trial and three in the follow up period.  During the study no 
accident occurred. Mean overall FC attendance was 87%±3.24, while EDU attendance at PA 
session was 100%. Between T1-T2, FC group shows significant improvement in %BMC (0.112 
±0.029, p<0.01), Biceps curl 1RM (1.9 ±0.6, p<0.05), Chest press 1RM (8.1 ±1.7, p<0.001), 
Balance test (48.5 ±14.2, p<0.05). EDU group shows significant modification in FAT (-736.4 
±240.0, p<0.05), BMI (-0.332 ±0.106, p<0.05), Leg Extension 1RM (7.2 ±2.4, p<0.05), Chest 
Press 1RM (6.1±1.7, p<0.05) and Back Scratch (2.7 ±0.7, p<0.01). The CG group shows 
significant differences in BMI (-0.588 ±0.157, p<0.01),  FAT (-1086.4.4 ±365, p<0.05), and BTM (-
1849.8 ±494.1 p<0.01). Between T1-T3, the FC shows significant improvement in %BMC (0.071 
±0.024 p<0.05), Chest Press 1RM (9.8 ±2.4, p<0.01), Balance (+108.92% p<0.001), IPAQ 
moderate activity (1024 ±272, p<0.01), IPAQ sedentary hours (-3.3 ±0.7, p<0.01) and MRF-26 (-
2.3 ±0.7, p<0.05). EDU group shows significant modification in 6MWT Borg score (-1.37 ±0.41 
p<0.05), IPAQ walking activity (618 ±208, p<0.05), IPAQ sedentary hours (-3.6 ±0.7, p=0.000)  
and MRF-26 (-2.1 ±0.7, p<0.05). CG group did not shows significant differences. At follow up, FC 
shows significant changes in %BMC (-0.069 ±0.020 p<0.05), 6MWD (-48.2 ±14.8, p<0.05), Leg 
Extension 1RM (-9.3 ±2.8, p<0.05), Chest Press 1RM (-11.6 ±2.1, p=0.000), Sit & Reach (-3.8 
±0.9, p<0.01), Balance (-21.0 ±7 p<0.05). EDU group shows significant modification in 6MWT 
Borg score (-1.36 ±0.41 p<0.05), Leg Press 1RM (-32.6 ±9.1, p<0.05), Leg Extension 1RM (-10+5 
±1.9, p<0.001), Chest Press 1RM (-14.3 ±1.3, p=0.000), Back Scratch (-4.3 ±1.3, p<0.05), IPAQ 
sedentary hours (-3.5 ±0.9, p<0.01) and MRF-26 (-2.9 ±0.8, p<0.05). CG group shows significant 
difference in Chest Press 1RM (-10.9 ±2.6, p<0.01). No significant modification were observed in 
SenseWear PRO-2 administration. 
 
Conclusion 
According to expert panel position stand (Glaab et al. 2010), our study’s results confirms the need 
of a multifaceted approach in PR programs. Our study demonstrates that also an easily applied-
field models of COPD specific APA training could be efficient in order to improve some of these 
HRQL. The improvements in bone mass content, strength of trunk muscles and patients’ self-
perceived disability seem to be better provide by the “well rounded” APA program. Moreover, our 
study shows that APA exercise specialist support is necessary to provide and maintain long-term 
significant health’s gains. Finally, our trial highlights that improvement in functional exercise 
capacity does not automatically turn into a more active lifestyle. According to Conn (2008), furthers 
studies are aimed to identify feasible, acceptable and effective APA intervention, which transfer 
achievements provide reachable changes in lifestyle, both at short- and long-term.    
  
 
Key words: COPD; exercise training; physical activity; short term; long term; lifestyle; active 
behavior; educational; well rounded program, quality of life; health-related quality of life   
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Background 
 
PR is considered a recommended standard of care and management for COPD patients (GOLD 
2013), and a multi-component intervention (Ries et al. 2007), in which ExT is the most effective 
part to improve exercise capacity, muscle strength, symptoms and QOL (GOLD 2013; Egan et al. 
2012; D. E. O’Donnell et al. 2008; Ries 2008; Nici et al. 2006). Any patient with mild to severe 
COPD and activity limitation should undergo ExT (Ries et al. 2007; Chavannes N.H. et al., 2001), 
despite impaired lung function continues to persist after PR (Dressendorfer et al. 2002). At 
current, the model of COPD-specific downward spiral of symptom-induced inactivity is widely 
accepted (B.R. Celli, MacNee, et al. 2004). In fact, sedentary lifestyle is recognized as one of the 
most important factor in physical deconditioning, worsening QoL, increasing disability and risk of 
death ( M.A. Spruit et al. 2004; Pitta et al. 2005; Pitta et al. 2006; Vorrink et al. 2011). Therefore 
long-term strategies to promote health, increase active behaviors and stress adherence to 
therapy are advocated in these patients, as well as the general population (Kahn et al. 2002; 
Wilson et al. 2005; Roche 2009; Caress et al. 2010). It was established that the “well-rounded PA 
programs” is the best ExT modality to achieve health benefits and promote active lifestyle in 
adults and elderly people (Jones C.J. & Rose, 2005). According to ACSM position stand, it is 
focused on endurance, strength, balance, flexibility training, posture and maintenance of a body 
composition (M. E. Nelson et al. 2007). Usually in clinical PR practice, ExT includes both aerobic 
and resistance training prescriptions (C. L. Rochester 2003; van Helvoort et al. 2010), despite 
COPD-specific ExT guidelines are not provided and yet under debate (Butcher & R. L. Jones 
2006; C. B. Cooper 2001; O’Shea et al. 2009). Panel discussion issues are concerned to 
intensity, i.e.  high vs. low intensity (Butcher & R. L. Jones 2006; C. L. Rochester 2003; C. B. 
Cooper 2001), type, i.e. resistance vs. endurance and/or vs. resistance coupled with endurance 
(M.A. Spruit et al. 2002; O’Shea et al. 2009) and frequency of training (Ringbaek et al. 2010). 
Moreover, evidences about benefits maintenance (C. L. Rochester 2003), compliance to long-
term ExT, i.e. home-based program vs. high-intensity maintenance (Troosters et al. 2005), 
effectiveness of short- and long-term adherence strategy, i.e. educational program vs. PA 
counseling vs. health mentoring  (C. L. Rochester 2003; Walters et al. 2012) and COPD-specific 
recommendations for adequate DPA level to achieve health benefits (Hartman et al. 2010) are 
still conflicting. Finally, the inclusion of ExT in the health care assistance is considered difficult 
due to a limited number of local health-care structured programs (Valero et al. 2009; Dourado et 
al. 2009). 
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Purpose 
 
Considered ExT effectiveness to improve several HRQL, current debates and limited number of 
local health-care structured program for COPD patients, further studies are necessary to assess if 
easily applied-field models of adapted fitness activity are effective to achieve the major PR 
outcomes and to provide reachable changes in lifestyle, both at short- and long-term. Therefore, 
aim of the study is to evaluate modifications in body composition, health-related physical 
parameters, life style and QoL provided by two different and easily applied-field models of 
adapted fitness activity for COPD patients.   
 
Methods 
 
Design 
 
This study is a longitudinal, randomized controlled trial, designed to assess modifications leaded 
by two different easily applied-field models of adapted fitness activity for COPD patients. 
Outcomes assessed are anthropometric parameters, i.e. BMI, body and bone composition, health 
related physical performances, i.e. exercise tolerance, upper and lower limb strength, flexibility 
and balance, life style behavior, i.e. DPA level, and QoL as measure of perceived disability. 
Ethical approval by Department of Neurological, Neuropsychological, Morphological and 
Movement Sciences (University of Verona), Medical Hospital Management approval of ULSS20, 
and informed consent by patients were obtained (Figure S2.a). 
 
 
Figure S2.a – Study 1 procedures 
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Procedures 
 
The data were obtained during the periods between January and December 2012, in which were 
recruited and randomized participants in the longitudinal trial. Administration was performed at 
baseline (T1), after 14 weeks (T2) and after 28 weeks (T3) of ExT. A 3-months follow up (T4) re-
administration was also provide.  
 
Sample 
 
The convenience sample of eligible patients enrolled in the clinical trial had the following criteria 
(Table S2.b).  
 
Table S2.b – Study 2 participant inclusion and exclusion criteria 
Inclusion Exclusion 
65 years ±5 4 stage of COPD 
males Instable cardiac disease 
Stage 1 to 3 GOLD classification 
Pneumonia, pulmonary embolism, pulmonary 
vascular disease, respiratory infections 
Clinical stability for  at least  1 months Lung cancer, thoracic malignancy, malignancies 
 Bone fractures, fractures   
 
 
Participants were recruited from the Cardiovascular and Thoracic Department, Respiratory 
Division, of ULSS 20, Verona, Italy. Between the period of September and October 2011, eligible 
patients were singled out and advised about trial with an introduction mail. Contacted patients 
were invited at a first introducing meeting at the Faculty of Science Sports of the University of 
Verona. During the meeting, research’s purpose and details were provided. Also information 
about disease and ExT benefits on health, QoL and exercise capacity were given. Subscribed 
patients provided informed consent. Therefore, 38 patients (post-bronch %FEV1 = 69.28% ±21.5 
of predicted; post-bronch %FEV1/FVC =57.68% ±13.9 of predicted) were randomized in three 
different groups: Fitness Center based group (FC=13), Educational PA group (EDU=12) and 
Control group (CG=13). Randomization parameters were disease stage, according to GOLD 
classification (GOLD 2013), total recorded score motivation, assessed by EMI-2 (Markland & 
Hardy 1997) and the share of practiced PA calculated by administration of the International 
Physical Activity Questionnaire-short form (IPAQ 2005). COPD patients randomized into the FC 
group attended 3 time/wk, 90-minute of supervised COPD-specific (B.R. Celli, MacNee, et al. 
2004; C. B. Cooper 2001; C. L. Rochester 2003; O’Shea et al. 2009) APA program, delivered by 
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a qualified APA exercise practitioner, for 6 months, i.e. period between March and October 2012, 
according to ACSM position stand (Table S2.c) (M. E. Nelson et al. 2007; Jones C.J. & Rose, 
2005).  
 
Table S2.c – Characteristics of ExT in FC group 
Characteristics Description 
Rationale Based on ACSM guidelines  
Adaptation ATS/ERS guidelines and panel recommendations 
Training support High support of  APA Exercise Specialist  
Duration 28 weeks (6 months), 3 times weekly, 90 min per session  
Intervention Well rounded program: endurance, strength, flexibility, balance 
ExT prescripition Written and individually tailored PA regimens  
 
 
Subjects of the EDU group were involved in 28 weeks low progressive supervised ExT, 
characterized by 14 weeks educational PA period and subsequently 14 weeks of self-selected 
PA. During the first educational period (Monninkhof et al. 2003), COPD patients were involved in 
practice PA session, i.e. 60 min/session, of traditional fitness center activity, aerobic group class, 
walking paths and nordic walking training in order to improve their knowledge about different 
training modalities (Karapolat et al. 2012) and management of exercise-induced symptoms 
(Langer et al. 2009). In order to improve patients active-choice in selection of preferred ExT 
(Cress et al. 2006), exercise specialist support was gradually reduced during the 14 weeks, i.e. 
from 1° to 5° week, 3 time/wk, from 6° to 10° week, 2 time/wk, from 11° to 14° weeks 1 time/wk. 
Stage-matched written material and information about different type of local PA facilities were 
provide to patients in order to stress and increase ExT adherence (Table S2.d). 
 
Table S2.d – Characteristics of ExT in EDU group 
Characteristics Description 
Rationale Based on ACSM guidelines and Trans Theoretical Model  
Adaptation ATS/ERS guidelines and panel recommendations 
Training support Monthly decreasing APA Exercise Specialist support – autonomous PA  
Duration 
28 weeks; 14 weeks of APA Exercise Specialist support and 14 weeks of 
autonomous PA 
Intervention 
Traditional fitness center program, Aerobic group class, Walking paths 
and Nordic Walking 
ExT prescripition Stage-matched written material; Information about local PA facilities. 
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Patients recruited in CG were not involved in any type of treatment but only in evaluation 
sessions. During the 6 months trial, 4 patients dropped out caused by instable onset clinically 
conditions, i.e. N=3 before halfway evaluation, from FC (N=1) and CG (N=2),  N=1 between 3 and 
6 months of training from CG. At fallow up administration 3 patients from CG dropped out caused 
by lack of available time (N=2) and onset of instable clinic condition (N=1)  (Figure S2.e). 
 
 
 
Figure S2.e – Patients recruitment to the Study 2 
 
 
Measurements 
 
Anthropometric characteristics 
 
Dual energy-X ray absorptiometry scanner, i.e. DXA (QDR explorer W®, Hologic, MA, USA) was 
used to detect body composition (A. G. N. Agusti et al. 2003), i.e. FFM and LBM, and bone mass 
content, i.e. BMC. Also, BMI was calculated with formula:  
BMI= kg / (mt)2 . 
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Health related Physical Parameters 
 
6-min walking test 
The 6-min walk test was conducted according to a standardized protocol (P. L. Enright & Sherrill 
1998). Subjects were instructed to walk from one end to the other of a 30 meters, i.e. 100-ft., 
hallway at their own pace, while attempting to cover as much ground as possible in the allotted 6 
minutes. Technicians encouraged subjects with the standardized statements “You’re doing well” 
or “Keep up the good work,” but were asked not to use other phrases. Subjects were allowed to 
stop and rest during the test, but were instructed to resume walking as soon as they felt able to 
do so. Rate of perceived exertion was measured with the Borg scale, i.e. 6-20 (C. B. Cooper 
2001), and pulse rate were assessed at the start and end of the 6-min walk test. Subjects were 
also asked at the end of the walk whether they had experienced any of the following symptoms: 
dyspnea, chest pain, lightheadedness, or leg pain (C. G. Cote et al. 2008). 
 
Muscular strength 
In the study patients performed three different submaximal test, i.e. biceps strength by Biceps 
Curl test, pectoralis major, deltoids and triceps muscles by test at Chest Press isotonic device 
(Tecnogym®, Gambettola, ITA), quadriceps, gluteus maximus and gastrocnemius by test at Leg 
Press isotonic device (Tecnogym®, Gambettola, ITA), and quadriceps by test at Leg Extension 
isotonic device (Tecnogym®, Gambettola, ITA),  calculating the 1RM value by Brzycki’s furmula 
(Dohoney et al. 2002): 
 
1RM = kg / (1,0278 - (0,0278 x repetitions’ number)). 
 
 
Flexibility and Balance tests 
In order to assess flexibility related activity of subjects, the study provided two different flexibility 
test, i.e. Back Scratch Test to record shoulder range of motion, and Sit & Reach Test to analyze 
lower back’s flexibility capacity (C. J. Jones & Rikli 2002). To investigate postural steadiness 
during a static position, subject were involved in 1-Min of One Leg Stance test assessment of 
both lower arms (Figure S2.f) (Jonsson et al. 2004). Data obtained by each leg test were summed 
to calculated a total score.   
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Figure S2.f – Flexibility tests provided;  a) Back Scratch test;  b) Sit & Reach test;  c) One Leg Stance Test. 
 
 
Lifestyle Behavior 
 
Daily Physical Activity Level 
SenseWear PRO2 Armband (Bodymedia®, Pittsburgh, USA) was used in order to assess DPA 
parameters performed by subjects, such as total steps number, total energy expenditure and 
active energy expenditure above 3.0 METs. DPA was monitored for 3 days and daily mean (SD) 
were obtained. In patients with COPD, the SenseWear PRO2 Armband provides a valid and 
reproducible estimate of energy expenditure during walking at a slow to moderate pace in a 
laboratory setting (H. Watz et al. 2009). 
 
International Physical Activity Questionnaire -short form 
IPAQ short form is an instrument designed for population surveillance of PA and it has been 
developed and tested for use in adults, i.e. age range of 15-69 years. The IPAQ short form asks 
about three specific types of activity such as walking, moderate-intensity activities and vigorous-
intensity activities. The items in the short IPAQ form were structured to provide separate scores 
on walking, moderate-intensity and vigorous-intensity activity. Computation of the total score for 
the short form requires summation of the duration, i.e. in minutes, and frequency, i.e. days, of the 
three assessed activity (Table S2.g) (Delbaere et al. 2009).(Delbaere et al. 2009; IPAQ 2005) 
Data cleaning and processing were carried out according to IPAQ guidelines (2005) in order to 
estimate the levels of PA (Table S2.h) 
  
c) b) a) 
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Table S2.g – MET Values and Formula for Computation of MET-minutes/week 
Activity Formula to estimate MET-minutes/week 
Walking 3.3 * walking minutes * walking days 
Moderate activity 4.0 * moderate-intensity activity minutes * moderate days 
Vigorous activity 8.0 * vigorous-intensity activity minutes * vigorous-intensity days 
Total physical activity  
MET-minutes/week 
sum of Walking + Moderate + Vigorous MET-minutes/week scores. 
  
Table S2.h – Levels of physical activity estimated by IPAQ 
Level Formula to estimate MET-minutes/week 
Low 
who not meet criteria for Categories 2 or 3 are considered to have a ‘low’ 
physical activity level: 
Moderate 
3 or more days of vigorous-intensity activity of at least 20 minutes per day; 
5 or more days of moderate-intensity activity and/or walking of at least 30 
minutes per day; 
5 or more days of any combination of walking, moderate-intensity or vigorous 
intensity activities achieving a minimum Total physical activity of at least 600. 
High 
vigorous-intensity activity on at least 3 days achieving a minimum Total 
physical activity of at least 1500 MET-minutes/week; 
7 or more days of any combination of walking, moderate-intensity or vigorous-
intensity activities achieving a minimum Total physical activity of at least 3000 
MET-minutes/week. 
 
 
Quality of Life 
 
Maugeri Respiratore Failure questionnaire, i.e. MRF-26 (Carone et al. 1999), was used in order to 
measure and quantify impairment in QoL due to the disease. It is characterized by assessment of 
impairment in ADL, i.e. 13 items, and self-perceived disability, i.e. 13 items. A total score were 
obtained for each patients at each evaluation session to record changes in self-patients viewpoint 
about their QOL. Choice of MRF-26 administration was based on its relation to patients ADL and 
easily application. 
 
Adherence, drop out and EMI-2 administration during the longitudinal randomized trial 
 
Adherence and/or drop out motivations were collected and recorded in a database. Moreover, 
EMI-2 (Markland & Hardy 1997) administration was performed in order to assess PA motivation 
scores and provide patients randomization. 
155 
 
Statistical methods 
 
To address the purpose of this trial, statistical analysis of the data began with calculations of the 
arithmetic means and standard deviations of COPD patients and different intervention groups. 
The differences between groups were assessed using two-way analysis of variance (ANOVA). 
Then, post hoc analysis using Bonferroni correction was used to compare difference among 
testing session and groups. P values less than 0.05 was considered to indicate statistical 
significance. Statistical analysis was performed with Statistical Package for the Social Sciences 
version 16.0 (SPSS Inc., Chicago, IL). 
 
Results 
 
Baseline 
 
All the assessed characteristics of the COPD patients recruited in the trial are depicted in Table 
S2.i.  The 38 male patients with COPD (mean age 66.63y ±4.6) are affected by mild to severe 
airflow obstruction, i.e. post-bronch %FEV1 = 69.28% ±21.5 of predicted, post-bronch 
%FEV1/FVC =57.68% ±13.9 of predicted. No significant differences were found between groups. 
 
Table S2.i – Characteristics of COPD patients at baseline (t1)  
mean (SD) 
Variables 
Tot COPD 
(N=38) 
FC  
(N=13) 
EDU  
(N=12) 
CG  
(N=13) 
Age 
(years) 
66.63  
(4.6) 
66.16  
(4.26) 
66.16  
(4.34) 
67.9  
(5.76) 
FEV1 
(%) 
69.28  
(21.5) 
60.12  
(24.32) 
71.17 
(18.80) 
77.27 
 (18.99) 
FEV1/FVC 
(%) 
57.68  
(13.9) 
53.73 
(17.73) 
58.33 
(13.74) 
61.30 
(8.84) 
 
 
Effects of PA models on Anthropometric Parameters 
 
Results related to anthropometric parameters are shown in Table S2.j.   
In BMC no time x group interaction resulted from ANOVA. No difference between groups were 
observed. Post-hoc analysis highlighted significant mean factor time differences in FC, i.e. T1<T2 
(p<0.01) and T1<T3 (p<0.05). No difference appeared in EDU and CG. In %BMC no time x group 
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interaction resulted from ANOVA. No difference between groups were observed. Post-hoc 
analysis highlighted significant mean factor time differences in FC, i.e. T1<T2 (p<0.01), T1<T3 
(p<0.05), T3>T4 (p<0.05). No difference appeared in EDU and CG. In FAT no time x group 
interaction resulted from ANOVA. No difference between groups were observed. Post-hoc 
analysis highlighted no significant mean factor time differences in FC. In EDU T1>T2 (p<0.05). In 
CG T1>T2 (p<0.05). In %FAT no time x group interaction resulted from ANOVA. No difference 
between groups were observed. Post-hoc analysis highlighted no significant mean factor time 
differences in FC, EDU and CG. In LBM and %LBM no time x group interaction resulted from 
ANOVA. No difference between groups were observed. Post-hoc analysis highlighted no 
significant mean factor time differences in FC, EDU and CG. In BTM no time x group interaction 
resulted from ANOVA. No difference between groups were observed. Post-hoc analysis 
highlighted no significant mean factor time differences in FC, EDU. In CG T1>T2 (p<0.01). In BMI 
no time x group interaction resulted from ANOVA. No difference between groups were observed. 
Post-hoc analysis highlighted no significant mean factor time differences in FC. In EDU T1>T2 
(p<0.05). In CG T1>T2 (p<0.01). 
 
Effects of PA models on Health related Physical Performances 
Results related to heath related physical parameters are shown in Table S2.k. 
 
Exercise tolerance 
In 6MWD and BORG no time x group interaction resulted from ANOVA. No difference between 
groups were observed. In 6MWD post-hoc analysis highlighted no significant mean factor time 
differences in EDU and CG. In FC T3>T4 (p<0.05). In BORG Post-hoc analysis highlighted no 
significant mean factor time in FC and CG. In EDU T1>T3 (p<0.05) and T1>T4 (p<0.05). 
 
1RM Muscle strength  
In Leg Press and Leg Extension no time x group interaction resulted from ANOVA. No difference 
between groups were observed. In Leg Press, post-hoc analysis highlighted no significant mean 
factor time differences in FC and CG. In EDU T2>T4 (p<0.05). In Leg Extension post-hoc 
analysis highlighted no significant mean factor time differences in CG. In FC T2>T4 (p<0.05), 
T3>T4 (p<0.05). In EDU T1<T2 (p<0.05) and T2>T4 (0.001). In Biceps Curl no time x group 
interaction resulted from ANOVA. No difference between groups were observed. Post-hoc 
analysis highlighted no significant mean factor time differences in EDU and CG. In FC T1<T2 
(p<0.05). In Chest Press significant time x group interaction resulted (p=0.010). Post-hoc analysis 
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highlighted significant mean factor time differences in FC, i.e. T1<T2 (p<0.001), T1<T3 (p<0.01), 
T2>T4 (P<0.001), T3>T4 (P<0.001). In EDU T1<T2 (p<0.05), T1>T4 (p< 0.01), T2>T3 (0.001) 
and T2>T4 (p<0.001). In CG T1>T4 (p<0.01). 
 
Table S2.j – Changes in anthropometric parameters  in FC, EDU and CG groups 
mean (SD) 
 
BMC 
(g) 
BMC 
(%) 
FAT 
(g) 
FAT 
(%) 
LBM 
(g) 
LBM 
(%) 
TBM 
(Kg) 
BMI 
Baseline 
FC 
2180 
(413.4) 
2.8 
(0.41) 
24338 
(10548) 
29.6 
(5.1) 
53052 
(11160) 
67.4 
(4.9) 
79.5 
(21.3) 
28.4 
(6.2) 
EDU 
2596 
(488.8) 
3.09 
(0.42) 
25324 
(8178) 
29.3 
(5.0) 
56923 
(9342) 
67.5 
(4.9) 
84.8 
(16.3) 
29.7 
(4.5) 
CG 
2091 
(467.5) 
2.79 
(0.3) 
19021 
(8033) 
24.7 
(5.6) 
53964 
(9256) 
72.4 
(5.4) 
75.0 
(16.0) 
25.3 
(3.2) 
3 months  
FC 
2246 
(424.3) 
2.91 
(0.44) 
23686 
(10374) 
29.0 
(4.8) 
53255 
(12131) 
68.0 
(4.6) 
79.1 
(22.3) 
28.2 
(6.4) 
EDU 
2615 
(492.2) 
3.14 
(0.43) 
24588 
(8204) 
28.7 
(5.3) 
56775 
(8924) 
68.1 
(5.2) 
83.9 
(15.8) 
29.3 
(4.4) 
CG 
2060 
(408.5) 
2.83 
(0.27) 
17935 
(7493) 
23.9  
(4.8) 
53232 
(9859) 
73.2 
(4.5) 
73.2 
(16.5) 
24.7 
(3.4) 
6 months  
FC 
2216 
(420.5) 
2.87 
(0.4) 
23852 
(10376) 
29.3 
(5.6) 
52756 
(10900) 
67.7 
(4.8) 
78.8 
(21.0) 
28.0 
(6.0) 
EDU 
2614 
(504.1) 
3.15 
(0.4) 
24500 
(7314) 
28.9 
(4.7) 
56349 
(9189) 
67.9 
(4.6) 
83.4 
(15.5) 
29.2 
(4.3) 
CG 
2110 
(493.5) 
2.84 
(0.26) 
18376 
(7897) 
24.1 
(5.4) 
53639 
(8949) 
72.9 
(5.2) 
74.1 
(15.8) 
24.9 
(3.0) 
Follow up  
FC 
2191 
(430.1) 
2.80 
(0.4) 
24638 
(10172) 
30.0 
(4.7) 
52996 
(11532) 
67.1 
(4.5) 
79.8 
(21.3) 
28.3 
(6.0) 
EDU 
2605 
(493.3) 
3.10 
(0.39) 
25425 
(7306) 
29.6 
(4.3) 
56560 
(9534) 
67.2 
(4.3) 
84.5 
(16.0) 
29.6 
(4.4) 
CG 
2135 
(503.4) 
2.82 
(0.26) 
19051 
(7008) 
24.8 
(4.4) 
54240 
(9926) 
72.2 
(4.2) 
75.4 
(15.9) 
25.4 
(3.2) 
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Back Scratch and Sit & Reach  
In Back Scratch test significant time x group interaction resulted (p=0.011). Post-hoc analysis 
highlighted no significant mean factor time differences in FC. In EDU T1<T2 (p<0.01) and T2>T4 
(p<0.05). In CG T1>T2 (p<0.01). In Sit & Reach test no time x group interaction resulted from 
ANOVA. No difference between groups were observed. Post-hoc analysis highlighted no 
significant mean factor time differences in CG and EDU. In FC T3>T4 (p<0.01). 
 
One Leg Stance Test 
In Balance no time x group interaction resulted from ANOVA. No difference between groups were 
observed. Post-hoc analysis highlighted no significant mean factor time differences in CG and 
EDU. In FC T1<T2 (p<0.05), T1<T3 (p<0.01) and T3>T4 (p=0.052). 
 
Effects of PA models on Lifestyle Behavior and Quality of Life 
 
Results related to Lifestyle Behavior and Quality of Life are shown in Table S2.l and Table S2.m. 
 
Lifestyle Behavior 
In SenseWear PRO2 administration, Total Energy Expenditure, Active Energy Expenditure and 
Steps Number no time x group interaction resulted from ANOVA. No difference between groups 
were observed. Post-hoc analysis highlighted no significant mean factor time differences in FC, 
EDU and CG. In IPAQ short form, no time x group interaction resulted from ANOVA in vigorous 
activities. No difference between groups were observed. Post-hoc analysis highlighted no 
significant mean factor time differences in FC, EDU and CG. Moreover, no time x group 
interaction resulted from ANOVA in moderate activities. No difference between groups were 
observed. Post-hoc analysis highlighted no significant mean factor time differences in EDU and 
CG. In FC T1<T2 (p<0.01), T1<T3 (p<0.01). Also, no time x group interaction resulted from 
ANOVA in walking activity. No difference between groups were observed. Post-hoc analysis 
highlighted no significant mean factor time differences in FC and CG. In EDU T1<T3 (p<0.05). 
Furthermore, no time x group interaction resulted from ANOVA in total MET-min/week. No 
difference between groups were observed. Post-hoc analysis highlighted no significant mean 
factor time differences in FC, EDU and CG. Finally, no time x group interaction resulted from 
ANOVA in total sitting hours per day. No difference between groups were observed. Post-hoc 
analysis highlighted significant mean factor time differences in FC, i.e. T1>T2 (P<0.001) and 
T1>T3 (p<0.01). In EDU T1>T2 (p<0.001) and T1>T4 (p>0.01). In CG T1>T2 (p<0.05). 
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Table S2.k – Changes in Health related Physical Parameters  in FC, EDU and CG groups  
mean (SD) 
 
6MWD 
(mt) 
Borg 
(6-20) 
Leg 
Press 
(Kg) 
Leg  
Ext 
(Kg) 
Biceps  
Curl 
(Kg) 
Chest 
Press 
(Kg) 
Back 
Scratch 
(cm) 
Sit & 
Reach 
(cm) 
Balance 
(sec) 
Baseline 
FC 
463 
(117) 
12.0 
(2.0) 
168 
(48) 
55 
(17) 
9.8 
(3.1) 
40 
(9) 
-7.4 
(19.0) 
-11.1 
(12.4) 
52 
(47) 
EDU 
591 
(72) 
12.7 
(0.9) 
206 
(76) 
64 
(21) 
11.3 
(1.9) 
67 
(15) 
-8.6 
(15.3) 
-13.5 
(13.8) 
72 
(47) 
CG 
549 
(91) 
12.0 
(1.2) 
199 
(60) 
71 
(21) 
12.6 
(1.2) 
49 
(8) 
2.2 
(4.5) 
-7.7 
(10.5) 
69 
(20) 
3 months 
FC 
455 
(145) 
12.0 
(2.3) 
179 
(69) 
60 
(21) 
11.8 
(3.3) 
48 
(8) 
-5.9 
(17.6) 
-7.9 
(13.5) 
101 
(38) 
EDU 
571 
(53) 
11.9 
(1.0) 
216 
(56) 
71 
(19) 
13.1 
(3.0) 
63 
(11) 
-5.9 
(14.9) 
-7.4 
(14.4) 
94 
(30) 
CG 
571 
(95) 
13.0 
(1.0) 
176 
(40) 
70 
(25) 
11.8 
(2.4) 
50 
(10) 
-2.0 
(4.9) 
-8.2 
(10.8) 
76 
(53) 
6 months 
FC 
495 
(127) 
12.2 
(1.8) 
203 
(77) 
62 
(18) 
11.9 
(2.7) 
50 
(9) 
-3.8 
(16.0) 
-4.5 
(10.7) 
109 
(22) 
EDU 
540 
(48) 
11.3 
(2.1) 
198 
(64) 
65 
(20) 
12.8 
(2.9) 
54 
(13) 
-8.0 
(15.7) 
-10.7 
(14.6) 
104 
(33) 
CG 
547 
(101) 
11.2 
(1.0) 
161 
(46) 
63 
(25) 
11.8 
(3.0) 
41 
(13) 
-2.0 
(4.0) 
-11.7 
(13.2) 
89 
(48) 
Follow up 
FC 
447 
(125) 
12.3 
(1.9) 
165 
(55) 
53 
(18) 
9.8 
(4.3) 
38 
(7) 
-5.9 
(18.6) 
-8.3 
(11.8) 
88 
(36) 
EDU 
506 
(65) 
11.3 
(1.9) 
184 
(55) 
60 
(17) 
12.2 
(2.4) 
49 
(9) 
-10.2 
(16.0) 
-11.6 
(12.7) 
89 
(36) 
CG 
543 
(101) 
12.8 
(0.8) 
160 
(29) 
64 
(28) 
11.9 
(2.8) 
38 
(9) 
-3.4 
(6.0) 
-10.2 
(10.4) 
86 
(53) 
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Quality of Life 
In MRF-26 no time x group interaction resulted from ANOVA. No difference between groups were 
observed. Post-hoc analysis highlighted no significant mean factor time differences CG. In FC 
T1>T3 (p<0.05) and T2>T3 (p<0.05). In EDU T1>T3 (p<0.05) and T1>T4 (p<0.05). 
 
Table S2.l – Changes in Lifestyle Behavior  in FC, EDU and CG groups (SenseWear PRO2) 
mean (SD) 
 N° steps 
Tot Energy 
Expenditure 
(j) 
Active Energy 
Expenditure  
(j) 
Baseline  
FC 5548 (3293.7) 8970 (1221.8) 1281 (892.7) 
EDU 5524 (3156.3) 11226 (1570.3) 1832 (1522.1) 
CG 6972 (86.97) 13150 (2189.2) 3580 (3771.7) 
3 months   
FC 5501 (2840.6) 9223 (1961.8) 1388 (945.9) 
EDU 6536 (3095.6) 10824 (2232.7) 2306 (2023.8) 
CG 11118 (881.8) 13815 (1711.2) 3411 (587.6) 
6 months   
FC 6046 (2775.4) 92.87 (1589.25) 1404 (644.35) 
EDU 8110 (2724.3) 12082 (2059.9) 2421 (2070.8) 
CG 10476 (1867.5) 13990 (15552.8) 4268 (2875.1) 
Follow up  
FC 6184 (3612) 9029 (1468.82) 1371 (840.8) 
EDU 5032 (2694) 10597 (1294.1) 1280 (1001.4) 
CG 8914 (3544) 11361 (647.7) 1399 (7.1) 
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Table S2.m –Changes in Lifestyle Behavior  (IPAQ-short form) and Quality of Life (MRF-26)  in FC, EDU and 
CG groups  
mean (SD) 
 IPAQ – short form MRF-26 
 
Vigorous 
(MET-
min/week) 
Moderate 
(MET-
min/week) 
Walking 
(MET-
min/week) 
Tot  
(MET-
min/week) 
Sedentary 
(hours) 
Disability  
(pt) 
Baseline 
FC 
720 
(2113) 
236  
(497) 
580  
(512) 
1409 
(2314) 
10.6  
(2.4) 
7.2  
(3.8) 
EDU 
523 
(1061) 
720 
(1544) 
330  
(357) 
2929 
(5229) 
8.4  
(2.4) 
5.3  
(2.1) 
CG 
2040 
(3192) 
750 
(1020) 
932 
(1231) 
334 
(2619) 
7.2  
(1.2) 
5.8  
(6.1) 
3 months 
FC 
720 
(2276) 
1608 
(1055) 
897 
(1452) 
3039 
(2815) 
7.3  
(2.7) 
6.6  
(4.4) 
EDU 
1440 
(3133) 
1338 
(1722) 
943  
(780) 
3959 
(4813) 
5.2  
(2.1) 
4.6  
(3.5) 
CG 
2200 
(3136) 
40  
(80) 
643  
(678) 
2832 
(2928) 
3.8  
(0.6) 
3.9  
(4.6) 
6 months 
FC 
640 
(1197) 
1260 
(543) 
892  
(782) 
2649 
(1506) 
7.3 
(2.2) 
4.5  
(4.5) 
EDU 
290  
(707) 
763 
(1497) 
948 
(906) 
1835 
(1687) 
5.2  
(2.0) 
3.1  
(2.7) 
CG 
0  
(0) 
1150 
(1544) 
317  
(238) 
1178 
(1621) 
3.8  
(0.6) 
5.7  
(7.4) 
Follow up 
FC 
0  
(0) 
534 
(1322) 
932 
(1224) 
1333 
(2418) 
8.3  
(4.7) 
6.2  
(4.3) 
EDU 
130 
(310) 
894 
(1436) 
1161 
(1205) 
3032 
(3563) 
5.2  
(2.7) 
2.2  
(2.1) 
CG 
0 
(0) 
720 
(1440) 
2343 
(1779) 
2807 
(2452) 
6.0  
(3.1) 
2.9  
(3.2) 
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Adherence and drop out  
During the trial, 4 patients dropped out caused by instable onset clinically conditions, i.e. N=3 
before halfway evaluation, from FC (N=1) and CG (N=2),  N=1 between 3 and 6 months of 
training from CG. At fallow up administration 3 patients from CG dropped out caused by lack of 
available time (N=2) and onset of instable clinic condition (N=1). FC adherence at ExT was 
~87%, whereas in EDU group was 100% at first 3 months. At the end of the 6 months only 2 
patients fill out the PA diary, 3 patients deliver the diary partially completed and 6 COPD patients 
didn’t deliver, preventing to obtain any significant information.   
 
Discussion 
 
In order to determine the effectiveness of our-designed field models of COPD-specific APA 
training, a differential analysis of each parameter assessed in each exercise groups seems 
appropriate. 
It was observed several nutritional and body composition abnormalities in patients with COPD 
(Bolton et al. 2004; A. G. N. Agusti et al. 2003; Steuten et al. 2006). Weight loss  and reduction in 
BMI and a loss of FFM are considered independent poor prognostic indicators for survival (A. G. 
N. Agusti et al. 2003; Steuten et al. 2006; GOLD 2013), leading to increased morbidity, worsen 
QoL, reduced exercise performance and an higher mortality (Bolton et al. 2004). However, loss of 
FFM is considered the most important prognostic parameters (A. G. N. Agusti et al. 2003; Bolton 
et al. 2004). In our study we did not find overall significant changes in COPD patients body 
composition both at short and long-term ExT, probably related to several confounding 
mechanisms, i.e. drugs intake, systemic inflammation, and/or tissue hypoxia (A. G. N. Agusti et 
al. 2003). Moreover, body composition abnormalities were particularly prevalent in patients with 
severe to very severe COPD and chronic respiratory failure, i.e. ~50% of COPD patients in Stage 
III and IV (A. G. N. Agusti et al. 2003; Bolton et al. 2004; Steuten et al. 2006; Lainscak et al. 
2011). In our study, very severe COPD patients were excluded and recruited only few (N=5) 
patients whit severe airflow obstruction. However, the significant modification about loss of FAT 
(g) and BMI reduction in EDU and CG groups were recorded only between the trial’s first 3 
months, i.e. between March and July 2012. We prompt a seasonal influence which affect these 
parameters and may lead into worsen QoL and survival rates in under- and normal weight 
patients (Franssen et al. 2008; Blum et al. 2011). Osteoskeletal dysfunctions were observed in 
patients with COPD (Bolton et al. 2004; A. G. N. Agusti et al. 2003). Osteoporosis is associated 
with poor health status and prognosis (GOLD 2013) and related to multiple causes, i.e. 
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malnutrition, sedentary behavior, smoking, steroid treatment, systemic inflammation and ageing 
(A. G. N. Agusti et al. 2003; GOLD 2013). In our study we found significant modifications in bone 
mass content only in FC group, recorded between T1-T2, i.e. ΔBMC(g) = 65.6 ±17  p<0.01, 
ΔBMC(%) = 0.112 ±0.029 p=0.001, between T1-T3, i.e. ΔBMC(g) = 35.8 ±10.6  p<0.05, 
ΔBMC(%) = 0.071 ±0.024 p<0.05, and between T3-T4, i.e. ΔBMC(%) =  -0.069 ±0.020 p<0.01. 
At the time of administration, none of FC patients were subjected to osteoporosis pharmacologic 
therapy, suggesting that a supervised COPD-specific APA program could influence favorably the 
bone health (Kohrt et al. 2004). Although endurance training is considered the fundamentally 
important component of any PR program (C. B. Cooper 2001;Ries 2008; Ries et al. 2007), at the 
end of our 6 months trial we did not observed an overall improvement in exercise tolerance 
assessed by 6MWT. A differential analysis of motivations for both exercise groups seems 
appropriate. Aerobic prescription in FC group was based on expert panel recommendations (C. 
B. Cooper 2001; C. L. Rochester 2003; Butcher & R. L. Jones 2006), i.e. aerobic interval training 
using large muscle groups of the legs, as treadmill and cycle ergometry, accumulation of 30 min 
of aerobic exercise on at least 3 d/wk, no use of maximum heart rate but regular use of RPE 
scale (range 6–20) to monitor exercise intensity. Progression of activities and intensity adjustment 
tailored to tolerance and preference were regularly provided (W. J. Chodzko-Zajko et al. 2009; 
Cress et al. 2006; Langer et al. 2009). No changes in FC exercise tolerance may be related to 
low level of DPA, suggesting that specific-COPD supervised APA training should be coupled with 
increased practice of autonomous PA (Pitta, Troosters, et al. 2008; Nici et al. 2006; Ferreira et al. 
2009; Lacasse et al. 2006; Ries et al. 2007). Similar observation could be carried out regarding 
EDU group, in which patients were involved in a educational program (Monninkhof et al. 2003; 
Cress et al. 2006), designed to improve knowledge about training modalities (Karapolat et al. 
2012) and exercise management (Langer et al. 2009), and to acquire an active behavior (Langer 
et al. 2009). In our study any modification in EDU group 6MWT performance was observed. 
Unsupervised training seems to lack transfer achievements in aerobic exercise capacity, 
improving only long-term RPE, i.e. between T1-T3 (ΔRPE (pt) = 1.36 ±0.41  p<0.05) and 
between T1-T4 (ΔRPE (pt) = 1.36 ±0.41  p<0.05). Therefore, as suggesting before, the best 
presumable intervention in COPD patients’ exercise tolerance seems to be the coalescence of 
both supervised and unsupervised training in order to accumulate at least 30 min of aerobic 
exercise, most of days in a week (W. J. Chodzko-Zajko et al. 2009; C. B. Cooper 2001). 
Significant reduction between T1-T4, i.e. Δ6MWD(mt) = -48.2 ±14.8  p<0.05)  observed in 6MWD 
of FC patients support our assumes. Most of recent researches suggested that sedentary lifestyle 
is unlikely to be the only explanation for COPD myopathy, which results in reduced muscle 
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strength performances of COPD patients (M. P. Engelen et al. 2000; Couillard & Prefaut 2005; 
Kim et al. 2008). COPD muscle wasting is usually characterized by several metabolic, 
morphological and/or structural muscle abnormalities that lead to dysfunction (Couillard & Prefaut 
2005). Moreover, COPD muscle strength alterations are not homogenous between various 
muscle groups, with prevalence in lower limbs (Mador & Bozkanat 2001; Kim et al. 2008). In fact, 
in our study we observed differences in ExT trends’ response between muscular groups 
assessed. The most responsivness muscular group to strenght-specific ExT is those of trunk, 
which was tested by 1RM Chest Press Test. Significant improvements in Chest Press 
performance were observed both ExT groups when involved in supervised training, i.e. FC 
between T1-T2, Δ1RM(kg) = 8.1 ±1.7  p=0.001, between T1-T3, Δ1RM(kg) = 9.8 ±2.4  p<0.01, 
and EDU between T1-T2, Δ1RM(kg) = 6.1 ±1.7  p<0.05. In case of interruption or reduction in 
supervision, Chest Press test performances decreased in both ExT groups, i.e. FC between T3-
T4, Δ1RM(kg) = -11.6 ±2.1  p=0.000,  between T2-T4, Δ1RM(kg) = -9.9 ±1.2  p=0.000, and EDU 
between T2-T3, Δ1RM(kg) = -9.6 ±2.0  p=0.001 and between T2-T4, Δ1RM(kg) = -14.3 ±1.3  
p=0.000. These observation are confirmed by CG and EDU groups recorded trend, i.e. CG 
between T1-T4, Δ1RM(kg) = -10.9 ±2.6  p<0.01, and EDU between T1-T4, Δ1RM(kg) = -8.2 ±1.9  
p<0.01. Different response was observed in lower limb strength performances. Significant 
improvements were recorded only in EDU patients at Leg Extension test, i.e. T1-T2, Δ1RM(kg) = 
7.2 ±2.4  p<0.05. However, in case of interruption or reduction in strength-specific ExT, 1RM of 
lower limb decreased in both ExT groups, i.e. FC between T2-T4, Δ Leg Extension (kg) = -6.8 
±2.1  p<0.05,  between T3-T4, Δ Leg Extension (kg) = -9.3 ±2.8  p<0.05, and EDU between T2-
T4, Δ Leg Extension (kg) = 10.5 ±1.9  p=0.000 and Δ Leg Press (kg) = -32.6 ±9.1  p<0.05.  We 
assume that no long-term modification provided by the lower limb strength training in ExT groups 
confirmed the unfavorable impact of muscle wasting on muscle performances (Kim et al. 2008) 
suggesting that traditional strength ExT is not enough effective to attack COPD lower limb 
strength impairment. Both interruption, reduction and lack of APA expert’s supervision affect 
negatively flexibility performances of COPD patients, i.e. FC between T3-T4, Δ Sit & Reach (cm) 
= -3.8 ±0.9  p<0.01,  EDU between T2-T4, Δ Back Scratch (cm) = -4.3 ±1.3  p<0.05, and GC 
between T1-T2, Δ Back Scratch (cm) = -4.2 ±1.1  p<0.01. Despite decrements observed in joint 
ROM with age and established links among poor flexibility, mobility, and physical independence 
(W. J. Chodzko-Zajko et al. 2009), surprisingly, to our knowledge there are no studies about the 
effects of specific ROM exercises on flexibility outcomes and its impact in QoL of COPD 
population. Modification into static position’s postural steadiness observed in FC group over the 
time, i.e. T1-T2, Δ1LST(sec) = 48.5 ±14.2  p<0.05 and T1-T3, Δ1LST(sec) = 57.0 ±13.3  p<0.01, 
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confirmed the effectiveness of “well rounded program” in improving balance in adults and elderly 
people (M. E. Nelson et al. 2007). Moreover, this result acquire more importance in PR 
considering that balance is a complex skill, i.e. integration and coordination of musculoskeletal 
and neural systems, and its deficit prevalence is increasingly recognized in COPD (Beauchamp 
et al. 2011). Both short- and long term impact in lifestyle of each ExT models were investigated 
by questionnaire administration, i.e. IPAQ, and by multisensor armband setting, i.e. SenseWear 
PRO-2. In IPAQ assessment, FC significantly improves MET-min/week in moderate activity, i.e. 
between T1-T2, Δ moderate (MET-min/week)= 1372 ±375  p<0.01 and between T1-T3, Δ 
moderate (MET-min/week) = 1024 ±272  p<0.01. Also EDU group shows significant changes only 
in walking activity between T1-T3, Δ walking (MET-min/week) = 618 ±208  p<0.05. These 
observation was confirmed by reported changes in sedentary time spent, i.e. FC between T1-T2 
and T1-T3, Δ sedentary (hr) = -3.3 ±0.7  p<0.01, and EDU between T1-T2, Δ sedentary (hr) = -
3.6 ±0.6  p=0.000, between T1-T3, Δ sedentary (hr) = -3.6 ±0.7  p=0.000 and between T1-T4, Δ 
sedentary (hr) = -3.5 ±0.9  p<0.01. Despite this positive results, modifications in daily energy 
expenditure and steps number (SenseWear PRO-2) were not recorded. Moreover total MET-
min/week by IPAQ didn’t show any modification. Therefore, we did not find objective data that 
support notion of an acquired COPD patients active behavior after participation at the ExT trial. 
Significant changes in IPAQ evaluation are probably due to an overestimation provided by 
patients about their self-perceived DPA. In fact, despite these questionnaire has been developed 
and tested for use in adults, i.e. age range of 15-69 years (Delbaere et al. 2009; IPAQ 2005), 
further investigations with large number of patients are aimed to verify effectiveness 
characterization of vigorous and moderate IPAQ items related to COPD breathe effort. Finally our 
study observed a significant short- and long term reduction of patients’ self-perceived disability 
after ExT, i.e. FC between T1-T3 Δ MRF-26 (pt) = -2.3 ±0.7  p<0.05, and between T2-T3, Δ 
MRF-26 (pt) = -2.5 ±0.7  p<0.05, and EDU between T1-T3, Δ MRF-26 (pt) = -2.1 ±0.7  p<0.05. 
This results confirmed previous reported importance of ExT (GOLD 2013; Egan et al. 2012; D. E. 
O’Donnell et al. 2008) and the effectiveness of our easily applied-field models of APA in 
increasing QoL of COPD patients.  
 
Conclusion 
 
The aim of the study was to evaluate modifications in several HRQL of patients affected by mild 
to severe airflow obstruction, in order to verify the effectiveness of two different and easily 
applied-field models of COPD-specific APA training. It is well known that COPD is a complex and 
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multi-component disease, in which its impact on patients’ daily life, health, and wellbeing is not 
heterogeneous (P. W. Jones 2001). According to expert panel position stand (Glaab et al. 2010), 
our study’s results confirms the need of a multifaceted approach in PR programs, suggesting that 
standardized designs of ExT programs do not appeared to be adequately effective in enhancing 
the overall of specific-HRQL outcomes. However, considered that COPD affects lungs, extra-
pulmonary organs, such as peripheral muscles and bone composition, and the interaction 
between patients and environment, our study demonstrates that also an easily applied-field 
models of COPD specific APA training could be efficient in order to improve some of these 
HRQL. The improvements in bone mass content, strength of trunk muscles and patients’ self-
perceived disability seem to be better provide by the “well rounded” APA program, i.e. FC, and 
may be resulting in enhanced bone health, increased in accessory respiratory function (Dourado 
et al. 2009) and better QoL. Improvements in patients’ QoL after a PR are necessary to evaluate 
the treatment in terms of effectiveness (P. W. Jones & R. M. Kaplan 2003; Domingo-Salvany et 
al. 2002). Moreover, our study shows that APA exercise specialist support is necessary to provide 
and maintain long-term significant health’s gains. Our results confirm previous studies finding 
about less effectiveness of education, verbal advice and guidance about exercise as compared to 
supervised ExT program (C. L. Rochester 2003), suggesting that APA exercise specialist should 
be considered as a resource, especially in aftercare programs. Finally, as observed by Breyer 
(2010), Pitta (2008) and Lacasse (2006) our trial highlights that improvement in functional 
exercise capacity does not automatically turn into a more active lifestyle. According to Conn 
(2008), furthers studies are aimed to identify feasible, acceptable and effective APA intervention, 
which transfer achievements provide reachable changes in lifestyle, both at short- and long-term.  
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Background 
Presence of muscle wasting is common in Chronic Obstructive Pulmonary Disease (COPD) 
patients across all disease stages (Seymour et al. 2010) which leads to a reduction in skeletal 
muscle strength of lower limb (Kim et al. 2008; Donaldson et al. 2012). Surprisingly it has been 
observed that eccentric contraction results greater compared to healthy control subjects when 
normalized for lean body mass (Mathur et al. 2007).  
 
Purpose 
The aim of this study is to outline a description of COPD strength performances as a function of 
contraction modalities and velocities. 
 
Design 
A case/control, crossover, observational trial was designed. 
 
Subjects  
Thirty-five COPD males (mean FEV1=64.76±20.08% of predicted; FEV1/FVC= 57.35±13.56% of 
predicted; age 67.21±4.7 years) and 25 HC males (FEV1= 115.06±17.43% of predicted; 
FEV1/FVC=101.87±6.62% of predicted; age 65.15±5.69 years) were involved. Ethical approval by 
Department of Neurological, Neuropsychological, Morphological and Movement Sciences, 
University of Verona, and informed consent by patients were obtained. 
 
Measures 
Subjects performed an isokinetic knee extensors concentric and eccentric peak torque at 30 and 
210 deg/s. Moreover, vastus lateralis muscle architecture, 6MWT and 1RM Leg Press were 
performed. One way ANOVA and Pearson coefficient were used to detect significant differences 
between groups and correlation between dependent and independent variables.  
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Results 
As expected HC subjects was significantly better in lung function parameters, i.e. FEV1 (p<0.001) 
and FEV1/FVC (p<0.001), and in exercise capacity, such as 6MWT performances (p<0.001) and 
1RM Leg Press (p<0.05). Of all contractions performed, only concentric 30deg/s peak torque was 
significantly higher in healthy control subjects compared to COPD patients (p<0.05). In this study, 
differences in muscle architecture, fast concentric and/or eccentric peak torque were no observed 
between groups. However, significant differences were found between groups in 
eccentric/concentric peak torque ratio (30 deg/sec p<0.001; 210 deg/sec p<0.01). Finally, 
significant correlations were found between FEV1 and 6MWT (0.719 p<0.001), 1RM Leg Press 
(0.449 p<0.001), peak torque contraction at 30 deg/sec (0.427 p<0.01; 0.280 p<0.05), at 210 
deg/sec (0.285 p<0.05; 0.276 p<0.05) and eccentric/concentric peak torque ratio at both velocities 
(-0.562 p<0.001; -0.292 p<0.05). Same results were observed between FEV1/FVC and parameters 
assessed. 
 
Conclusion 
In conclusion COPD patients showed lower health related parameters and performed lower 
concentric contraction compared to healthy controls. Interestingly, COPD preserved eccentric 
contractions and fast concentric torque. Considered that eccentric contraction seems to involve fast 
twitch motor units (Duchateau & Enoka 2008) and COPD hypoxia leads fiber shift towards IIx fibers 
(H.R. Gosker, Van Mameren, et al. 2002), COPD males seem to develop a favorable profile to 
minimize the strength loss likely due to neural-muscular modification. 
 
 
Key words: COPD; Lung function; Muscle dysfunction; Strength performance; Concentric peak 
torque; Eccentric peak torque; Isokinetic device 
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Background 
 
Patients affected by COPD suffer from irreversible and mostly progressive airflow limitation 
caused by inflammation of the airways, lung parenchyma and pulmonary vasculature as a 
reaction to noxious gases such as cigarette smoke (B.R. Celli, MacNee, et al. 2004). In advanced 
stages, COPD is characterized by dyspnea, cough and excessive mucus production. These 
characteristics reduce the level of DPA of people affected by COPD and consequently have a 
great impact on their exercise capacity and QoL (P. W. Jones 1995; Nici et al. 2006; Van der Vlist 
& Janssen 2010). Despite an initial skepticism, several randomized-controlled trials and meta-
analyses (Nici et al. 2006; Ries et al. 2007; Ries 2008) have supported notion that exercise 
training is a main component of a comprehensive pulmonary rehabilitation, becoming the 
cornerstone in the management of COPD (I. M. Weisman et al. 2003; Nici et al. 2006; W.D-C 
Man et al. 2009a). In addition to pulmonary manifestations, patients affected by COPD develop a 
great number of extrapulmonary manifestations, such as organ-specific dysfunction, nutritional 
abnormalities, weight loss and skeletal muscle wasting (A. G. N. Agusti et al. 2003; Barnes & 
B.R. Celli 2009; Huertas & Palange 2011). In fact several studies demonstrated that the main 
exercise limiting factor in COPD is related to leg fatigue and not, as expected, to dyspnea.Such 
outcome suggests that skeletal muscle function is also a fundamental factor in COPD patients 
exercise capacity (Van der Vlist & Janssen 2010). Moreover, these findings hinder more 
importance when related to notions that leg muscle mass and strength have been shown to better 
predict mortality, morbidity, health status and quality of life in COPD patients than lung function 
measures (Couillard & Prefaut 2005; W.D-C Man et al. 2009b; Butcher et al. 2012). Therefore, in 
the last decades, a considerable number of research focused their interests to better understand 
the characteristics and the mechanisms of COPD patients skeletal muscle wasting (Bernard et al. 
1998; H.R. Gosker et al. 2000; H.R. Gosker, van Mameren, et al. 2002; Couillard & Prefaut 2005; 
Kim et al. 2008; W.D-C Man et al. 2009a; W.D-C Man et al. 2009b; Barreiro & Sieck 2013), and, 
furthermore, to describe their implications into strength performances, ExT and pulmonary PR 
(Mathur et al. 2007; W.D-C Man et al. 2009a; Butcher et al. 2012). Despite the evidence of 
clinical benefits due to ExT, the different mechanisms leading to changes in skeletal muscle are 
not yet fully understood (Barreiro & Sieck 2013). Moreover, a considerable debate continues with 
regards to the relative merits of additional strength training over traditional endurance training 
adopted during PR (M.A. Spruit et al. 2002; W.D-C Man et al. 2009a). Finally, the majority of 
research has focused on examining leg muscle function in patients with COPD has used either 
isometric or concentric quadriceps torque as correlates or outcome measures (Butcher et al. 
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2012). Recent trials suggest that peak eccentric torque of quadriceps is better correlate with 
functional tasks, than concentric one (Roig et al. 2008; Roig, Eng, D. L. Macintyre, D. Road, et al. 
2010). To assess the eccentric contractions or fast-velocity contractions in healthy older adults 
and with disabilities an isokinetic device may be more useful as methods of assessing functional 
performance (Gur et al. 2002).  
 
Purpose 
 
Considered the lack of knowledge about the association between eccentric muscle strength and 
fast-velocity muscle contractions in COPD patients (Mathur et al. 2007; Butcher et al. 2012), this 
study would to investigate COPD patients strength performances as a function of contraction 
modalities and velocities 
 
Methods 
 
Design 
 
This study is a case/control, crossover, observational trial. It was designed to assess differences 
between HC group and COPD patients in lifestyle, health related physical parameters, vastus 
lateralis muscle architecture and concentric/eccentric peak torque of quadriceps muscle. 
Assessment of parameters were obtained in two different testing sessions, i.e. one to recorded 
lung function parameters, architectural measurements and health related physical parameters, 
and a second evaluation to perform concentric/eccentric contraction at the isokinetic device, in 
randomized order. . The data were obtained during the periods between September and 
November 2012, in which were singled out, contacted and recruited the healthy control subjects 
and tested both the subjects’ groups.One familiarization session was provided for both subjects’ 
groups using the isokinetic dynamometer. Moreover, the DPA parameters were obtained by 
SenseWear PRO2 Armband (Bodymedia®, Pittsburgh, USA). Ethical approval by Department of 
Neurological, Neuropsychological, Morphological and Movement Sciences, University of Verona, 
Medical Hospital Management approval of ULSS20, and informed consent by participant were 
obtained (Figure S3.a). 
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Sample 
In the study 60 male subjects were recruited, i.e. 35 COPD patients and 25 HC subjects. The 
convenience sample of COPD patients enrolled in the trial had the following criteria: age 65 
years±5, affected by mild to severe COPD and clinically stable for at least 1 months no diseases 
that would interfere with exercise, such as no evidences of instable cardiac diseases, no 
malignancies and bone fractures (Table S3.b). Participants were recruited from the 
Cardiovascular and Thoracic Department, Respiratory Division, of ULSS 20, Verona, Italy. 
 
 
 
Figure S3.a – Study 3 procedures. 
 
Table S3.b – Study 1 COPD patients inclusion and exclusion criteria 
Inclusion Exclusion 
65 years ±5 4 stage of COPD 
males Instable cardiac disease 
Stage 1 to 3 GOLD classification 
Pneumonia, pulmonary embolism, pulmonary vascular 
disease, respiratory infections 
Clinical stability for  at least  1 months Lung cancer, thoracic malignancy, malignancies 
 Bone fractures, fractures   
 
The sample of HC subjects enrolled in the trial had the following criteria: age 65 years±5, without 
cardiovascular, metabolic and pulmonary disease, clinically stable for at least 1 months, no 
diseases that would interfere with exercise, such as no evidences of malignancies and bone 
fractures (Table S3.c). Participants were recruited between the participants at the local initiative 
“La Salute nel Movimento”, supervised by the Faculty of Exercise and Sports of the University of 
Verona, which involve adults and elderly people in different specific PA programs. 
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Table S3.c – Study 3  HC subject  inclusion and exclusion criteria 
Inclusion Exclusion 
65 years ±5 Pulmonary diseases 
males 
Pneumonia, pulmonary embolism, pulmonary vascular 
disease, respiratory infections 
clinical stability for  at least  1 months Instable cardiac disease 
 Metabolic disease 
 Lung cancer, thoracic malignancy, malignancies 
 Bone fractures, fractures   
 
As a result of this screening process, 60 subjects were recruited and involved in assessments, 
i.e. 35 COPD patients (FEV1=64.76±20.08% of predicted; FEV1/FVC= 57.35±13.56% of 
predicted; age 67.21±4.7 years) and 25 HC subjects (FEV1= 115.06±17.43% of predicted; 
FEV1/FVC=101.87±6.62% of predicted; age 65.15±5.69 years). 
 
Measurements 
 
Pulmonary Function Test 
 
FEV1 and FVC were measured according to the methods of the ATS/ERS Task Force (M.R. 
Miller, R. Crapo, et al. 2005; M.R. Miller, Hankinson, et al. 2005; Wanger et al. 2005; Pellegrino et 
al. 2005) using a pulmonary function instrument with computer processing (Quark, Cosmed, 
Italy). The predicted value of FEV1 and FEV1/FVC were calculated according to American 
Thoracic Society/European Respiratory Society (1999). 
 
Daily Physical Activity Level 
 
SenseWear PRO2 Armband (Bodymedia®, Pittsburgh, USA) was used in order to assess DPA 
parameters performed by subjects, such as total steps number, total energy expenditure and 
active energy expenditure above 3.0 METs. DPA was monitored for 3 days and daily mean (SD) 
were obtained.  In patients with COPD, the SenseWear PRO2 Armband provides a valid and 
reproducible estimate of energy expenditure during walking at a slow to moderate pace in a 
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laboratory setting and a high correlation between steps per day and movement counts as 
measured by a different accelerometer (H. Watz et al. 2009) 
 
Health related Physical Parameters 
 
6-min walking distance test 
The 6-min walk test was conducted according to a standardized protocol (P. L. Enright & Sherrill 
1998). Subjects were instructed to walk from one end to the other of a 30 meters, i.e. 100-ft., 
hallway at their own pace, while attempting to cover as much ground as possible in the allotted 6 
minutes. Technicians encouraged subjects with the standardized statements “You’re doing well” 
or “Keep up the good work,” but were asked not to use other phrases. Subjects were allowed to 
stop and rest during the test, but were instructed to resume walking as soon as they felt able to 
do so. Rate of perceived exertion was measured with the Borg scale, i.e. 6-20 (C. B. Cooper 
2001), and pulse rate were assessed at the start and end of the 6-min walk test. Subjects were 
also asked at the end of the walk whether they had experienced any of the following symptoms: 
dyspnea, chest pain, lightheadedness, or leg pain (C. G. Cote et al. 2008). 
 
Muscular strength 
In the study patients performed three different submaximal test, i.e. biceps strength by Biceps 
Curl test, pectoralis major, deltoids and triceps muscles by test at Chest Press isotonic device 
(Tecnogym®, Gambettola, ITA), quadriceps, gluteus maximus and gastrocnemius by test at Leg 
Press isotonic device (Tecnogym®, Gambettola, ITA), and quadriceps by test at Leg Extension 
isotonic device (Tecnogym®, Gambettola, ITA),  calculating the 1RM value by Brzycki’s furmula 
(Dohoney et al. 2002): 
 
1RM = kg / (1,0278 - (0,0278 x repetitions’ number)). 
 
Flexibility and Balance tests 
In order to assess flexibility related activity of subjects, the study provided two different flexibility 
test, i.e. Back Scratch Test to record shoulder range of motion, and Sit & Reach Test to analyze 
lower body’s flexibility capacity (C. J. Jones & Rikli 2002). To investigate postural steadiness 
during a static position, subject were involved in 1-Min of One Leg Stance test assessment of 
both lower arms (Tinetti M.E. 1986; Jonsson et al. 2004)(Figure S3.d).  
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Figure S3.d – Flexibility tests provided;  a) Back Scratch test;  b) Sit & Reach test;  c) One Leg Stance Test. 
 
 
Architectural Muscle Measurements 
 
Architectural muscle characteristics, i.e. Fascicle Length, Fascicle Thickness and Angle 
Pennation,  were provided by the images’ analysis recorded at ultrasound scanner (ACUSON 
P50 SIEMENS, Germany) at 39% distal of vastus lateralis muscle (Blazevich A.J. 2006). Two 
images were obtained for each subjects and by Image J. Ink software (…), fascicle thickness and 
pennation angle were directly measured. Fascicle length was assessed by Guilhem’s formula 
(2011) (Figure S3.e):  
Lf1=d5 6 
d2 6
sin 1
 
d4 5
sin 1
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S3.e –a) Muscle site to record with ultrasound scanner;  b) References Guilhem’s muscles analysis; 
 
(from Blazevich A.J. 2006 and Guilhem & Cornu 2011) 
 
 
  
a) b) c) 
a) b) 
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Isokinetic Dynamometer Strength Evaluation 
 
To assess subjects’ strength performances of extensor muscles of lower limbs as a function of 
contraction modalities and velocities, we performed an isokinetic dynamometer (Cybex Norm, 
Ronkonkoma, USA) protocol in order to record concentric and eccentric contraction of the 
quadriceps dominant limb at both 30deg/s and 210 deg/s (Mathur et al. 2005). After a warm up 
session, subjects performed 3 maximal repetitions of each contractions at both angular velocities. 
For each subjects it was recorded the maximum score provided in each of the four contractions 
assessed.  
 
Statistical methods 
 
To address the purpose of this trial, statistical analysis of the data began with calculations of the 
arithmetic means and standard deviations of COPD and HC groups in each test. The differences 
between groups were assessed using one-way analysis of variance (ANOVA). Pearson 
coefficient was used to detect correlation between dependent and independent variables. P 
values less than 0.05 was considered to indicate statistical significance. Statistical analysis was 
performed with Statistical Package for the Social Sciences version 16.0 (SPSS Inc., Chicago, IL). 
 
Results 
 
Pulmonary Function Test 
 
The characteristics of the COPD patients and HC group are depicted in Table S3.f. The 35 
patients with COPD presented mild to severe airflow obstruction, i.e. FEV1 64,76% ±20,08 post-
bronch. predicted, FEV1/FVC 57,35% ±13,56 post-bronch. predicted. The 25 HC subjects shown 
absence of any pulmonary disease, i.e. FEV1 115.06% ±17.43 predicted, FEV1/FVC 101.87% 
±6.62 predicted. Significant differences (p < 0.001) were found between groups, both in %FEV1 
and %FEV1/FVC. 
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Table S3.f – Pulmonary function parameters in COPD group and HC group  
mean (SD) 
Variables COPD group HC group p 
Age 67.21 (4.7) 65.15 (5.68) N.S. 
%FEV1 64.76 (20.08) 57.35 (13.56) 0.000 
%FEV1/FVC 115.06 (17.43) 101.87 (6.62) 0.000 
 
 
Daily Physical Activity Level 
 
The characteristics of the COPD patients and HC group are depicted in Table S3.g. Lower 
significant value of DPA at each variables recorded, i.e. steps number (p < 0.001), total energy 
expenditure (p < 0.01) and active energy expenditure among 3.0 METs (p < 0.01) than HC group 
were found. 
 
Table S3.g – Daily physical activity level in COPD group and HC group  
mean (SD) 
Variables COPD group HC group p 
steps number 6023 (2950) 10592 (5686) 0.000 
tot energy expenditure 
(j) 
10103 (1827) 11367 (1429) 0.006 
active energy 
expenditure (j) 
1723 (1731) 3077 (1889) 0.006 
 
 
Health related Physical Activity Parameters 
 
The characteristics of the COPD patients and HC group are depicted in Table S3.h. COPD 
patients shown significant lower performances in each variables assessed, i.e. 6MWT distance (p 
< 0.001), 1RM Leg Press (p < 0.05), 1RM Biceps Curl (p < 0.001), 1RM Chest Press (p = 0.001), 
Back Scratch test (p < 0.05), Sit & Reach test (p < 0.05) and total score at One Leg Stance test (p 
< 0.01) than HC group. 
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Table S3.h – Health related physical activity parameters in COPD group and HC group  
mean (SD) 
Variables COPD group HC group p 
6MWD  
(mt) 
474 (107)  668 (69)  0.000  
1RM Leg press  
(kg) 
183 (59)  215 (37)  0.019  
1RM Biceps curl  
(kg) 
10.3 (2.3)  12.6 (1.9)  0.000  
1RM Chest press  
(kg) 
44 (12)  55 (11)  0.001  
Back Scratch test  
(cm) 
- 6.7 (15)  0.7 (7.2)  0.024  
Sit & Reach test 
(cm) 
- 9.8 (12.9)  - 3.9 (7.9)  0.048  
Tot One stance leg test 
(sec) 
57 (46)  103 (30)  0.000  
 
 
Architectural Muscle Measurements 
 
The characteristics of the COPD patients and HC group are depicted in Table S3.i. No significant 
differences were found between groups in each variables assessed, i.e. Fascicle Length, Fascicle 
Thickness and Angle Pennation. 
 
Table S3.i – Architectural muscle measurements in COPD group and HC group  
mean (SD) 
Variables COPD group HC group p 
Fascicle length  
(mm)  
126 (16)  128 (17)  N.S.  
Fascicle Thickness (mm)  20,1 (3,8)  20,3 (3,0)  N.S.  
Penn. Angle  
(°)  
8,5 (2,6)  8,6 (2,7)  N.S.  
 
Isokinetic Dynamometer Strength Evaluation 
The characteristics of the COPD patients and HC group are depicted in Table S3.j. Only 
concentric peak torque at 30 deg/s resulted greater in HC group (p<0.05) than COPD group, 
instead concentric contraction at 210 deg/s and eccentric contraction at both angular velocities, 
i.e. 30 and 210 deg/s, didn’t show any differences. Nonetheless, eccentric/concentric peak torque 
ratio was significantly greater in COPD at 30 deg/s (p<0.001) and at 210 deg/s (p<0.05) than HC 
group. 
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Table S3.j – Isokinetics dynamometer strength evaluation in COPD group and HC group  
mean (SD) 
Variables COPD group HC group p 
Conc 30°/s  
(N/m) 
158 (47)  181 (27)  0.038  
Conc 210 °/s  
(N/m)  
90 (24)  99 (16)  N.S.  
Ecc 30°/s 
(N/m)  
209 (57)  219 (41)  N.S.  
Ecc 210 °/s  
(N/m)  
189 (46)  203 (36)  N.S.  
Ecc /conc 30°/s  1.43 (0.15)  1.21 (0.16)  0.000  
Ecc /conc 210°/s  2.27 (0.25)  2.06 (0.32)  0.008  
 
 
Correlation between Pulmonary Function Parameters and Performances assessed 
 
Pulmonary Function and Daily Physical Activity Level 
Correlation between Pulmonary function parameters and DPA variable recorded are depicted in 
Table S3.k. Direct significant correlation were found between %FEV1 and of DPA at each 
variables recorded, i.e. steps number (p < 0.001), total energy expenditure (p < 0.01) and active 
energy expenditure among 3.0 METs (p < 0.05). Same results were observed between 
%FEV1/FVC and DPA variables, i.e. steps number (p < 0.001), total energy expenditure (p <0.01) 
and active energy expenditure among 3.0 METs (p < 0.05). 
 
Table S3.k – Correlation between %FEV1, %FV1/FVC and Daily physical activity level  
R;  * p < 0.05;  ** p < 0.01;  *** p < 0.001 
Variables %FEV1 %FEV1/FVC 
steps number 0.472***  0,452***  
tot energy expenditure  0.406**  0,411**  
active energy expenditure  0.329*  0,289*  
 
 
Pulmonary Function and Health related Physical Parameters 
Correlation between Pulmonary function parameters and Health related physical parameters 
recorded are depicted in Table S3.l. Direct significant correlation were found at the analysis 
between %FEV1 and variables assessed, i.e. 6MWT distance (p < 0.001), 1RM Leg Press 
(p<0.001), 1RM Biceps Curl (p < 0.001), 1RM Chest Press (p > 0.01). Same results were 
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observed between %FEV1/FVC and variables, i.e. 6MWT distance (p < 0.001), 1RM Leg Press (p 
< 0.01), 1RM Biceps Curl (p < 0.001), 1RM Chest Press (p > 0.01). 
 
Table S3.l – Correlation between %FEV1, %FV1/FVC and Health related physical parameters 
R;  * p < 0.05;  ** p < 0.01;  *** p < 0.001 
Variables %FEV1 %FEV1/FVC 
6MWD  
(mt) 
0.719 ***  0,735 ***  
1RM Leg press  
(kg) 
0.446***  0,423**  
1RM Biceps curl  
(kg) 
0.451***  0,512*** 
1RM Chest press  
(kg) 
0.384**  0,411**  
 
 
Pulmonary Function and Isokinetic Dynamometer Strength Performances 
Correlation between Pulmonary function parameters and Isokinetic dynamometer strength 
performances are depicted in Table S3.m. Direct significant correlation were found at the analysis 
between %FEV1 and variables assessed, i.e. concentric contraction at 30deg/s (p < 0.01), 
concentric contraction at 210 deg/s (p<0.05), eccentric contraction at 30 deg/s (p < 0.05), 
eccentric contraction at 210 deg/s (p < 0.05). Same results were observed between %FEV1/FVC 
and variables, i.e. concentric contraction at 30deg/s (p < 0.001), concentric contraction at 210 
deg/s (p<0.05), eccentric contraction at 30 deg/s (p < 0.05), eccentric contraction at 210 deg/s (p 
< 0.05). Moreover, results shown that eccentric/concentric peak torque ratio was inversely 
correlated with FEV1 (p < 0.001) and FEV1/FVC (p < 0.001). Same results were observed 
between eccentric/concentric peak torque ratio and pulmonary function parameters, i.e. FEV1 (p < 
0.05) and FEV1/FVC (p < 0.01). 
 
Discussion 
 
As expected, HC subject showed a normal morphology of flow-volume curve and no-evidences of  
airflow limitation were observed. The analysis of DPA levels confirmed that COPD patients are 
markedly inactive, showing a more sedentary behavior than HC group (Schonhofer et al. 1997; 
Pitta et al. 2005; Hernandes et al. 2009; Walker et al. 2008; Troosters et al. 2010; Gouzi et al. 
2011; Vorrink et al. 2011).  
 
 
180 
 
Table S3.m – Correlation between %FEV1, %FV1/FVC and Isokinetic Dynamometer Strength performences 
R;  * p < 0.05;  ** p < 0.01;  *** p < 0.001 
Variables %FEV1 %FEV1/FVC 
Conc 30°/s  
(N/m)  
0.427 **  0.443 ***  
Conc 210 °/s  
(N/m)  
0.285 *  0.332 * 
Ecc 30°/s 
(N/m)  
0.280 *  0.263 *  
Ecc 210 °/s  
(N/m)  
0.276 *  0.297 *  
Ecc /conc 30°/s  
- 0.562 ***  - 0.615 ***  
Ecc /conc 210°/s  
- 0.292 *  - 0.371 **  
 
Moreover, the significant lower levels of health related parameters’ performance of COPD 
patients are in line with results of several previous studies (Steiner & M. D.  L. Morgan 2001; 
Butcher & R. L. Jones 2006; Kim et al. 2008; W.D-C Man et al. 2009a), confirming a COPD 
patients reduction in functional fitness. Surprisingly, the analysis of strength performances at the 
Isokinetic dynamometer confirmed not entirely Mathur's findings (2007). In fact, in our study we 
observe only a significant lower strength performance in COPD patients when they are involved 
in a slow-concentric contraction of lower limbs, whereas Mathur and colleagues (2007) observed 
significant lower performances of COPD patients in both absolute knee extensor concentric and 
eccentric torque at 30 deg/sec than the HC. These differences between our and Mathur’s study 
could be due to the COPD number and stage disease of the sample recruited, i.e. 35 mild to 
severe vs. 20 moderate to severe COPD patients. Finally, in our study, the COPD patients’ 
eccentric/concentric peak torque ratio at both slow and fast velocities resulted significantly higher 
than HC, suggesting that HC concentric and eccentric contraction of the knee extensors express 
similar torque value, whereas COPD patients maintain a normal range only in the eccentric 
contraction at both velocities. In terms of correlation, our study’s results confirm airflow 
obstruction as a key factor leading in reduction of moderate PA and DPA (Steele et al. 2003), 
which values are the most outcome in terms of HRQL (Jehn et al. 2012) and better predictors of 
physical function (Pitta et al. 2005). Moreover, our findings are in line with previous studies’ 
observations, which highlighted an early reduction of DPA before the disease and symptoms 
onset (Gouzi et al. 2011; Vorrink et al. 2011). Also, we confirm that health related physical 
parameters, such as exercise tolerance and strength performance, are negative influenced by 
pulmonary obstructive disease (Bernard et al. 1998; Serres et al. 1998; Mador & Bozkanat 2001; 
Kim et al. 2008; C. G. Cote et al. 2008; W.D-C Man et al. 2009b). Furthermore, the analysis of 
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correlation between concentric/eccentric contraction at both velocities and pulmonary function 
showed an influence of airflow obstruction into muscular peak torques, resulting in enhancement 
of eccentric/concentric peak torque ratio as a function of increased disease severity. These 
results are according to previous studies which considered eccentric strength as a strong 
contributor of functional performance in patients with COPD (Butcher et al. 2012). Finally, no 
evidences of different muscle architecture between groups lead us to assume that low strength 
performances recorded in COPD patients are not due to neural-muscular modifications. In 
literature it was observed COPD patients’ chronic moderate-to-severe hypoxemia and/or 
repeated episodes of hypoxemia due to exercise-induced desaturation or sleep apnoea (Couillard 
& Prefaut 2005; Kim et al. 2008). These observations, couplet to evidence of a change in 
proportion of slow twitch fibers in favor of fast ones (Couillard & Prefaut 2005; Kim et al. 2008), 
led to hypothesize that COPD hypoxemic condition may be a determining factor in this 
mechanism shift (H.R. Gosker, Van Mameren, et al. 2002). Furthermore, Enoka (1996) and 
Duchateau (2008) observed that eccentric contraction seems to be characterized by a unique 
neural mechanisms involving fast twitch motor units. Therefore, considered these evidences, we 
assume that COPD patients develop a favorable contraction profile, performing an eccentric 
torque, in order to minimize strength loss related to low ratio of type I fibers. 
 
Conclusion 
 
In conclusion, COPD patients showed lower health related parameters and performed lower 
concentric contraction compared to healthy controls. Interestingly, COPD preserved eccentric 
contractions and fast concentric torque. Considered that eccentric contraction seems to involve 
fast twitch motor units (Duchateau & Enoka 2008) and COPD hypoxia leads fiber shift towards IIx 
fibers (H.R. Gosker, Van Mameren, et al. 2002), COPD males seem to develop a favorable profile 
to minimize the strength loss likely due to neural-muscular modification. Further investigations 
would be aimed to assess neural contribution in contraction performances of COPD patients 
(Komi et al. 1987). Whereas  6MWD less than 350mt (Cote 2008) was estimated to predict 
increased risk of mortality. Muscle strength was considered a poor predictor of functional 
impairment (Pitta et al. 2005) . Current knowledge about muscle wasting (W.D-C Man et al. 
2009b) and recent researches about COPD eccentric contraction  (Butcher et al. 2012) lead us to 
consider to use eccentric/concentric peak torque ratio as a clinic threshold of impairment . Finally, 
considered the preservation of eccentric contraction in COPD patients provided by our study, the 
effectiveness of lengthening training in strength increments and the lower cardio-respiratory 
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response in eccentric exercise than concentric (Roig et al. 2008), further investigations are aimed 
to verify strength improvement, reduction of muscle wasting and increment on QoL provided by 
eccentric training in comparison with traditional exercise.  
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